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Abstract 
Although drug molecules are designed to bind specifically to targets such as receptors 
that are embedded within biological membranes, it is becoming increasingly evident 
that a large fraction of these compounds interact non-specifically with the membrane 
and / or other proteins. In particular, the non-specific binding of positron emission 
tomography (PET) radioligands to tissue, both in-vivo and in-vitro, is poorly 
understood. This phenomenon is a major confounding factor in the development of 
new radioligands for receptor imaging in-vivo. 
To address this issue, studies on the interaction of central nervous system (CNS) 
drugs, belonging to the cationic amphiphilic drug (CAD) family, with model 
membrane assemblies were conducted. 
Experiments were performed using three CADs: Haloperidol (HPD), Spiperone 
(SPIP) and WAY, on condensed fluid lamellar phases and membrane vesicles. CAD-
membranes interactions were studied by small angle X-ray scattering (SAXS), solid-
state nuclear magnetic resonance (SS-NMR), fluorescence assays, and fluorescence 
microscopy. 
CADs were found to partition rapidly to the polar / apolar region of the membrane; 
this was demonstrated by SAXS where CADs affected the bilayer spacing. At 
physiological pH, the protonated groups on the CAD catalyze the acid-hydrolysis of 
the ester linkage present in the phospholipid chains, producing a fatty acid and single-
chain lipid. The single-chain lipids destabilize the membrane, causing membranous 
fragments and small vesicles to separate and diffuse away from the host. These 
membrane fragments carry the drug molecules with them. The entire process, from 
drug adsorption to drug release within micellar fragments, occurs on a timescale of 
seconds / minutes. Given the rate at which this occurs it is probable that this process is 
a significant mechanism for drug transport. 
Kinetic studies were conducted to determine the rate of the lipid hydrolysis in the 
condensed fluid lamellar phase, by varying CAD's counterions, the lipid composition 
and the stored curvature elastic stress in the bilayer. The lipid hydrolysis kinetics was 
fitted to a pseudo-first order exponential decay, and hydrolysis rates were determined. 
Hydrolysis rates are specific to the CAD molecules, with WAY hydrolysing the 
bilayer as twice as fast as SPIP. In addition, evidence is presented that the stored 
curvature elastic stress in the membrane modulates the hydrolysis kinetics. 
Interestingly, the rate of membrane hydrolysis appears to correlate with in-vivo non-
specific binding of the PET radioligands. The measured rate of membrane hydrolysis 
may provide useful insight into the mechanism of non-specific binding on a molecular 
level and possibly in the design of new radiotracers. 
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CHAPTER 1 
Introduction 
Each year thousands of chemical compounds designated to be potential central 
nervous system (CNS) drugs are synthesized and tested in an effort to find one that 
can achieve a desirable result. From this large number of drug candidates, more than 
70% fail when entering clinical drug development [1]. Numerous causes can be 
responsible for this, one of them being the poor correlation between in-vitro and in-
vivo measurements, which mainly arises from the non-specific binding signal of the 
tested drug compounds in-vivo. In this matter, the tested drug is trapped at any 
location other than its specific target, one of them being the plasma membrane. This 
phenomenon highlights the lack of data on drug interactions with membranes since 
drug discovery research mainly focuses on drug / ligand interactions with specific 
targets in the form of ligand / membrane receptor complexes; it is generally assumed 
that the lipid environment only plays a passive role. The non-specific binding of drugs 
in-vivo implies that the interactions between ligands and membrane embedded 
receptors may be more complex than those described by the traditional ligand / 
receptor model, and that the plasma membrane characteristics are to be considered in 
a higher extent. To overcome this issue, screening methods that encompass 
pharmacological and physicochemical properties of the tested drug and its binding 
environment need to be developed to predict and map the non-specific binding in-
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vivo. In this respect, the focus of this thesis is on the effect of CNS drugs upon 
phospholipids present in membranes. 
This section will first give an introduction to non-specific binding in relation to the 
physicochemical properties of CNS drugs, in particular the cationic amphiphilic drugs 
(CAD), followed by a description of the biophysical characteristics of phopholipid 
membranes. Then, an overview of CAD-membrane interactions and their relevance 
in-vivo will be presented. 
LI Non-specific binding and physicochemical 
properties of drugs: Relevance to Positron 
Emission Tomography 
1.1.1 Definition and characterization of Non-Specific Binding 
(NSB) 
Drug molecules are designed to bind specifically to their target which typically 
consists of membrane embedded receptors or enzymes. When the drug molecule 
reaches its target it may also bind to sites other than its specific site. Other binding 
sites (which can include binding to cell membranes [2], and other receptors or sites 
distinct from the active site) will be referred to as non-specific sites. 
Specific binding is characterized by a saturation profile, i.e. the specific sites are all 
filled by the substrate, whereas the NSB is non-saturable. NSB can be determined 
experimentally by radioactivity measurements, using a saturating concentration of a 
drug, which is chemically different from the radioligand to be tested but is specific for 
the same receptor [3]. To determine the non-specific binding component for a 
particular compound, radioligand binding studies need to be performed in order to 
record two measurements. 
(a) The amount of bound radioactivity for a specific displacer for a specific protein (in 
a protein-rich tissue). This measurement will record the total amount of bound 
radioactivity which will be due to specific labelling of the protein of interest, plus the 
labeling of non-specific sites (as defined above). 
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(b) The second set of measurements will be recorded in exactly the same manner as in 
(a) except they will be recorded in the presence of a saturating concentration of a 
chemically dissimilar unlabelled compound highly selective for the specific binding 
site on the protein. Therefore this measurement will only record the amount of bound 
radioactivity associated with the non-specific sites. The specific binding (SB) 
component is the difference between the total amount of bound radioactivity (T) and 
the non-specific amount of bound radioactivity (NSB). (Figure LI) [3]. 
Non-Specifically bound 
radioactive ligand Specific receptor 
Specifically bound ligand 
Figure 1.1: Cartoon representing the determination of specific binding of a given compound, 
(a) A radioactive ligand is added to tlie tissue and bind to specific and non-specific sites. The 
radioactivity corresponds to the total binding (T). (b) The radioactive ligand is added to the tissue in 
the presence of a more selective compound that is not radioactive. The radioactivity measured 
corresponds to the non-specific binding (NSB) sites only. The specific binding is calculated by 
substracting the NSB to the total binding. 
Figure 1.2 represents the signal obtained for a saturation analysis with the linear NSB 
trace and the resulting hyperbolic specific binding curve. The saturation curve allows 
the determination of the drug's dissociation constant Kj, that is the concentration of 
drug which, at equilibrium, occupies 50% of the receptors. 
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[radioactive ligand] 
Figure I. 2: A saturation diagram for the binding of a 
radioligand. The graph is constructed from the total binding 
values (T), and the non-specific binding values are calculated 
from the presence of the unlabelled compound. The specific 
binding (SB) signal is obtained from subtracting the N S B 
values to the T values. 
The non-specific binding phenomenon apphes to many systems, from DNA binding 
to nuclear receptors [4], to protein-protein interactions, protein binding to cell 
cytoplasm, drug-protein interactions [5, 6] and ligand-membrane interactions [7]. 
NSB is a major confounding factor in the development of new molecules, and its 
molecular origin is poorly understood. However, a huge effort and a wide variety of 
experimental techniques are undertaken to unravel its origins and minimize its effect. 
1.1.2 NSB as measured by Positron Emission Tomography 
(PET) 
1.1.2.1 Description of PET 
Positron Emission Tomography (PET) is an analytical molecular medical imaging 
technique that has the ability to localize the distribution of specific proteins in target 
organs / tissues in-vivo [8-10]. PET is used to examine the molecular basis of 
biological functions of receptors and cells [11] and is a distinctive technology in the 
comparison to that of traditional imaging techniques such as bone X-rays and 
molecular resonance imaging (MRI) which primarily assesses morphology and 
flmction of general structures [12]. In PET, proteins are labeled with specific 
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radiotracers over time; this imphes the development of PET radioligands designated 
to bind specifically to their targets. 
1.1.2.2 Physics of PET 
The binding of the radiotracer to the proteins is detected using a PET camera with the 
target organ / tissue placed in the field of view. This technique requires the utilization 
of radiolabeled agents emitting positrons as a molecular probe. PET can measure the 
concentration and movement of a positron emitting isotope in living tissue. '^F and 
'^C are common radioisotopes used in PET studies. These radioisotopes have very 
short-half lives (20 minutes for and 109 minutes for '^F) and subsequently more 
than one scan may be performed in a subject per day. A dose of radiolabeled 
compound is injected into a subject, followed by scanning the individual using a 
tomographic system. During the radiotracer decay process, the radionuclide emits a 
positron which, travels a distance of 2-3 mm before it encounters an electron from the 
surrounding environment. The two particles combine and annihilate each other 
resulting in the emission in opposite directions of two gamma rays of 511 keV each. 
These two gamma rays are then detected by an array of detectors surrounding the 
subject in the PET camera. Quantification of the regional concentration and the 
distribution of the injected radiopharmaceutical over time in organs such as the brain 
can subsequently be determined from the acquired datasets. Data are reconstructed as 
slices of few a millimeters in thickness to allow clinical read out (Figure 1.3). 
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Injection of a radiolabeled 
ligand emitting positron 
electron 
Coincidence electronics 
Processing unit 
Image reconstruction Detector rings 
m 
positron ^ 1 / 
nucleus 
Final PET scan 
Figure I. 3: Principles of PET. A radiolabeled ligand is injected and spreads throughout the body via 
the bloodstream. A positron is emitted from the labeled nucleus ('^F or " C ) travels a short distance and 
annihilates with an electron. The collision energy is converted into two y rays of 51 IkeV traveling at 
180° to each other, which are detected by the scanner. The data are then processed and tomographic 
images reconstructed accordingly. 
PET is able to aid in the investigation of molecular mechanisms of human disease and 
facilitate the development of new drugs [13]. At a molecular level, PET allows the 
evaluation of binding properties in-vivo (see section 1.1.2.3). Several radiotracers 
have been developed for imaging specific molecular targets such as the brain 
dopamine system. The neurotransmitter systems, which have been the most 
extensively studied, are the serotoninergic and the dopaminergic systems [14, 15]. 
However, there are few appropriate selective radiotracers available for use in humans 
with a known ability to cross the blood brain barrier (BBB) and gain entry into the 
brain. 
1.1.2.3 The degree of NSB as determined by PET 
Accurate determination of neuroreceptor binding properties in the brain requires 
fitting to a mathematical model. A widely used approach is the three compartment 
models, in which the ligand concentration is assumed to be homogeneous [16]. The 
ligand concentration exchanges between compartments (each represents a 
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physiological space). This model takes into account the free hgand concentration in 
the plasma and the hgand concentration that is specifically and non-specifically bound 
in the tissue (Figure 1.4). 
Plasma 
K, 
C . i ^ < C2 
• 
< C 3 
k. k. 
Free 
Non-Specific 
Specific 
Figure I. 4: Configuration of the three compartment model 
for neuroreceptor analysis used in PET studies. Cg is the 
concentration of the ligand in the plasma (arterial 
compartment), C2 is the concentration of the free and non-
specifically bound ligand, and C3 is the concentration of the 
specifically bound ligand. K, , k2,k3 and are the rate 
constants for the transfer between each compartments [15]. 
PET allows the quantification of the binding potential (BP) which is the ratio of the 
bound radiotracer / radioligand concentration (B) over the free ligand concentration 
(F). According to the law of mass action, BP is generally given by dividing the total 
number of binding sites Bmax by the equilibrium dissociation constant (Kd) of the 
radiolabelled compound (Equation I . l) 
B 
K, F 
Equation I. 1 
Compartments are characterized by distribution volumes Vi, which is defined as the 
ratio of the ligand concentration in the compartment i to the free arterial concentration 
at equilibrium Ca (equation 1.2) 
C. 
Equation I. 2 
where f\ is the plasma free fraction of the compound. Hence this equation is 
applicable to C2 and C3 (equation 1.3) where: 
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Vj = and F3 = 
' / , c , / c . 
and the total volume Kj-is defined as (equation 1.4): 
Equation I. 3 
Equation I. 4 
Equation I.l states that BP is equal to the ratio of bound concentration to free 
concentration of ligand. As the bound concentration is C3, the free concentration is 
not C2 but 72C2, with 72 being the free fraction in the non-specific compartment. This 
leads to equation 1.5, where 
a: , f .AC", 
Equation I. 5 
At equilibrium the concentration of the free ligand in the plasma equals to the 
concentration of the free ligand in the tissue, i.e. the brain (equation 1.6): 
Therefore, a new expression for BP can be written (equation 1.7): 
Equation I. 6 
c . 
a , f 
= K 
Equation I. 7 
/ / is considered as being constant across experiments [17], hence BP is defined as BP' 
(equation 1.8) : 
BP' = = ^ = V' 
K„ F C„ 
Similarly, V2 can be rearranged to (equation 1.9): 
_ Cz _ 1 
Equation I. 8 
A Q A 
Equation I. 9 
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This leads to a third expression of BP (equation 1.10): 
I _ ^2 ^ max _ •^ max _ f Z^ max _ ^3 _ y 
Equation I. 10 
This quantity obtained from equation 1.10 is used to quantify the degree of non-
specific binding. 
C2 is assumed to be constant in all brain regions [17]; therefore C2 can be determined 
from reference regions devoid of specific receptors. Thus BP" can be obtained from 
the difference between the total concentration CT= C2 + C3 from the region of interest 
containing the receptor and the reference region. 
Therefore BP" can also be represented by the specific (SB) to non-specific coefficient 
(NSB) (equation I.l 1); 
3 2 
Equation I. 11 
A high BP" value is expected for compounds with low non-specific binding. 
An ideal brain penetrant radiotracer can be chosen according to many criteria. The 
radiotracer should be easy to label and pass toxicological profiling. Its metabolism 
should not produce radiolabelled metabolites or pharmacologically active unlabelled 
metabolites, which are centrally penetrant. The selectivity and the affinity for the 
target protein should be high, along with a high target protein density in order to 
detect a useful quantifiable signal using PET. Additionally, it should cross the blood 
brain barrier (BBB), thus implying an appropriate lipophilicity (log P 1.5-4.0), and 
exhibit a high BP" value i.e. a low degree of non-specific binding [18]. 
Figure 1.5 illustrates PET images for two radiotracers specific for the Dz-dopamine 
receptor, raclopride and remoxipride. A baseline is made by injecting " C remoxipride 
(figure 1.5a) and raclopride (figure 1.5b). This step shows the binding of the 
molecule to the proteins of interest, here the Dz-dopamine receptor in the striatum, 
plus the labeling of non-specific sites. Then a pretreatment is made by injecting 
remoxipride, which has a lower affinity to the receptor (Ki=200nM). Remoxipride 
exhibits little specificity to the D2-dopamine receptor, and also binds to different 
regions of the brain. 
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10094 
Remoxipride 
Ki=200 nM 
striatum 
Raclopride 
Ki=1.3 nM 
Baseline Preatreatment 
with remoxipride 
Figure I. 5: PET images for radiotracers exhibiting high specific binding (raclopride 
system) and high non-specific binding (remoxipride system). Both molecules are specific to 
the Dz-dopamine receptor, but raclopride exhibits higher specific binding (Courtesy of 
Pr.A.D.Gee). 
PET is a very useful tool for the investigation of the NSB in-vivo\ however it gives no 
information of the origin and the molecular basis of the NSB of drugs. 
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1.1.3 Molecular basis of NSB and lipophilicity 
Lipophilicity is a critical parameter for the permeation of the BBB by central nervous 
system (CNS) drugs [19]. Crossing the BBB is complex as it is formed by brain 
capillary endothelial cells that form tight junctions which separate the brain from the 
blood periphery (Figure 1.6). 
Nerve cells 
Tight junctions 
Brain vessel 
Endothelial cells 
Blood cell 
Brain capillary Endothelium 
Tight junctions 
Figure I. 6: (a) longitudinal view (b) transversal view of 
the BBB. Brain endothelial cells are joined by tight 
junctions that form a highly impermeable barrier. 
The BBB exists within 400 miles of capillaries that course through the brain [20] and 
limits to a certain extent the delivery of drugs to the CNS by it high impermeability. 
In addition, the presence of specific metabolizing enzymes and efflux pumps located 
within the endothelial cells rejects exogenous molecules out of the brain. Drug 
molecules can traverse the BBB by passive diffusion; this requires an appropriate 
lipophilicity (See section below). Molecules can also undergo active transport across 
the BBB [21]. At a molecular level, the BBB consists of a lipid bilayer [22]. 
Investigation of lipid composition from in-vitro BBB systems involving endothelial 
cell lines has been undertaken. The BBB lipid composition consists of 
glycosphingolipids, glysosylceramides, sphingomyelins, and phosphatidylcholine 
lipids [23-25]. The lipid composition in these cells lines is inhomogeneous from one 
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cell line to the other, nevertheless, it has also been established that 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) lipids are present in 
varying ratios, and that a relatively high fraction of long polyunsaturated fatty acids is 
present [26, 27]. 
1.1.3.1 Lipophilicity measurements 
Lipophilicity as defined by the International Union of Pure and Applied Chemistry 
(lUPAC) is the affinity of a compound towards a lipophilic environment. Parameters 
such as the molecular weight, size, and hydrogen bonding capacity are involved in its 
characterization. Several methods such as experimental and computational methods 
exist to measure a drug's lipophilicity. Reviews on computational methods can be 
found in references [28-30] 
One of the most popular experimental methods is the liquid-liquid partitioning 
between two solutions, referred to the shake-flask method. Lipophilicity is measured 
as the partition coefficient of the compound between a highly polar solvent such as 
water and buffer and a highly non-polar solvent such as octanol, heptane, or hexane 
[31]. Once the partitioning has occurred, the unbound fraction is measured by 
analytical or / and spectroscopic techniques. The log of the compound concentration 
in octanol and water / buffer (log P oct / water) is given as the measure of lipophilicity. 
Highly lipophilic molecules exhibit a log P oct / water value higher than 6 [32]. This 
method was first used in 1900 to establish a linear relationship between narcotic 
activity and an oil-water partition coefficient [33], it has been concluded that some 
biological activities were observed within a certain range of lipophilicity. 
Log Poet / water is the most frequently exploited property in structure activity 
relationship (SAR). Its use has led to a huge log P oct / water data base available for 
pharmaceutical compounds [32]. The use of log P oct/water is also assumed to mimic 
the partition coefficient of compounds within biological membranes, in particular it is 
thought to be a model for crossing the BBB [34]. Nevertheless, log P oct / water refers to 
the partitioning of only neutral species and does not take into account any charged 
groups on the drug molecule nor its hydrogen bonding capacity which leads to an 
enormous discrepancy between the partitioning of drugs between octanol and water, 
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and partitioning in biological membranes. Octanol fails to mimic biological 
membrane features [35] (see section 1.2), such as their ionic interactions. Membranes 
are proton acceptors as a result of the polar and negative charged surface of the 
phospholipids with varying headgroups. These features are of importance in 
characterizing the membrane environment. However correlation measurements 
between log P oct / water and partition coefficients using lipid membranes in the forms of 
vesicles showed contradictory results ranging from poor correlations [36, 37] to more 
accurate correlations [38]. 
1.1.3.2 Prediction of the NSB for CNS drugs 
Drug lipophilicity has been extensively studied and analyzed to probe the NSB 
phenomenon related to crossing the BBB. As said above, relationships have been 
established between drug's physicochemical properties and SAR, i.e. CNS chemical 
properties and the BBB crossing. In this regard, the Lipinski rule of five has been 
developed [39] to probe successful ligands. This rule of thumb describes successful 
brain penetration by taking into account various parameters such as the molecular 
weight, log Poet / water, and the hydrogen bonding capacitiy of the CNS drug. Successful 
CNS drugs are characterized by; a molecular weight smaller than 500 g.mol"', a log 
Poet/water Smaller than 5, and less than 5 H-bond donors (expressed as the sum of OHs 
and NHs). Diffusion across the BBB is dependent on these factors. 
Although a linear correlation exists between passive diffusion across the BBB and 
lipophilicity of CNS compounds in-vitro [40]; a highly lipophilic compound can also 
increase the non-specific binding in-vivo. This is observed by a parabolic feature 
(Figure 1.7) [41]. Figure 1.7 represents the correlation between Log P for spiperone 
(SPIP), a successful ligand used in many PET studies, and SPIP based molecules. A 
significant increase of the brain uptake is seen in N-methyl-SPIP, whereas increasing 
the alkylation considerably reduces the brain uptake. This is not unexpected since 
increasing SPIP molecular weight by alkylation increases the lipophilicity, and 
therefore the NSB [41]. 
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Figure I. 7: correlation of Log P values and rate brain uptake 
for spiperone and N-alkyl spiperone derivatives. Figure 
adapted from reference [41]. 
The lipophilicity has a major impact on the CNS PET radioligands. This quantity is 
constantly measured when a new compound is designed and synthesized and usually 
lies in the range of 1.5-3 for useful radioligands. However, lipophilicity alone is not a 
sufficient parameter to guarantee brain entry with a high degree of specific binding. A 
more systematic study of small molecule physicochemical properties and their 
interaction with biological membranes may provide a valuable insight into the poorly 
understood phenomenon of non-specific binding. 
1.1.4 Application to Cationic Amphiphilic Drugs (CAD) 
CNS drugs represent the fastest growing therapeutic field in pharmaceutical research. 
It appears that these molecules share common structural features as they contain a 
hydrophilic moiety consisting of one or more primary substituted nitrogen, and a 
hydrophobic moiety that consists of an aromatic or aliphatic ring, potentially 
substituted by a halide moiety. These molecules are also protonated at physiological 
pH on the nitrogen (pka~7-9) [42-44]. Therefore, CNS drugs belong to the Cationic 
Amphiphilic Drug (CAD) family. Examples of CADs acting as successful CNS drugs 
are given in figure 1.8. 
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Figure I. 8: Examples of CADs of the CNS drug family, (a) Haloperidol 
(b) Spiperone (c) Raclorpide (d) Chlorpormazine (e) WAY (f) Flumazenil 
All drugs listed in figure 1.8 are specific to neurorecptors such as Dz-dopamine 
receptors, benzodiazepine receptors, and 5-HT2 serotonin receptors and all exhibit 
different good specific binding ratios in-vivo, implying that they have crossed the 
BBB readily, with log P values being within the right range to give a specific signal. 
Physicochemical characteristics of these molecules are given in table 1.1. 
CAD L o g P Oct / water pKa MW (g.mol"') 
WAY 3.1 8.6 422.64 
Flumazenil 1.1 7.9 303.29 
Spiperone 1.7 8.3 395.47 
Raclopride 1.2 347J2 
Haloperidol 2.2 8.7 3 7 5 j # 
Chlorpromazine 5.8 8.6 35533 
Table I. 1: CNS CADs physicoproperties (from ref [42-45]. 
CADs exhibit different lipophilicities and remain poorly water soluble. When they 
interact with membranes, they tend to migrate to the bilayer interface due to the 
hydrophobic effect, and are able to form lipid / CAD conjugates [38, 46]. This has 
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been specifically studied with WAY, haloperidol and spiperone (please refer to 
chapter 3 for more details). 
CADs bind to membranes, readily cross the BBB and exhibit a relatively high 
lipophilicity associated to a high specific to non specific binding ratio. Hence, it is 
getting increasingly evident that the interactions of CADs with membranes are very 
complex and have to be considered in order to answer the following questions: What 
are the effects that govern CADs interactions with membranes? How does the 
membrane contribute to non-specific binding? 
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1.2 Biological membranes and membrane 
biophysics 
1.2.1 Cell membrane 
Cell membranes are structures that compartmentalize cells and their intracellular 
components such as nuclei, endoplasmic reticulum and mitochondria [47]. They are 
essential structures that maintain a difference between the cytosol and the 
extracellular environment and regulate the concentration of ions and metabolites. Cell 
membranes all have a common feature: they are all formed by the non-covalent 
assembly of various amphiphilic phospholipids, in different proportions organized in 
bilayers and associated to peripheral or embedded proteins [48, 49]. The lipid bilayer 
provides the basic structure of the membrane and acts as an impermeable barrier to 
the passage of most solutes such as ions, sugars and peptides, though specific 
transport processes exist to allow them to cross the cell membrane [50]. 
Transportation processes will be defined in section 1.2.2. Biological membranes 
contain hundreds of lipid components [51] with the exact lipid composition varying 
between membranes and being asymmetric in the outer and the inner leaflet. Species 
such as sphingomyelins (SM) and phosphatidylcholine (PC) lipids are predominant in 
the outer layer, and phosphatidylserine (PS) and phosphatidylethanolamine (PE) are 
localized mainly in the inner layer [52]. 
Biological membranes were described in 1972 by Singer and Nicholson as forming a 
"fluid mosaic" system [53] where the lipids arrange themselves to form a two 
dimensional fluid system where lipids and proteins are able to diffuse freely in the 
plane of the bilayer and exhibit rapid lateral diffusion (Figure 1.9). 
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Figure I. 9: A cartoon representing the plasma bilayer as a fluid mosaic system where lipids and 
proteins can d i f fuse freely in the plane of the bilayer. ( f romwww.ncnr .n is t .gov) 
In such structures, lipids are also able to undergo free rotation around their vertical 
axes (-10"'s) and diffuse within the plane of the bilayer (-lO^cm^.s"') [54]. Lipids can 
exchange between the outer and the inner layer via "flip-flop", this process is 
facilitated by lipid flippases, as the movement of lipids across the bilayer is 
energetically unfavorable [55]. 
Limitation of this model comes from the ability of specific phospholipid types to 
segregate into domains and recruit specific receptors [56]. It is believed that these 
domains are important in signalizing processes where the receptors are activated, but 
a big controversy still exists about the nature of these domains and their physiological 
implication [57], even if they were detected soon after the development of the fluid 
mosaic model of lipid membranes [58, 59]. 
1.2.2 Transport models across membranes 
It is of great importance to the cell to be able to transport molecules for its own 
survival [47]. Given the importance of membrane transport, cells utilize a wide range 
of transport mechanisms which fall into three categories: simple diffusion, facilitated 
diffusion, and active transport. Although there are numerous features that do not allow 
the free diffusion of molecules across the lipid bilayer, under certain circumstances 
free diffusion is mainly seen for drug molecules. 
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1.2.2.1 Passive transport 
Simple diffusion means that molecules can pass directly through a membrane. 
Diffusion is always down a concentration gradient without the expenditure of energy. 
This limits the maximum possible concentration of the molecule inside the cell, or 
outside the cell if it is a waste product. The effectiveness of diffusion is also limited 
by the diffusion rate that is slowed down due to the complexity of biological 
membranes. 
The rate of diffusion of a molecule from two compartments separated by a 
homogeneous lipid bilayer follows Pick's law [60]: 
(fg / Xc, - c J 
Equation I. 12 
where D is the diffusion coefficient, Cy and Q the species concentration in the outer 
and inner compartment respectively, A the surface area of the membrane, Kp the 
partition coefficient and d the membrane thickness. 
Since D, Kp and d are constant for a given drug-membrane system and C/ » C2, the 
diffusion rate can be simplified to: 
dQ/ dt — PC^ 
Equation I. 13 
where P is the permeability constant. Greater P leads to faster equilibrium. 
Many CNS drugs are believed to transverse the BBB by passive diffusion as a result 
of their favorable lipophilicity [61]. 
Although diffusion is an effective enough transport mechanism for lipophilic 
substances, the cell must utilize other mechanisms for the transport of polar 
compounds. 
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1.2.2.2 Facilitated transport 
As some molecules are too big or too polar to diffuse freely through the bilayer, their 
diffusion is facilitated by transport intermediates [62]. Facilitated diffusion is a 
process of diffusion where molecules cross membranes with the aid of integral 
membrane proteins such as ion transporter or glucose transporters [63]. After the 
binding of the molecule, the protein changes its shape and allows the molecule to 
reach the other side of the membrane. Facilitated transport is driven by a gradient of 
concentration and does not require the expenditure of energy. 
Penicillin [64], biotin [65], dopamine and morphine are examples of drug molecules 
that are transported via facilitated transport. 
1.2.2.3 Active transport 
Active transport is a process that requires energy as it goes against a gradient of 
concentration. It requires the presence of a transmembrane protein such as the P-
glycoprotein, which avoids toxic compounds from entering the brain [66]. 
The three types of transport described above are represented on figure 1.10. 
Passive diffusion Facilitated transport Active transport 
Figure I. 10: Transport mechanisms across membrane bilayers. Passive 
diffusion follows a gradient of concentration and facilitated transport is 
mediated by a carrier protein. Active transport goes against a gradient of 
concentration and requires expenditure of energy. 
Substances such as hormones can diffuse through the hydrophobic core of the bilayer 
whereas molecules like neurotransmitters bind preferentially to their specific 
receptors. 
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1.2.3 Model membranes, bilayer properties and structure 
The complexity of the plasma membrane has led to the development and use of model 
membranes, simplified to one or two lipid species. Analysis of the component in the 
model membrane leads to a better understanding of the plasma cell membrane. The 
most common model membranes can be classified into categories such as monolayers, 
bilayers, giant vesicles and inverted structures [67-69], Structural data can be obtained 
from model membranes by using complementary techniques such as Small Angle X-
ray Scattering [67], Electron Spin Resonance (ESR) [70], Solid-State Nuclear 
Magnetic Resonance (SS-NMR) [71, 72], Fourier Transform Infrared Spectroscopy 
(FT-1R)[73], and fluorescence; these can also be used to study biological events such 
as binding of molecules to membranes. 
1.2.3.1 Lipid description 
Lipids are surfactant molecules that consist of a polar entity, which is a headgroup 
and a non-polar entity corresponding to the hydrocarbon tail. Three main classes of 
lipids exists in cell membranes, the glycerophospholipids, sphingolipids and sterols 
[47]. 
The lipids investigated in this work belong to the glycerophospholipid family. They 
are glycerol-based phospholipids with saturated or unsaturated fatty acids esterified to 
the glycerol backbone. The phosphate headgroup can vary with the diacyl-
phosphatidyl base; this produces a variety of lipid headgroup species (Figure I.l 1). 
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Figure I. 11: Glycerolipid structure that are present in biological membranes. The glycerol 
backbone is represented in red. R, and R2 represent the saturated / unsaturated fatty acid chains 
and R3 the headgroup. 
Lipids can adopt various structures varying with the type of fatty acid and headgroup. 
PE and PC hpids are zwiterrionic lipids with no net charges, whereas PG, PS and PI 
are anionic lipids with a net negative charge. 
1.2.3.2 Forces in the bilayer 
When dissolved in water the lipids arrange themselves so that the polar heads are in 
contact with the water and the hydrocarbon tails are associated together due to the 
hydrophobic effect [74]. As described above; lipids have different structures and 
shapes so when associated they will form different mesophases that are characteristic 
[75, 76] (see section 1.2.3.4). The formation of a mesophase is controlled by numerous 
forces that are present in the bilayer at the headgroup and hydrocarbon chain region. 
A bilayer is formed by two monolayers that sit back to back, and its formation is 
driven by attractive forces such as the hydrophobic effect which is stabilized by 
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hydrogen bonding around the headgroups and van der Waals interactions. At the 
interface, the hydrophobic effect acts to reduce the contact between the hydrocarbon 
chains and the water. Repulsive forces are also found both in the headgroup and chain 
regions such as the pressure in the chain region that is mainly due to the trans / gauche 
rotation in the C-C bonds, and the hydrational forces, steric and repulsive interactions 
around the headgroup [68, 75]. Lateral forces in a bilayer and a lateral stress profile 
across a lipid are represented on figure 1.12, where t(x) is the distribution of the lateral 
stress, and x the depth in the membrane. 
Electrostatic repulsion 
Hydrogen bonding 
Steric repulsion 
Van der Waals attractions 
Hydropiiobic effect 
Hydration forces 
interracial pressi r 
Headgroup repulsion, hydration pressure 
Lateral t(x) 
Chain steric pressure 
Depth in membrane (x) 
Figure I. 12: (a) The lateral forces within a bilayer. (b) The lateral stress 
profile across a lipid monomer. The headgroup and chain pressure are 
repulsive lateral forces. 
The lateral pressure resulting from the forces mentioned above is zero at equilibrium 
(equation 1.14). 
^t{x)dx = 0 
Equation I. 14 
However, the first moment of the lateral pressure profile is not equal to zero. This is 
indicative of a torque being stored in a monolayer (equation 1.15). 
^t{x)xdx ^ 0 
Equation I. 15 
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The torque that is stored within the bilayer is referred as the stored curvature elastic 
energy. 
1.2.3.3 Interfacial curvature 
Amphiphiles impart a desire for interfacial curvature. As the distribution of lateral 
pressure is non-uniform in the bilayer, they bend toward the chain region if the 
headgroup pressure is dominant; or toward the water if the repulsive forces due to the 
chains are dominant. However, because bilayers are composed of two superimposed 
monolayers, they will want to bend in the same direction, leading to a frustration 
state, until they reach a phase which is the most favourable energetically. 
To describe interfacial curvature, we first have to define the geometrical concepts of 
membrane curvature. Biological membranes are described as a two-dimensional 
surface that spans three dimensional space. The interfacial curvature c at a point p in 
the monolayer is defined by a normal to the surface, as shown in figure 1.13. Ri and R2 
are the principle radii of curvatures and the principle curvatures c/ and C2 are their 
inverse values (equation 1.16). a and C2 can be obtained as the maximum and 
minimum values of curvatures respectively [67, 68]. 
1 
c = — 
R 
Equation I. 16 
Figure I. 13: The curvature of a surface is 
characterized by a maximum and 
minimum value of curvature such as 
Ci=]/Ri and C2=7/R;. (Figure adapted 
from ref [68]). 
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The total curvature J and the mean curvature H are then defined by equation 1.17 and 
equation 1.18 respectively: 
J = (ci +C2) 
Equation I. 17 
^ +<^2) 
and the Gaussian curvature is defined by 
Equation I. 18 
K = 
Equation I. 19 
The shape of the surface can be determined from the mean and Gaussian curvatures. 
For example, a flat surface has a zero mean curvature; therefore the Gaussian 
curvature is zero too. The mean curvature changes in a cylinder, but its Gaussian 
curvature remains zero [68, 77]. 
To define the sign of the membrane curvature we need to distinguish between the two 
sides of the surface i.e. the monolayer. Any lipid monolayers have curvature that will 
depend on the shape and size of the polar headgroups and tails. By convention 
monolayers that bend towards the polar headgroup have a negative curvature and 
inversely monolayers that bend towards the tails have a positive curvature (figure 
1.14). 
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Figure I. 14: Examples of (a) positive and (b) negative curvatures. 
It is reasonable to classify lipids into shapes according to their spontaneous curvature 
[78]. The shape of lipids or "packing parameters" 5* is defined by equation 1.20: 
S = • 
cIQI^ 
Equa t ion I. 20 
ao is the headgroup surface area, Ic the lipid chain length, and v the molecular volume 
of the chains. The shape of lipid aggregates in water is directly related to packing 
parameter S. Thus if the monolayer has a negative spontaneous curvature the lipid 
molecular shape is conical (Type II). The positive curvature is associated with 
molecules with the shape of an inverted cone (type I) and finally molecules with a 
cylinder shape will be considered as type 0 molecules that remain flat in a bilayer 
(Figure 1.16) [67, 68, 77] . An estimation of lipids spontaneous curvature Jg can be 
found in reference [77] 
Figure I. 15: Shape of lipid, (a) type II lipids are represented as an 
inverted cone, (b) type I lipids as a cone and (c) type 0 lipids as 
cylinders, 
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The estimation of the membrane curvature is based on the bilayer thickness d. The 
curvature c is said to be large when the radius of curvature R is much larger than d 
and inversely. 
1.2.3.4 Stored curvature elastic energy 
In a bilayer, the two monolayers are forced to sit back to back. When type I and type 
II lipids are, they both tend to curve away or towards the water according to their 
spontaneous curvature. Deformations from the spontaneous state lead to a deviation 
from the spontaneous state to the frustrated state. These deformations have an 
associated energy cost (gc) dependent on the mean and Gaussian curvatures H and K. 
The energy cost per unit area is given by the bending modulus K and the Gaussian 
modulus Kg- These parameters were combined by Helfrich [79] to give the curvature 
elastic energy per unit area gc for a membrane (Equation 1.21): 
Equa t ion I. 21 
where Ho is the spontaneous mean curvature. 
The first term of the equation describes the energy that is required to deform a 
monolayer from its spontaneous shape. The second term is characterized by the 
Gaussian elastic moduli kq that describes the energy accumulated in the monolayer in 
response to the creation of the Gaussian curvature [77]. 
Instinctively if the spontaneous curvature of the outer lipid monolayer is larger than 
the inner one, the bilayer tends to have a positive curvature with the direction of the 
bilayer curvature controlled by the outer monolayer and vice versa. If the tendencies 
of the monolayers to bend are balanced, than the bilayer membrane curvature will 
equal zero. 
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1.2.3.5 Bilayer mesophases 
The four main lyotropic mesophases are the micellar phase, the lamellar phase, the 
hexagonal phase and the bicontinuous cubic phase; which are described below [67, 
76], 
• Micellar phase: 
Micelles are spherically shaped entities formed by amphiphiles. A positive 
spontaneous curvature facilitates the formation of micelles in a polar solvent such as 
water or buffer. According to the amphiphiles shape, there are two micelle types; 
Type I and Type II. Type I micelles (also called normal micelles) occur when the 
hydrocarbon chains are associated together and the polar headgroups are pointing 
towards the water. Type I micelles are formed by conical amphiphiles (e.g. monoacyl-
chained lipids lyso-PC (LPC)) [80]. Type II micelles are structured so that the water is 
enclosed within the polar headgroup. Type II micelles occur with some double-
chained amphiphiles such as DOPE (figure 1.16). Micelles are all of the same size for 
a given hydrocarbon chain length. The more concentrated the micelle the greater their 
ability to dissolve non-polar compounds. 
a b 
Figure I. 16: Representation of a (a) normal type I micelle, and (b) inverted type II micelle. 
• Lamellar phase 
At higher concentrations the amphiphiles aggregate to form built mesophases of 
bilayer systems separated by water layers. The lamellar phase is organised so that the 
hydrophobic tails are facing each other and the polar head groups are facing the water. 
41 
There are three main types of lamellar phases; the La (fluid), Lp (gel) and Lc (crystal). 
All three are temperature dependant [75]. The La fluid lamellar phase occurs at high 
temperatures, when the hydrocarbon chains are melted leading to a high degree of 
disorder with a large proportion in the gauche / trans state. This low viscosity phase 
allows the free lateral diffusion of molecules. The molecules have typically lateral 
diffusion constants of 10"'^-10"" m^.s'% and have long-axis rotational correlation 
times of 10"^-10"^ s [81]. The La fluid lamellar phase is used to mimic biological 
plasma membranes properties, as cells keep their membrane bilayers in the La fluid 
lamellar phase until a certain point [75]. When cooling, the Lp gel phase arises. The 
hydrocarbon chains are all in a trans conformation. Finally the Lc crystal phase occurs 
when the chains are all frozen into the trans position. The Lp and Lc phases are also 
characterised by a higher viscosity relative to the La phase that reduces the motion of 
molecules. The LQ liquid ordered phase is another type of lamellar phase, which 
appears when cholesterol is added to the bilayer [82]. The acyl chains are constrained 
and ordered but the lateral diffusion is still comparable to the LQ phase (Figure 1.17). 
Figure I. 17: Cartoon representing (a) tlie fluid lamellar phase, (b) the Lp gel phase, (c) the Lc 
lamellar crystal phase. 
• Hexagonal phase 
The hexagonal phase is a phase that is involved in several biological processes 
including cell division and membrane fusion [83]. This phase is formed by cylindrical 
aggregates packed in a two-dimentional lattice where the chains remain fluid [76]. 
Lipids can produce hexagonal shapes when the spontaneous curvature has a value Js = 
1/2R. There are two types of hexagonal phases: the H, (normal) hexagonal phase and 
the Hii (inverted) hexagonal phase. Lipids having small weakly hydrated headgroups 
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and attractive headgroup-headgroup interactions such as PE, form preferentially Hh 
phases. (Figure 1.18) 
Figure I. 18: Cartoon representing the (a) normal hexagonal H, and (b) the inverse hexagonal Hn phase. 
• Bicontinuous cubic phases 
Bicontinuous cubic phases are complex systems, where the bilayer is draped over a 
periodic minimal zero surface with mean curvature at all points, and where the 
amphiphiles and solvent can diffuse in three dimensions. Cubic phases are extensively 
investigated for elucidating the mechanism of cell membrane fusion [84] and for gene 
and drug delivery applications [85, 86] (Fig 1.20). 
Figure I. 19: Representation of the Im3in bicountinuous cubic phase (from ref [87]). 
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1.2.3.6 Electrostatic properties of membranes 
Charged lipids are found in biological membranes. Lipids such as PS, PG and PI are 
present give a net negative charge on biological membranes [88]. Electrostatic 
interactions are very important as they are involved in several biological processes 
such as cell adhesion [88]. These interactions are also important in membrane 
biology, as they affect conductance of channels in membranes [89], ion transport 
processes [90], and the catalytic properties of certain enzymes [91], although these 
interactions can be screened because of the high salt concentration in biological 
systems. 
Charges associated with the membrane surface give rise to electric potentials, which 
participate to biological processes and interactions. Membrane potentials are 
described in chapter 2 (section II.3.1). 
Charges on membranes create electric fields which act on and depend upon the 
distribution of ions near the membrane surface. Electric charges also regulate the 
adsorption of charged species [88], and consequently the binding of cationic 
amphiphilic drugs as they are protonated at physiological conditions (pH=7.4). 
Many membrane structural properties depend on electrostatic interactions. A bilayer 
that is immersed in an ionic environment such as a buffer has the property of 
attracting a cloud of opposite charges that will form "the diffuse electric double layer" 
with a thickness equal to the Debye length [92, 93]. This is controlled by the 
coulombic surface-ion interaction. In other words, the double layer is appearing when 
an ion with a distinctive charge is in a bulk aqueous phase containing an electrolyte; it 
will then attract counterions, and repel co-ions, and produce an ionic atmosphere in its 
vicinity. The Debye length Xd equals Inm for a 100 mM salt solution, (Equation 1.22) 
I s,s,.RT 
Equa t ion I. 22 
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where Sq is the permittivity of the free space, 8r the dielectric constant of the solution, 
F the faraday constant, R the gas constant, T the temperature, and Cj the ions 
concentration with a valence of Zj 
The diffuse double layer is composed of one layer where the counterion is strongly 
bound; the Stern layer and a layer where it diffuses away of the surface, the diffuse 
layer (Figure 1.20). Gouy and Chapman [92] have extensively described these 
electrostatic interactions and predicted the statistical tendency of the counterions to 
diffuse away from a region of high concentration, with the membrane potential 
varying with distance from the surface. 
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Figure I. 20: Representation of the Stern layer and the diffuse layer (Adapted from ref [87]). 
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As part of transverse interactions, electrostatic forces act between adjacent bilayers 
and tend to stabilize bilayer mesophases that were described in section 1.2.3.4 [94]. 
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1.3 Cationic Amphiphilic Drug (CAD) interactions 
with membranes. 
Most cellular activities involve membrane based ligand interactions and it is assumed 
that most hgand binding occurs with membrane-embedded proteins. However, a large 
portion of these ligands also interact with the plasma membrane in particular in the 
non-specific binding issue. Consequently plasma membranes are potentially targets 
for drugs of different therapeutic classes. 
1.3.1 CNS drugs interaction with membranes 
Amphiphilic molecules affect membrane bilayer properties and induce membrane 
disorders in the lipid packing, which may lead to the expansion, fluidization, and 
permeabilisation of the membrane [95, 96]. Binding of the drugs is affected by the 
membrane heterogeneity, phospholipid headgroups, chain types, and also temperature 
[97]. 
Drugs can reach the phospholipid hydrocarbon chain, this is the case for anesthetics 
such as lidocaine [98], and reorganize the headgroup orientation, as seen by ^'P solid 
state NMR of antidepressants such as imipramine [99]. Amphiphilic drugs also bind 
to the water-membrane interface, and alter membrane's physicochemical properties 
and the lateral stress profile [100]. For example, anti-arrhythmic drugs bind to the 
bilayer interface, inducing a hexagonal packing of the hydrocarbon chains and 
disruption of DMPC bilayers as detected by X-ray scattering [101]. 
Interestingly, it appears that binding at the interface and changing the lateral 
organization of the bilayer also modulates the activity of membrane proteins such as 
the opiate receptor which is a target of neuroleptic amphiphilic drugs [102]. 
Amphiphilic drugs bind to phospholipid bilayers specifically, as the observed change 
in the lateral stress profile is dependant on the structure of the drug [97]. The 
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following sections describe how popular CNS drugs such as CPZ and HPD interact 
with membranes, in-vitro and in-vivo. 
1.3.1.1 Chlorpromazine (CPZ) 
The interaction of CPZ with membranes has been extensively reported in the 
literature. CPZ is an antipsychotropic drug of the phenothiazine group which is 
believed to antagonize neuronal Di-dopamine receptors. CPZ is a CAD which 
partitions effectively in both biological and model membranes, with a hydrophobic 
tricycling ring partitioning into the bulk hydrocarbon phase of the bilayer system, and 
a hydrophilic propylamine tail interacting with the phospholipid head group [103]. 
CPZ is known for perturbing the shape of human erythrocytes by creating an 
"intrabilayer non-bilayer phase" [104]. At concentrations above 40 |j.M, CPZ makes 
the cells permeable for low molecular weight molecules and at 100 juM CPZ makes a 
14 A hole in red cell membranes [105]. 
In model membranes, CPZ perturbs the bilayer properties in the headgroup and the 
chain regions [106-108] and also affects electrostatic properties [109]. This CAD 
increases the lipid headgroup mobility and strongly binds to charged lipids such as PS 
[110] and forms a 1:1 complex with the headgroup [111]. It has also been shown that 
CPZ increases the molecular area of phospholipids like PS, PA and PI, but had no 
effect with neutral phospholipids like PC and PE. Other studies revealed that CPZ 
also penetrates the acyl chain region of phospholipids [106]. Studies showed that at a 
1:1 molar ratio of CPZ: DMPC, CPZ disrupted the bilayer structure whereas at a 1:1 
molar ratio of CPZ:DMPE, the drug had no effect on the bilayer structure [112]. 
Therefore, the membrane perturbation depends strongly on the lipid composition and 
the headgroup type. 
1.3.1.2 Haloperidol (HPD) and Spiperone (SPIP) 
Unfortunately, not many studies have been undertaken on HPD and SPIP binding to 
membranes. HPD and SPIP are neuroleptic drugs belonging to the butyrophenone 
drug family that binds specifically to the D2-dopamine and 5-HT2-serotonin receptors 
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respectively [42, 113]. Haloperidol was reported to increase the lipid peroxidation in 
brains [114], which could affect the functionality of the Da-dopamine receptor [115]. 
Contradictory effects of HPD interacting with membranes were reported in-vivo. HPD 
tends to decrease the permeability of a variety of biological membranes for various 
molecules; this effect is generally exerted at low concentrations [116]. However, 
recent fluorescence polarization studies showed that HPD increased the fluidity and 
permeability of rat brain; which could be responsible for neurotoxic effects [117, 
118], 
At the membrane bilayer level, HPD and SPIP binding is controlled by electrostatic 
interactions as these drugs are protonated, but also by hydrophobic forces [119]. 
Similarly to CPZ, their incorporation in the bilayer depends on the lipid composition 
and the temperature [37]. HPD and SPIP induce disorders in the lipid chains, at 
different depths in membrane lipid brain extracts [120]. HPD increases the disorder to 
a greater degree in the interfacial region than in the hydrophobic core [97]. It also 
incorporates better to short aliphatic chains than to longer chains, reducing then the 
voids for the drug molecule. 
1.3.2 Biological relevance: CADs induced phospholipidosis 
CADs have been reported to induce phospholipid disorders and cytotxic effects upon 
cells. This effect, better known as phospholipidosis is characterised by the 
development of excessive membrane growth and accumulation of concentric lamellar 
bodies within the cells [121]. The lamellar bodies (Figure 1.22) appear as storage 
vesicles [122], where the membranous structures are tightly packed. The mechanism 
by which this phenomenon occurs is poorly understood, and it is believed that CADs 
inhibit phospholipases (PLA) activity, by forming a complex with the lipid or the 
protein [123]. Phospholipidosis is CAD dose dependant, and its effect is suppressed 
once the CAD is removed [121]. 
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Figure I. 21: (A)Example of one lamellar body, (B) and two lamellar bodies fusion (Figure taken from 
ref[122]) . 
Efforts have been undertaken towards understanding the molecular basis of 
phospholipidosis. NMR experiments reported that strong interactions occur between 
lipids and CADs which cause the formation of complexes driven by hydrophobic and 
electrostatic forces [124]. Other studies showed that CADs interact specifically with 
PC anc PE lipids [125]. Also some phospholipidosis biomarkers were identified such 
as bis-monoglycerolphosphate (BMP) which is also referred to as lyso-bis-
phosphatidic acid [123, 126]; phenylacetyglycine [127] and an increase in the level of 
polyunsaturated fatty acids. In addition, changes in the phospholipid profile have been 
reported where the level of PC, PE and PI lipids has increased [126, 128]. 
1.4 Aims and approaches 
Although drug molecules are designed to bind specifically to targets such as receptors 
that are embedded within biological membranes it is becoming increasingly evident 
that a large fraction of these compounds interact non-specifically with the membrane. 
The aim of this thesis is to understand and elucidate the molecular interaction between 
a phospholipid bilayer and CADs. Many studies have shown that CADs bind to 
membranes in the interfacial region, and hence affect bilayer properties and change 
the membrane lateral organisation. However, in the literature there is a paucity of 
consistent data regarding CADs or CNS drugs molecular interactions with 
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membranes. A second aspect is to correlate CADs membrane binding properties to the 
NSB in-vivo. 
These investigations have been undertaken by using a variety of biophysical 
techniques including Small Angle X-ray Scattering, Solid-State Nuclear Magnetic 
Resonance and Fluorescence on ternary lipid:CAD:buffer samples, where the lipid 
type and the CAD have been varied. 
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CHAPTER 2 
Theory and methods 
CAD interactions with membranes were monitored using biophysical and biochemical 
techniques that give complementary information on this topic. This chapter will focus 
on the theory of the techniques employed such as small angle X-ray scattering 
(SAXS), solid-state nuclear magnetic resonance (SS-NMR), both describing the 
microsopic and macroscopic state of the bilayer when the drug is added to it, and 
fluorescence binding studies that inform on the binding constant and kinetics. 
II. 1 X-ray diffraction 
X-rays are primarily used for medical diagnostics and crystallography. SAXS is a 
reliable and non destructive technique for the analysis of structured materials on the 
macroscopic scale. 
11.1.1 X-ray generation 
X-rays are electromagnetic waves whose wavelengths are of the same order of 
magnitude as the separation of atoms, i.e. 1-2 A. They are generated when accelerated 
electrons bombard a piece a metal such as copper, tungsten or molybdenum. After the 
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collision the electrons are decelerated and eject an electron from the inner shell of the 
metal atom. As a result electrons from higher energy levels then fill up the vacancy 
and X-rays are emitted. Not all the electrons are decelerated at the same rate; 
consequently a continuous spectrum of differing wavelength is obtained for a given 
accelerating voltage. Ka and Kp are produced when the vacancy is filled by an 
electron from the L or M shell respectively. For X-ray diffraction experiments Kp will 
be removed by a monochromator. 
II. 1.2 X-ray diffraction theory 
What happens when X-rays interact with a crystal? X-rays have a wavelength of the 
order of 1-2 A ; they will be diffracted when they interact with a structured matter 
such as lyotropic liquid crystals. William Bragg showed that X-ray diffraction 
patterns are the result of X-rays reflected from different planes interfering 
constructively or destructively. The geometry of X-ray diffraction is illustrated on 
figure II.1 and Bragg's law derived accordingly (Equation II.1): 
Incident beam 
Reflected beam 
d sin e 
Figure II. 1: Diffraction of X-rays by parallel planes illustration. 
nX = 2d sin 9 
Equa t ion II. I 
where: 
X is the wavelength of the incident X-ray 
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d is the distance between the planes of atoms 
9 is the incidence angle 
and n is an integer multiple of the wavelength. 
The angle between the incident beam vector so and the vector of the diffracted beams 
s is defined as 2 9. The magnitude of the two vectors is equal and defined as the 
reciprocal wavelength (Equation II.2): 
1 
I 
and the scattering vector as S (equation II.3): 
Equation II. 2 
1 
Equation II. 3 
Diffraction techniques allow the determination of various lipid mesophases based on 
the symmetry of the phase. The long range organization of the lipid mesophase 
appears in the low angle regime, with the diffraction very close to the direct beam 
(SAXS), whereas the structural information on the headgroup and chain packing can 
be deduced from the wide angle regions (WAXS). 
II. 1.3 Identification of bilayer mesophases by SAXS and WAXS 
Lipid mesophases are ordered structures that can produce characteristic X-ray 
diffraction patterns satisfying the Bragg's law conditions, whose reciprocal spacing 
(sh,k,i) occurs at characteristic ratios [75] (equation II.4) 
1 
6", {h,kj) r 
Equation II. 4 
where d (h,k,i) is the spacing between successive lattice planes, characterized by the 
Miller indices h,k,I. 
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The lamellar phase consists of a one dimensional stack of bilayers, therefore two of 
the Miller indices are set to zero (Equation II.5) [67]. 
/ 
s, = — 
d 
Equation II. 5 
For lamellar phases, the diffraction pattern will consist of equally spaced concentric 
rings that will index as 1 , 2 , 3 , 4 etc Parameters such as the d-spacing can be 
determined from the diffraction pattern. Most of the time, diffraction from the 
lamellar phase is well defined and easily recognised. Swollen diffuse lamellar phases 
can also be detected when the lipid system hasn't reached equilibrium, and when 
small molecules such as CADs are added to the system. 
The hexagonal phase consists of a two dimensional regular lattice of lattice parameter 
a, hence: 
k) - +k^ + hkY / V ^ ) 
Equation II. 6 
and the peaks index as 1, Vs , 2, V? , 3 etc... 
As already described in chapter I, two types of hexagonal phases exist: the normal 
(HI) and inverted (HN) hexagonal phases, however they lead to the same diffraction 
pattern. Figure 11.2 illustrates the typical diffraction patterns obtained for a lamellar 
and hexagonal phase. 
Figure II. 2: Characteristic small angle X-ray diffraction patterns 
for a lamellar (left) and hexagonal phase (right). 
54 
WAXS uses the same diffraction principles, but gives information on the short order 
of the bilayer sample, such as the headgoup and chain packing. WAXS is a very 
useful technique for distinguishing between the La, Lp and Lc phases as they give 
distinctive diffraction patterns. 
II. 1.4 Instrumentation 
Three X-ray beamlines were used over the course of this study. The next section will 
give an overview of the used instrumentation. 
The principle features of an X-ray beamline are shown in Figure II.3. It consists of an 
X-ray generator, followed by a focusing optics chamber equipped with collimators 
and pinholes which enable the intensification of the X-ray beam. The X-ray beam 
passes through the sample and is diffracted. The main beam is terminated by a beam-
stop while the diffracted beam is collected on the detector. 
X-Ray 
source 
Collimators Sample 
^ c h a m b e r Beam stop 
I I 
I I 
Optics 
chamber 
/ - . A M 
Detector 
Evacuated 
beam path 
Fixed sample 
interface 
Main beam 
Diffracted beam 
Figure II. 3: A schematic X-ray beamline representation. 
The X-ray beamlines used in the project mainly differ with respect to their optics 
apparatus. 
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II. 1.4.1 The "kinetics" beamline 
The kinetics beamline used in this project was based around a FR591 rotating anode 
X-ray generator (Nonius-Netherland). A Ni filter is used so as to monochromate and 
isolate the CuKa radiation (A-=1.54A). The Ni-filtered CuK^ was focused using 
toroidal optics, which gives a high level of X-ray flux and focuses the beam into a 
focal point in the range of 400 nm-700|im. The sample was inserted in glass 
capillaries {GLAS-\.5 mm diameter- Germany) and then in a sample holder that is 
electronically linked to and controlled by a Scorpion Micro-Controller unit. Typical 
exposure times were 90 seconds and samples were allowed to equilibrate for 60 
seconds. Once the beam passes through the sample, the scattered X-rays were 
detected by a camera (XIDIS Photonic Science), with the main beam blocked by a 
lead stop. The image was read out and transferred to a local PC and analysed using 
the IDL-based Axcess software package, developed by Dr A.Heron at Imperial 
College (see section 2.1.4.4 below). 
II. 1.4.2 The "osmotic" beamline 
The osmotic beamline is based around a Bede (Durham, UK), copper Microsource X-
ray generator with integrated monolithic polycapillary optics which can achieve high 
collimation and focusing of the main beam. The X-ray beam passes through the 
sample in the sample chamber, and is evacuated through the evacuated beam path, 
and terminates against the beam stop. Diffracted X-ray beams are collected via a 
Gemstar intensified CCD X-ray detector, which is connected to the beamline PC for 
image acquisition and analysis. The beamline is mounted on an Ealing linear 
transition stage for the orientation of the mounted beamline components parallel to the 
main beam. Cumulative diffraction plots were obtained after 5 x 60s X-ray exposures 
at room temperature. The osmotic beamline can be used to analyze samples with a d-
spacing range from 2.5 A to 150 A . The resulting diffraction patterns were analyzed 
with the IDL based AXcess software package. 
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II. 1.4.3 The nanoSTAR 
The nanoSTAR beamline is coupled to a kristalloflex 760 X-ray generator with a 
copper source and cross-coupled Goebel mirror optics. The monochromated X-ray 
beam is passed through a 100 |im diameter pinhole and to a 300 p,m anti scatter 
pinhole that forms a focus beam. The temperature was controlled by a eurotherm 847 
series controller. This beamline was used to analyze samples with large d-spacings as 
this system can be used to obtain diffraction pattern from systems exhibiting spacings 
up to 300A. Samples were also inserted in glass capillaries. The whole system was 
linked to a computer terminal and the nanoSTAR operation was controlled using the 
bruker AXS program. The images were transferred and analysed using AXcess 
software. 
II. 1.4.4 Image analysis 
Images are collected and analysed using Axcess software package developed at 
Imperial College by Dr A.Heron. The program automatically locates the centre of the 
image. The diffraction pattern is integrated radially through a user defined section in 
order to visualise a one-dimensional linear intensity plot of intensity vs pixel number. 
Each peak can be indexed individually and the mesophase and lattice parameter (d-
spacing) determined accordingly. Each experiment requires a prior calibration with 
silver behenate (d-spacing = 58.38 A ) (Figure II.4). 
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Figure II. 4: The Axcess software package for analysis of X-ray data, (a) Silver Behenate 
powder diffraction pattern, (b) ID density plot that allows the determination of the lattice 
parameter, d-spacing =58.38±0.16A. 
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11.2 Solid-state Nuclear Magnetic Resonance 
Nuclear magnetic resonance spectroscopy is a powerful and complex technique, 
which is based on the nuclei of atoms placed in a magnetic field. This section will 
give a succinct introduction of NMR principles and its application to liquid crystals. A 
more extensive coverage of NMR theory can be found in references [129-131]. 
11.2.1 NMR principles 
Briefly, the NMR concept can be described as follows; if a sample is placed in a 
magnetic field, and subjected to radiofrequency (RF) radiations at the appropriate 
frequency, then nuclei in the sample are able to absorb this energy. 
Subatomic particles (electron, proton and neutron) possess a nuclear magnetic 
moment |i which interacts with an external magnetic field. The magnetic moment 
is characterized by a property called spin angular momentum, I, which arises from 
the ratio of protons to neutrons in the nucleus. According to quantum mechanics, the 
nuclear magnetic moment p, of a nucleus will align with an externally applied 
magnetic field Bo in only 21+1 ways. As a result a nucleus with spin 1=1/2 will have 
two possible orientations. The energetically preferred orientation has the magnetic 
moment aligned parallel to Bo (spin m=+l/2), and is given the notation a whereas the 
higher energy anti-parallel orientation (spin m=-l/2), is referred as (3. The transition 
between the two energy states is determined by equation IL7; 
E = hv 
Equa t ion II. 7 
where h = Plank's constant = 6.626x10'^'* J s 
V is the resonance frequency (Larmor frequency). 
The energy level for a nucleus with a spin 1=1/2 placed in a magnetic field is 
represented by the following diagram (Figure II.5). 
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Field on 
Field off 
Figure II. 5: Diagram 
representing the level energy of 
two spin state in a magnetic 
field. 
Nuclear spins are able to interact with the applied magnetic field; this is called the 
Zeeman effect. 
The populations of energy levels follow Boltzmann statistics, for I = (Equation 
II.8): 
Equation 11. 8 
where Na is the number of nuclei in the a-state and Np the number of nuclei in the In-
state, T is the temperature in Kelvin and k is the Boltzmann constant. The difference 
in population between the Na and Np state is very small. 
The rotational axis of the spinning nucleus is not perfectly parallel or anti-parallel, but 
must precess at an anglular velocity as defined by equation II.9: 
Equation II . 9 
where COQ is the Larmor frequency and y a proportionality constant; the magnetogyric 
ratio, that relates the magnetic moment jj, and the spin I, defined as (equation 11.10) 
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r 
In/Li 
E q u a t i o n II. 10 
If a RF corresponding to COQ is applied to the sample, the nuclear spin absorbs the 
energy, this causes a transition form higher to lower energy state, as well from lower 
to higher energy state. This feature is defined as the resonance or exchange of energy 
at a specific frequency between the spins. The absorption of the energy causes the 
spin to reach a non equilibrium state. After the excitation the individual spins of the 
system will decay exponentially with time and return to equilibrium through a 
relaxation process. This process creates a voltage that can be detected and amplified, 
and a time domain emission signal is emitted and displayed as a free induction decay 
(FID). The FID signal is transformed by a Fourier Transform (FT) that allows the 
detection of the signal as a function of the frequency (Figure II.6). 
FT 
t V 
Figure II. 6: An FID signal (a) and FT specrum (b). 
NMR is an absorption process and nuclei must relax and return to the ground state. 
There are two relaxation processes, the longitudinal, or spin-lattice relaxation and the 
transverse, or spin-spin relaxation. The longitudinal relaxation energy is transferred to 
the molecular framework or lattice, and is lost as vibrational or translational energy. It 
is characterized by the spin-lattice relaxation time Ti. T | can be in the order of 
seconds. Transverse relaxation energy is transferred to a neighbor nucleus and is 
characterized by the spin-spin relaxation time Ti. The peak width on the spectrum is 
dependent on both T, and Ti. 
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The precise frequency at which each atom comes into resonance is determined by the 
applied magnetic field and also from differences in the magnetic moment experienced 
by each nucleus. The movement of electrons creates a local magnetic field which 
shields the nuclear spin from the external magnetic field. This results in individual 
chemical groups having distinct resonances in NMR, characterized by the chemical 
shift. The chemical shift is commonly reported as a value 5 , defined by equation 
11.11: 
S = <^ 0 -
CO. Ore/ 
E q u a t i o n II . 11 
where COQ ref is the chemical shift associated to a reference peak, such a 
tetramethylsilane (TMS) for carbon and hydrogen nuclei , and H P O 4 for phosphorus. 
5 has no dimension and is expressed as part per million (ppm). The different chemical 
shift expected for and NMR are represented on Figure II.7 and II.8. 
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F i g u r e II . 7: Chemical shifts ranges for common functional groups in'^C N M R (top) and ^'P 
N M R (bot tom) spectroscopy. 
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11.2.2 SS-NMR of liquid crystals 
II.2.2.1 Principles 
This section will give a brief introduction of SS-NMR principles and its application to 
liquid crystals. A more exhaustive coverage of SS-NMR principles can be found in 
references [132, 133]. 
SS-NMR applies to solids and also obeys the fundamentals properties mentioned 
above. SS-NMR spectroscopy is a particularly sensitive technique, allowing the 
determination of the three-dimensional organization of phospholipids in membranes. 
However the resolution of NMR in solids suffers from a number of intrinsic problems 
which will give broad lines while acquiring the data. Spectral manifestations of 
anisotropic interactions are averaged to zero in solution by fast and isotropic motions; 
this does not happen in solids as the motion is usually absent, which causes the line 
broadening of the resonance. The main cause of line broadening in solids comes from 
the chemical shift anisotropy (CSA) and the dipolar coupling. 
• The chemical shift anisotropy (CSA) 
The chemical shift is a nuclear-electron interaction, and a very important concept of 
SS-NMR is that the chemical shift of a given nucleus within a solid depends on the 
orientation of the solid, therefore, the resonance frequency will vary with the 
orientation of the molecules. This orientation dependence of the chemical shift is 
referred to as chemical shift anisotropy (CSA). The CSA which arises from a non 
uniform electronic environment can be described by a 3x3 tensor which consists of 
nine independent components (equation 11.12). The chemical shift tensor is expressed 
in a coordinate frame where all off-diagonal elements vanish. This results in the 
detection of broad peaks on the NMR spectrum. The corresponding signal 
corresponds to a powder pattern or CSA pattern. 
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0 0 ' 
O" = 0 (J 22 0 
. 0 0 ^33 y 
Equa t i on II. 12 
The components can be read from the NMR spectrum (please refer to section 2.2.2.2). 
• The dipolar coupling 
The dipolar coupling arises from electron-electron interactions. Each nucleus has a 
magnetic moment |a, which interacts with a neighboring magnetic moment. This 
effect depends on the distance and the geometry of the molecule. Dipolar coupling 
generates line broadening in solids because of the presence of multitude of spins, but 
is averaged to zero in solution due to molecular tumbling. 
• Magic Angle Spirming (MAS) 
The CSA and the dipolar interaction give rise to broad spectral lines in the NMR 
spectra of solid samples. The restoration of high-resolution spectra is realized using 
the magical angle spirming method (MAS). The orientational dependence of the 
magnetic interaction varies according to equation 11.13: 
3cos^ 6 ^ - \ = Q 
Equa t ion II. 13 
and averages to zero when 9m = 54.7. 
Experimentally, the sample is rotated at the magic angle 9 - 54.7° relative to the 
magnetic field, and spun to remove the line broadening, with the frequency of 
spinning exceeding the magnitude of the dipolar coupling in order to completely 
remove the line broadening (Figure II.8). 
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Figure II. 8: Magic Angle Spinning. 
The sample is rotated at 8^=54.74° 
and spun so the line broadening is 
removed (Figure taken from ref [134], 
MAS also removes the CSA by averaging the chemical shift tensor. This generates a 
spectrum where each chemical shift is represented by a single isotropic value, and is 
equivalent to the solution state. 
11.2.2.2 Application to liquid crystals 
Liquid crystals are not real solids. Lipids in membranes are able to undergo fast 
rotational motions around the normal of the bilayer in a limited angular domain. NMR 
of membrane samples can provide information on local molecular motions in lipid 
assemblies. This gives rise to characteristic signals for lipid mesophases. Two main 
nuclei were investigated in this thesis: ^'P and '^C. 13/ 
31 P SS-NMR of phospholipids 
As ^'P is present in biological membranes and has a spin 1=1/2, it is therefore a useful 
probe to determine structure and motion. Phospholipids contain ^'P nuclei in the 
headgroup region, which have a natural abundance of 100%. This feature allowed for 
the studies of natural membranes using ^'P NMR. The NMR signal is dominated by 
the CSA, and the shape of the CSA powder pattern gives an insight in the structure of 
the phase as well as information on the motional degree around the lipid headgroup 
[71]. The dipolar coupling may be removed from long axis rotation and molecular 
diffusion through the bilayer. 
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For membranes in the liquid crystalline state, fast rotation of the lipid molecules 
around an axis perpendicular to the bilayer surface can occur. This generates effective 
tensors which are axially symmetric to the director axis (rotation axis). The effective 
tensor o^fcan be treated mathematically by a 3x3 matrix (equation 11.14): 
0 o l 
0 0 
. 0 0 1^1 y 
and Act = cr n -
Equa t ion II. 14 
Equa t i on II. 15 
where cTJ^ and a \\ are the chemical shift tensors perpendicular and parallel to the 
director axis. The CSA can be derived from NMR spectra. 
Static ^'P patterns can show line broadening that occurs in the lipid mesophases such 
as the lamellar phase, the inverse hexagonal phase and the isotropic phase. 
The NMR signal obtained for lamellar phases is characteristic and is the result of an 
averaged powder pattern where Aa corresponds to the shoulder of the powder pattern, 
as exemplified on figure II.9a with cr^ corresponding to the lower intensity region 
and <j II corresponding to the higher intensity region. Aa =50 ppm in the case of 
DOPC fluid lamellar phase. It is not possible however to distinguish between La, Lp, 
Lc and Lo phase. In order to distinguish between a fluid and gel lamellar phase, other 
NMR experiments such as MAS NMR can be done (see section below). 
Phospholipids arranged in a hexagonal lattice possess an additional averaging 
mechanism which corresponds to the diffusion of the lipid around the cylinder (D= 
-10"^ cm^s"') [75]. The lipids rapidly diffuse around the cylinders, while the cylinders 
are organized around a main axial symmetry. Then the chemical shift tensor can be 
defined as follows: cr n corresponds to the case where the cylinder has a collinear axis 
to the magnetic field, and cr^ corresponds to the case where the axis cylinder is 
normal to the magnetic field. The phosphorus pattern corresponds to the reversed 
lamellar pattern with a width corresponding to the half of the magnitude of the 
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lamellar phase (Figure II.9b). Details on the calculation of CSA tensor can be found in 
reference [71]. 
Isotropic phases such as micellar phases lead to a complete averaging of the chemical 
shift tensor, due to fast tumbling comparable to solution state. The recorded signal 
corresponds to a single sharp peak (Figure II.9c). 
Lamellar 
Hexagonal 
_L 
I I I T" 
Micellar 
Figure II. 9: Typical P CSA pattern of (a) lamellar, (b) hexagonal, and (c) 
micellar phase. 
• '^C MAS SS-NMR of phospholipids 
'^C NMR provides a useful tool to probe the state of the lipid polar headgroup and the 
hydrocarbon chain, thanks to the natural abundance of '^C (-1%). As discussed 
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above, MAS removes all anisotropic interactions, so NMR signals are only dictated 
by chemical shift interactions. 
The distribution of the chemical shifts corresponds to lipid segments such as the 
methyl end group, the hydrocarbon chain, the interface and the headgroup. '^C MAS 
SS-NMR experiments can be undertaken to determine if the lipid system is in a fluid 
or gel phase. The rate of exchange between lipid chain conformations i.e. the trans / 
gauche effect is slow in a gel phase, which is detected by a broad peak whereas the 
exchange between the allowed conformations occurs faster in a fluid phase. This is 
characterized by sharp well resolved peaks on the NMR spectrum which corresponds 
to an average of all conformations. In the gel phase, the peaks appear broader because 
of the packing of the chains that does not allow the trans / gauche isomerisation, and 
the lower motion of the lipid in the bilayer. 
Combination of static and MAS SS-NMR measurements will inform about the 
membrane state, i.e. the conformation of the lipid headgroup and the state of the 
hydrocarbon chain, in particular when CADs are added to bilayers (see chapter 4). 
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IL3 Fluorescent binding studies 
Binding of charged CADs at physiological pH can be evaluated and measured using 
an original method developed by O'Shea and coworkers [135] which involves the 
electrical properties of the bilayer. This section will describe the theory underlying 
this method. 
11.3.1 Theory 
Molecular interactions in nature are essentially electrical, and some of the physical 
properties of membranes contribute to these interactions. Membrane electrical 
properties are believed to participate to biological events [88, 135, 136]; therefore, 
these properties can be used to investigate them. Membrane electrostatics and the 
underlying physical properties have been extensively reviewed by McLaughlin [92] 
and Cevc [88]. 
Membranes can be characterized by three electrical potentials, which are: the 
transmembrane potential Ay which is associated to a gradient of electric charges 
across the lipid bilayer, the membrane surface potential 0 , which arises when net 
excess electric charges are bound to the membrane interface, and finally the 
membrane dipole potential ©d which arises from electrical dipoles associated to the 
carboxylic group and the oxygen-bonded phosphate components of the membrane 
[137]. The A\|f and Od will not be discussed any further, a more exhaustive coverage 
of these potentials are found in references [136, 138-140]. 
The membrane surface potential's feature can be investigated in binding studies, in 
particular in the detection of the physical parameters that underlie the molecular 
interactions between charged CADs and phospholipid membranes. The membrane 
surface potential can be described by the Gouy-Chapman theory (equation 11.16): 
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Equa t i on II. 16 
where a is the surface charge density, X the Debye length, Sa the dielectric constant of 
the aqueous phase, and so the permittivity of the free space. 
The membrane surface potential can also vary with distance from the 
surface x according to equation II. 17: 
(D(x) = 
Equa t i on II. 17 
This potential can be described as adjacent to a phospholipid bilayer membrane. 
The membrane surface potential depends on the presence of ions and charges, and 
acts upon them. This potential causes an irregular distribution of charges at the 
membrane surface, as counterions are attracted to the surface, whereas ions of the 
same charges are repelled. Therefore, the concentration of ions at the membrane 
surface is dependent on the membrane surface potential 0 ; and is described by the 
Boltzman equation (equation 1.18): 
Equa t ion II. 18 
where Cg is the concentration of ions at the surface, Cy the concentration of ions in the 
bulk phase, Z the number of charges, F the Faraday's constant, R the gas constant and 
T the temperature (K). Therefore, any change in the ionic concentration will result in 
a change of the surface potential. 
Characterization of electric features of membrane potentials can be achieved by using 
fluorescent lipids which have the advantage of being non invasive as they don't alter 
the integrity of the membrane. These lipid probes can also be utilized at low 
concentration in the lipid bilayer. Fluoresceinphosphatidylethanolamine (FPE) whose 
structure is represented on figure 11.10 has proven to be remarkably indicative of 
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membrane electrostatic features, in particular the membrane surface potential in both 
model and cell membranes. 
COOH 
Figure II. 10: Structure of fluoresceinphosphatidylethanolamine FPE. 
This fluorescent lipid was initially used to assay the proton pumping function of 
reconstituted cytochrome c oxidase in liposomes by measuring the intra liposomal pH 
[141]. 
FPE has the ability to incorporate into lipid bilayers via its phosphatidylethanolamine 
segment, while the fluorescein moiety is exposed to the aqueous phase. Fluorescein is 
a widely used fluorescent probe in biology, biochemistry and chemistry research. It is 
well characterized and its spectral properties have been widely studied. Fluorescein 
can exist in several ionization states [142]. As a result, FPE is also sensitive to a 
change in the surface potential induced by addition of charges. 
The Hendersson-Hasselbach equation, describes the derivation of the pH with acidity 
(equation 11.19); 
C„ 
+ log 
C HB 
Equa t ion II. 19 
where PKA is the acidity constant, Cq and CHB the concentration of the dissociated and 
protonated species of the acid-base pair of the fluorescein moiety. 
Rearranging equation 11.14 and 11.15 yields equation 11.20: 
\og-^ = pH-
'HB 
pka-
RTlnlQ 
Equa t ion II. 20 
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FO 
The quantity pka — is considered as the pkapp for proton binding of the acid-
RTlnlO ^ 
base pair on the membrane surface. 
Equation 11.16 shows that FPE is sensitive to a change in the surface potential 0s, thus 
a change in the fluorescence corresponds to a change of the surface potential. 
Therefore, FPE can be used to study charged molecules, i.e. CADs binding to 
membranes by following the change in the fluorescence, as addition of charged 
molecules alters the value of the surface potential and consequently the fluorescence. 
11.3.2 Experimental 
FPE fluorescence signals can be used to monitor the interactions of charged molecules 
with membranes in real time with great sensitivity. Additions of charged molecules 
cause an alteration in the surface potential, which leads to the protonation or 
deprotonation of the fluorescein ring, which results in an enhancement or decrease in 
the fluorescence intensity. 
Extruded unilamellar vesicles were labeled with the fluorescent probe in the outer 
layer. The labeling is stable as no flip-flop was observed over a week [143]. 
Subsequent additions of positively charged molecules of known concentration are 
reflected by a sharp increase in the fluorescence signal; the increase is proportional to 
the added quantity (Figure 11.11). Additions are made until no further fluorescence 
change is observed. At this point the binding is considered to be saturated. Binding 
events occur within the mixing procedure and can be resolved by using stopped-flow 
rapid mixing techniques [144]. 
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F i g u r e II . 11: Schematic representing the FPE f luorescence assays. Vesicles are f luorescently labeled 
in the outer layer, which yields an initial f luorescence intensity value. Posi t ively charged molecules 
added to the labeled vesicles cause an increase in the f luorescence intensity. T h e increase is relative to 
the added quantity of molecules , (a,b,c), until saturation is reached (d,e,f). Subsequent additions are 
represented by black arrows. 
The overall fluorescence change due to subsequent additions of charged molecules 
can be utilized to construct binding profiles (Figure 11.12). The obtained data points 
are fitted to a hyperbolic function, which yields binding constants such as K j values 
(Equation 11.21). 
E q u a t i o n II. 21 
where F is the fluorescence change, Fmax the maximum fluorescence change, [M] the 
concentration of the charged added molecule and Kd the affinity of the molecule for 
the membrane. 
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Figu re II. 12: Typical binding profiles obtained from FPE 
fluorescence assays. Data points are fitted to a hyperbolic 
function from which a K j value is calculated. 
The use of PFE fluorescent assay is highly revealing as it allows real time 
measurements of charged molecules to membranes. Therefore, this technique will be 
applicable to CADs since they are charged at physiological pH and binding properties 
will be investigated (Chapter 3). 
11.4 Methods: 
II.4.1 Lipids 
1,2-Dioleoyl-6'/7-Glycero-3-Phosphocholine (DOPC), 1,2-Dilauroyl-5'«-Glycero-3-
Phosphocholine (DLPC), l,2-dioleoyl-^M-glycero-3-phosphoethanolamine (DOPE), 1-
01eoyl-2-Hydroxy-5n-Glycero-3-Phosphocholine (MOPC) and 1,2-Di-O-
Octadecenyl-j-n-Glycero-S-Phosphocholine (Ether linked-PC) were purchased from 
Avanti Polar Lipids Inc., (Alabaster USA, 99.0%) in lyophilized powder form and 
used with no further purification. Fluoresceinphosphatidylethanolamine (FPE) was 
purchased from Sigma Aldrich (Gillingham UK). 
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11.4.2 Drugs 
Haloperidol HCl and Spiperone HCl were purchased from Tocris-Cookson. 
Fluorescent-tagged spiperone (NBDAminohexanoylaminophenetylspiperone) and 
WAY 100635 were obtained from Sigma Aldrich (Gillingham UK). Haloperidol salts 
(Formate, TFA and Maleate) salt, were synthesized in house as described in reference 
[145]. 
11.4.3 Buffers 
Experiments were performed in using the following buffers: 
Buffer A: 50 mM Bis Tris (Fluka 99%), 100 mM NaCI (Fluka 99%) pH 7.4 
Buffer B: 10 mM Tris HCl (Sigma 99%) pH 7.4 
Buffer C: 10 mM Tris HCl, 100 mM NaCl pH 7.4 
11.4.4 Sample preparation for SAXS, Solid State NMR and 
HPLC 
Dry lipids and drugs were dissolved in chloroform methanol (1:1) to obtain a 4:1, 9:1 
or 20:1 lipid to drug molar ratio. The solvent was then removed gently with a nitrogen 
stream and the samples were left to dry in a vacuum oven at 40°C at 1000 mBars for 
36 hours. The obtained dried lipid-drug mixture was hydrated with the desired buffer 
at a 1:3 lipid: buffer mass ratio, vortexed until homogenized and left to equilibrate for 
15 min. At that point the samples are labeled t=0. 
11.4.5 Small Angle X-ray diffraction 
Three beamlines were mainly used in this project, namely the "kinetics beamline", 
"the Bede" and the "nanoSTAR". Samples for x-ray measurements were prepared by 
transferring the required amounts of co-lyophilised lipid / CAD / buffer to glass x-ray 
capillary tubes with a diameter of 1.5 mm (Gulmay Medical, TBD). The capillaries 
were flame sealed and then a silicon sealant plug (Dow Coming Corp) was applied to 
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ensure airtight sealing required to maintain the excess water hydration level. SAXS 
patterns were obtained by using a high intensity laboratory point source. The X-ray 
experiments were computer controlled using software originally developed by E.F. 
Eikenberry (Paul Scherrer Institute, Switzerland) and S.M. Gruner (Cornell 
University, New York) and now customized for use at Imperial College. Image 
analysis was performed using the Axcess software package developed by Andrew 
Heron (Imperial College, London). (Please refer to chapter 2 for more details on the 
beamlines, the X-ray generators used and the image analysis procedure). 
11.4.6 Nuclear Magnetic Resonance 
The homogenised sample was placed in a 4mm zirconium rotor in a 4 ml probe. NMR 
spectra were acquired on a Bruker 600 MHz FT-NMR spectrometer (14.09T) with the 
following frequencies: ^'P = 242 MHz, 'H = 600 MHz, and a '^C =150 MHz. The 
magic angle spinning experiments were done at speeds of 3 kHz with 9=54.74. Single 
pulse and proton-decoupled experiments were acquired using standard Bruker pulse 
programs 
11.4.7 Normal Phase High Performance liquid chromatography 
Normal phase liquid chromatography was carried out using a HPLC system consisting 
of an autosampler (Waters 717 plus autosampler), dual pump (Waters 626) operated 
by a 600S controller (Waters) with a 100 |il loop connected to a Kromasil Diol 
column (25 cm long, 60 A pore size, 5 |j,m particle size, HiChromLtd, Berkshire, UK). 
Eluate from the column was sent to the evaporative light scattering (ELS) detector 
(ESA 301- ESA Analytical Ltd, Buckinghamshire, UK). The ELS detector 
nebulisation and evaporation temperatures were set at 31°C and 55 °C respectively 
and the Nz flow pressure was set to 1.5 bars. The data were collected with the 
millenium LC system software (Waters). 
Two solvents at a constant flow rate of 1 ml / min were used to elute the lipids. The 
solvent gradient involved an increase in hydrophylicity: Solvent A: 101:21:2:0.1 
Hexane, Isopropanol, Acetic Acid, Triethylamine (v/v/v/v). Solvent B: 105:17.5:2:0.1 
Isopropanol, Water, Acetic Acid, Triethylamine (v/v/v/v). All solvents used were 
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HPLC grade. The gradient was set to 0%B to 30%B from 2min to 7 min, 30%B to 
50%B from 8 min to 37 min, 50%B to 0%B from 37mm to 40mm, and the system 
was held in 100%A for 5 min to regenerate the column. Blanks were run every 10 
samples to avoid any contamination. 
11.4.8 Vesicle preparation 
The desired lipids were dissolved in chloroform (2mg/ml) and dried under a nitrogen 
stream in a round bottom flask to form a homogeneous film [146]. The film was then 
left under vacuum for 8 hours and hydrated with the desired buffer to the desired 
concentration and left to interact overnight. The resulting multilamellar solution was 
freeze-thawed 10 times and extruded 20 times trough a 100 nm diameter 
polycarbonate filters (Nucleopore). The resulting vesicles were found to be 
homogeneous in size. Monodispersity of the vesicles was checked with dynamic light 
scattering. 
11.4.9 Binding studies using Fluorescein 
Phosphatidylethanolamine (FPE) 
The formed vesicles were labeled on the outer layer with FPE added in ethanol (5 )al 
of a Img.ml"' stock solution in chloroform) in a 0.05 mol% lipid; probe ratio and left 
to incubate for an hour at 37 degrees in the dark. Fluorescence measurements were 
performed by adding the desired amount of drug solution in DMSO (3 mM) to 3 ml of 
a 300JJ.M vesicle solution. Kinetics measurements were recorded on a Perkin -Elmer 
LS SOB Luminescence Spectrometer. The excitation and emission wavelength were 
490 and 530 nm respectively with the slits 5 nm wide. All experiments were done 
under controlled light conditions. 
The fluorescence amplitude of FPE was averaged and standarised so the initial 
intensity was equal to zero. The change in fluorescence was plotted against the drug 
concentration and fitted according to equation 11.21 [147]. 
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11.4.10 Dynamic light scattering 
The mean diameter, size-distribution, and polydispersity index of the DOPC vesicle 
preparations were monitored by dynamic light scattering (DLS) (HPPS 5001 Malvern 
Instruments). The instrument was equipped with a He-Ne laser operating at a 
wavelength of 633 nm. The size analysis was made at a lipid concentration of 400 
|j,M, at 25 °C. In each measurement the buffer was filtered through a 0.22 |im filter 
(Sartorius). 
11.4.11 Fluorescence microscopy 
Giant Unilamellar Vesicles (GUV) were electro formed as described previously [148] 
at room temperature, with an custom built in-house designed device (Figure 11.13). 
25 mm 
AC Reld 
R electrode 
Glass Coverslide 
Ffemovable bridge ^ 
" S T^nm ^  I 
Figure II. 13: Electroformation set-up (Courtesy of X.Mulet) 
Lipids were dissolved in 9:1 chloroform: methanol mixtures and deposited on Pt 
electrodes 5mm apart. Once the solvent had been removed in vacuo, the electrodes 
were hydrated in lOOmM sucrose, 10 mM bis-tris pH 7.4 at 25°C solution. The A.C 
field applied was slowly varied from 0.2V to l.OV at 10 Hz over 10 mins. The 
vesicles were allowed to grow for one hour before the field was slowly reduced and 
finally stopped. The vesicles grown by this method were stable for 6 hours. The 
GUVs were imaged on an inverted Nikon TE2000 microscope fitted with DIG set up 
(Nikon UK Limited, Surrey) equipped with a lOOW Xenon burner and a CFI Plan 
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Fluor 20X optic. For fluorescence imaging a cube fitted with a 465 nm excitation 
filter and 505nm emission filters (Chroma Technology, Rockingham USA) was used. 
An ND4 filter was used to minimise the effects of photo bleaching. The images were 
acquired on a Hamamatzu Orca ER camera set to maximum gain for the fluorescence 
data acquisition. The exposure lengths were 150 ms, with a 5 s delay between each 
frame. The total time period for the video was 500 frames (2500 s). 
The fluorescent Spiperone (NBDAminohexanoylaminophenetylspiperone) was added 
in ethanol in the presence of non-fluorescent spiperone HCl in a 1:100 molar ratio. 
11.4.12 Polarising microscopy 
Observation of lipid CAD samples was performed at room temperature with direct 
light and polarizing microscopy using a Nikon E600 polarizing microscope, equipped 
with a Nikon DXM1200F digital camera at a magnification of 40 x. Images were 
analyzed with the NikonACT-1 software. 
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CHAPTER 3 
Degradative transport of Haloperidol 
and Spiperone across bilayers 
The results presented in this section have been published in the "Philosophical 
Transactions of The Royal Society" Oct 2006, 364(1847):2597-614 [149]. 
III.l Background 
Studies of drug interactions with membranes have been widely investigated in the 
literature from the early eighties to the present [32] [150] [100], Advances in the 
understanding of effects of drugs on membranes were achieved using a wide array of 
techniques [151] [152] [153] [105]. These studies are of importance as biological 
bilayers act as a barrier to the passage of many molecules including drugs. As already 
described earlier, the elucidation of the mechanisms associated with drugs binding to 
membranes is relevant to numerous problems occurring in membrane biology such as 
drug transport through membranes and the non-specific and specific binding of drugs 
to receptors and membranes. As the non-specific binding is related to diffusion of 
central nervous system (CNS) drugs through the BBB [17], it is of main importance to 
investigate the CNS drugs interactions with bilayers in general. 
80 
This section will describe the preliminary results concerning the interaction of two 
CNS cationic amphiphilic drugs, haloperidol (HPD) and spiperone (SPIP), on bilayers 
made of dioleoylphosphatidylcholine (DOPC) (Figure III.l). A description of the 
lipid:drug systems will be followed by a investigation of the drug catalysed membrane 
degradation by spectroscopic and biophysical techniques. 
L-
Figure III . l : Structures of DOPC (l,2-Dioleoyl-5n-Glycero-3-
Phosphatidylcholine, (a), HPD, (b) and SPIP (c). 
III. 1.1 DOPC systems 
The investigation of the lipid drug system was carried out using phosphatidylcholine 
(PC) lipids. These lipids are extensively used in model systems as they are one of the 
major constituents in mammalian cells [154] [49]. PC lipids have a common 
headgroup which is phosphatidylcholine, but differ according to their hydrocarbon 
chains in terms of the number of carbons as well as degree of unsaturations. For 
example, DOPC lipids have 18 carbons and one double bond (CI8:1) at carbon 9 [75]. 
When DOPC lipids are mixed together in excess buffer (buffer A: 50mM Bis-Tris, 
lOOmM NaCl, pH 7.4), they will tend to form the La fluid lamellar phase at room 
temperature (Tm=-22°C) as described in chapter one. As stated, this phase has the 
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ability to mimic the plasma membrane bilayer as it is fully hydrated and the lateral 
diffusion coefficients are in the same order of magnitude (~ 10"^  cm^) [54]. Therefore 
the self-assembled bilayer stacks can also be compared to a hydrophobic barrier i.e. 
the BBB as the latter consists of a number of a highly anisotropic lipid bilayers [21]. 
III. 1.2 Drug systems 
The drugs that will be investigated in this section belong to the CNS family and are 
extensively used to treat neuro-psychiatric diseases such as Parkinson's disease, 
Alzheimer's disease, psychosis, and schizophrenia [113] [155]. These drugs have 
features common to the cationic amphiphilic drugs (CAD) family, as they consist of a 
hydrophobic and a hydrophilic moiety. One of the major features of CADs that is 
relevant to this work is the protonation of the nitrogen at physiological pH. 
From their amphiphilic character, it is expected that CADs partition effectively into 
both biological [156] and artificial bilayers [150] [103] and bind preferentially to the 
bilayer interface causing bilayer perturbation [107] [110] [157] as was described for 
HPD and SPIP causing disorder in the interfacial region [120]. Partitioning of CADs 
changes the degree of membrane lateral organization and is dependent on the 
membrane composition as well as the drug's structure, showing that these changes are 
caused by specific interactions between the compounds and the lipids [158]. 
III.2 Biophysical measurements 
Small Angle X-ray Scattering (SAXS) and Solid State-Nuclear Magnetic Resonance 
experiments were undertaken on condensed fluid lamellar phases made of DOPC in 
the presence of HPD and SPIP at various lipid:drug molar ratio in excess buffer (25 
wt % lipid 75 wt % buffer A). 
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III.2.1 Small Angle X-ray Scattering (SAXS) 
SAXS studies have the advantage of giving macroscopic details including identifying 
the membrane mesophase and determining the spacing between the bilayers (d-
spacing). DOPC: CAD samples at different molar ratios were investigated over the 
course of one month. 
Figure III.2a depicts a typical diffraction pattern corresponding to a DOPC lamellar 
phase that consists of spaced rings with a repeat spacing of 61.76 A . In the presence 
of HPD at a molar ratio of 4:1 (Figure III.2b), 9:1 (Figure III.2c) and 20:1 (Figure 
III.2d) a marked swelling is noted. The 4:1 sample gives a very broad, diffuse 
diffraction pattern, where it is difficult to distinguish between the first and the second 
order rings as the first is probably obscured by the beam stop and the second is very 
broad (Figure III.2.d). This could be a result of a high drug to lipid ratio disrupting the 
bilayer. For these reasons, it was not possible to determine a d-spacing for this 
system. The 9:1 and 20:1 samples also gave broad diffuse diffraction patterns but with 
the two first order rings distinguishable and typical of a lamellar phase with d-spacing 
values at 35A higher that of pure DOPC (Figure III.2b,c). 
The diffraction patterns obtained are markedly different to that of pure DOPC. The 
presence of the drug is characterized by a marked swelling of the phospholipid 
bilayer. The broad diffuse diffraction pattern is a result of a wide distribution of d-
spacing in between the bilayer stacks. This may be a result of sample metastability. 
This has been observed previously with chlorpromazine, another CAD molecule with 
dimyristoylphosphatidylcholine (DMPC) [112]. 
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Figure III .2: SAXS diffraction pattern of (a) pure DOPC in physiological buffer A, and (b) 
DOPC: HPD 20:1, (c) DOPC:HPD 9:1, and (c) DOPC:HPD 4:1 systems in physiological 
buffer A. The presence of the HPD is represented by a marked swelling of the DOPC biiayers 
that is a result of a low degree of ordering of the system. 
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This swelling of all of the DOPC: HPD samples was also found to be time dependent. 
The d-spacing was seen to increase over a period of a week reaching a plateau at 
82.72 A in DOPC: HPD 20:1 samples at 35°C. This is contrary to pure DOPC 
systems that are known to equilibrate after 20 minutes. The DOPC lattice parameter is 
stable at 62 A over the course of the experiment (Figure 111.3). 
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Figure I I I .3; Evolution of the d-spacing in D O P C : H P D 20:1 samples 
with t ime in physiological buffer A, The sample equilibrates af ter one 
week at 82.72 A. The d-spacing value for D O P C is shown in a red circle. 
The broad diffraction pattern with high d-spacing associated values is what might be 
expected from a charged membrane interface which causes the bilayers to repel each 
other, leading to an increase of the lattice parameter [159]. Here, DOPC: HPD 
systems are made in buffer; therefore HPD is protonated at pH 7.4 (pKa=8.7) [42], 
consequently the protonation of the drug at the interface triggers the repulsion 
between the bilayers. This result suggests that HPD resides at the membrane interface. 
The swelling behavior was also noticed for SPIP which is the other protonated CAD 
(pKa=8.3) [42] investigated in this section. Broad and diffuse diffraction patterns 
characterized by high d-spacing values are observed in DOPC: SPIP 20:1 systems, 
with the lattice parameter reaching 76.0 A after 17 days. However the system is seen 
to evolve into another liquid crystalline mesophase after 3 weeks, with the formation 
of an Hn inverse hexagonal phase at 35°C. The Hn inverse hexagonal phase does not 
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occur in the control as bilayers made of DOPC lipids over this timescale form 
preferentially the La phase at room temperature (Figure III.4). 
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Figure III.4: SAXS pattern obtained for DOPC:SPIP 20; 1 in physiological buffer A (50mM Bis Tris, 
100 mM NaCI, pH 7.4). The presence of the SPIP is characterized by a distinct swelling of the 
phospholipid bilayers until breaking up into the inverse hexagonal phase after 28 days (Figure taken 
from ref [149]). 
III.2.2 Solid State NMR (SS-NMR) 
SS-NMR spectroscopy is a particularly sensitive technique for the determination of 
the tliree-dimensional structure of membranes with atomic resolution [71]. Static ^'P 
SS-NMR allows the distinction of the three main lipid mesophases: lamellar, 
hexagonal and isotropic phases i.e. cubic or micellar phases. Specific powder patterns 
are obtained from the chemical shift anisotropy (CSA) that is related to the average 
orientation of the phospholipid headgroup and the molecular motion of the lipid. 
Removing anisotropic interactions using '^C SS-NMR magic angle spinning (MAS) 
gives high resolution information about the framework and structure of the 
phospholipid bilayer such as the state of the chains (see chapter II for more details). 
Therefore ^'P and '^C SS-NMR MAS give complementary information on the 
structure and the phase of bilayer systems. 
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III.2.2.1 Static solid state NMR 
Figure III.5a illustrates a characteristic lamellar powder pattern of DOPC bilayers that 
arises from the broadening of the CSA. This pattern also shows that the sample is in a 
single phosphorous environment with a CSA of 50 ppm. 
In the presence of HPD at 20:1 and 4:1 lipid to drug molar ratios, the static ^'P pattern 
is drastically altered (Figure III.5b,c). The static ^'P powder pattern of DOPC: HPD 
4:1 consists of a single large peak centered at ~3ppm, showing that the sample has 
evolved into an isotropic environment (Figure III.5c). In DOPC: HPD 20:1 samples 
an additional narrow lamellar powder pattern is superimposed upon the original one 
with a CSA of 30ppm, as well as a sharp peak that appears at ~3 ppm (Figure III.6b). 
These features show that the samples are in different mesophases at different CAD 
concentration. 
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Figure I II .5: Static P Solid-State powder pattern for (a) 
pure DOPC, (b) DOPCiHPD 20:1, (c) DOPC:HPD 4:1. The 
appearance of an isotropic peak at 3ppm is revealing of the 
formation of an additional mesophase. 
The sharp isotropic peak observed at 3 ppm in DOPC: HPD 20:1 and 4:1 is what 
could be expected from an isotropic phase such as a cubic or micellar phase as sharp 
isotropic lines arise from the rapid averaging on the NMR timescale. This result can 
be correlated to SAXS data where assumptions of the presence of micellar phases 
were made. 
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The second superimposed narrower lamellar powder pattern is characteristic of 
interactions of single chained lipids with phospholipids [160]. The narrower CSA 
arises from the increase of conformational freedom of the glycerol region of lipid in 
the bilayer. Single chained lipids can also form micellar phases when aggregated 
together, with the hydrocarbon chains sequestered from the polar aqueous medium by 
a spherical shell formed by the polar headgroups. The single chained lipid formed in 
this sample is a lysoPC lipid or LPC (l-oleoyl-2-hydroxy-i'?7-glycero-3-
phosphocholine). The LPC signal evolves with time. The static ^'P SS-NMR powder 
pattern of DOPC: HPD 20:1 starts from a lamellar mesophase with one CSA 
enviromnent to two lamellar mesophases with two CSAs due to the presence of LPC 
in the bilayer within one day (figure III.6b). After tliree days, the sample reaches an 
isotropic / micellar phase (figure III.6c); this pattern is similar to the static ^'P NMR 
DOPC: HPD 4:1 described above. Similar patterns were obtained with DOPC: SPIP 
:20:1. 
. Isotropic peak 
" • - - LPC in tlie bilayer 
DOPC bilayer 
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Figure I II .6: Evolution of the static ^'P powder pattern with time for 
DOPCiHPD 20:1 in physiological buffer A. (a) Pure DOPC, (b) Iday: 
The presence of LPC in the bilayer leads to a change of the ^'P pattern 
with a narrower CSA, (c) 3 days: the LPC is predominant and leads to 
the formation of the isotropic phase. The sample has evolved froin a 
lamellar phase to an isotropic phase that is predominant after 3 days. 
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Figure III.7 gives a schematic representation of the evolution of the bilayer as seen by 
^'P SS-NMR. From SAXS and ^'P SS-NMR data it is reasonable to assume that the 
CAD resides at the bilayer interface and also that the DOPC: CAD systems evolve 
from a lamellar phase to an isotropic micellar phase that causes the disruption of the 
lamellar state. 
1 CSA that comes from 
the DOPC in the bilayer 
2 superimposed CSAs 
from the DOPC and 
LPC in the bilayer 
2 superimposed CSAs 
from the DOPC and LPC 
in the bilayer 
1 isotropic peak from the 
micelles 
Figure III .7: Evolution of the DOPC bilayer in the presence of the CAD. The CAD resides 
at the polar / apolar interface and triggers the formation of LPC (red) that gives a naiTower 
CSA in the bilayer superimposed to the DOPC CSA. The LPC phase separates into micelles 
/ fragments that give the isotropic signal on the ^'P powder pattern. 
III.2.2.2 MAS '^C solid-state NMR 
MAS ^^ C solid-state NMR is a highly revealing technique as it shows clear signals 
from the '^C nuclei in the structure of the phospholipids. Rapid trans / gauche 
isomerisation conformation leads to sharp and well resolved peaks for the fluid 
lamellar phase. 
Figure 111.8a shows the characteristic spectrum obtained from DOPC La phase 
samples as the peaks are sharp and well resolved. The fluid phase is correlated to 
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sharp peaks as a result of an averaging of the lipid trans / gauche isomerisation. The 
spectrum can be divided into four regions that correspond to the hydorophobic core 
(10-50 ppm), the glycerol backbone (50-80 ppm), the C=C bond at 133 ppm and the 
esterified carbonyl at 177.1 ppm. The peak assignments are given in Table III.l. 
Chemical shift 6 Assignement 
(ppm) 
177.1 DOPC carbonyl 
133.0 DOPC double bond C8-C9 
7 4 2 Cg2 
6 9 ^ CP 
6 7 2 Cg3 
6&8 Cgl 
63.1 Ca 
5%8 Cy 
26.1-37.6 DOPC chain 
17.4 Chain methyl end group 
Table I I I .1 :"^C N M R DOPC peak assignments. 
In the presence of the HPD, the system remains in the fluid lamellar state with the 
peaks being sharp and well defined. The spectrum shows a large number of peaks, 
which correspond to the DOPC and HPD signals confirming the binding of the HPD 
to the membrane. The state of the chains is not altered in DOPC: HPD samples but is 
in the carbonyl region (-175-185 ppm) where an extra peak is appearing at 181 ppm 
and also a minor peak at 178 ppm in addition to the ester carbonyl group of DOPC at 
177 ppm (figure III. 8b). The chemical shifts of these two additional peaks are 
indicative of the presence of the carbonyl group of a fatty acid i.e. oleic acid (OA) 
(181 ppm). The minor peak can be attributed to the ester carbonyl group from LPC 
[161]. 
The appearance of the oleic acid in a DOPC: CAD sample has a critical effect on 
DOPC lamellar mesophases. OA has been reported to promote the formation of the 
Hit phase in PC bilayers [162]. 
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Figure III .8: (a) '^C MAS spectrum of pure DOPC in the fluid state, (b) '^C MAS 
spectrum of DOPC: HPD in physiological buffer A showing the evidence for the formation 
of oleic acid at 181.0 ppm and LPC at 178 ppm (expanded region) 3 days after the sample 
was made. 
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III.2.3 CADs induce the acid hydrolysis of the bilayer 
From both the SAXS and NMR studies it is evident that in the presence of the CADs, 
the fluid La lamellar phase coexists with a micellar phase before ultimately forming a 
new phase, the Hn phase. From the results discussed above, it appears that CADs have 
a considerable effect on DOPC bilayers in a buffered system. 
First, it was shown by SAXS that HPD and SPIP have an effect on the d-spacing at 
every ratio. It was found that the DOPC bilayer was completely disrupted showing 
only one broad ring reflecting the presence of a micellar phase in DOPC: HPD 
systems at a molar ratio of 4:1. There is still some residual integrity of the lamellar 
bilayer at a ratio of 9:1 and 20:1, however the d-spacing is seen to increase 
considerably with time reaching equilibrium at a value of 81 A after one week. At this 
time the diffraction pattern is similar to the 4:1 ratio, showing very broad and diffuse 
rings. This swelling behaviour is due to the charged DOPC: CAD interface with the 
proto nation of the drug repelling the membranes. The CAD is seen to bind to the 
water-bilayer interface as described elsewhere [97] [37] [107] [110] [157]. SAXS 
diffraction patterns also showed that the CAD promoted the formation of another 
mesophase: the inverse hexagonal phase Hn. 
Secondly, from the SS-NMR results it appears that HPD and SPIP had a critical effect 
on the membrane shape and integrity as it was established from the ^'P static spectra 
where the isotropic peak appeared at ~3ppm which corresponds to the appearance of 
LPC. In addition, this isotropic peak can also be the result of the formation of 
fragments and small vesicles [163]. ^'C MAS spectra showed the formation of oleic 
acid at 181 ppm and confirmed the presence of LPC in DOPC: HPD samples. The 
same effects were observed for DOPC: SPIP. 
Membrane fragments formation has been observed previously in CAD-lipid systems, 
and has been attributed to the formation of CAD-lipid conjugates [46] [164]. 
However, this carmot explain the time-dependent formation of the inverse hexagonal 
phase as well as the isotropic micellar phase. The simplest hypothesis to explain the 
appearance of both these phases is that an acyl chain is being formed via the 
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hydrolysis of DOPC, resulting in the creation of a single chained lipid i.e. LPC and 
the associated fatty acid, OA. It is known that LPC will phase separate from the 
parent membrane at high concentration and form micelles [165] [166] [163]. 
CADs potentially act as an acid catalyst until the whole membrane is degraded into 
LPC and the associated fatty acid, oleic acid. Protonated CADs reside at the water-
lipid interface of the bilayer, which enable them to activate the lipid ester function and 
therefore catalyse the hydrolysis of the ester bond. The mechanism by which the lipid 
is degraded by the CAD follows the classical pathway of an ester acidic hydrolysis by 
water, is shown on Figure III.9. 
Prolonaled CAD 
a 
DOPC 
Hydrolysis 
LPC 
Micelle formation 
OA 
Signal a* 181 ppm on NMR 
J . 
c 
ro:-H OH 
Rl—^ . H , 0 
Al-H-O-A, 
hV 
'^9 H 
R1—^  
Protonaled CAD regenerated 
Figure III .9: Representation of DOPC; CAD catalyzed digestion. The hydrolysis of the DOPC in LPC 
and OA is represented on the left hand side; The protonated CAD resides at the lipid interface, and 
activates the lipid ester carbonyl bond to make it more electrophilic. The mechanism of the ester acid 
hydrolysis is given on the right hand side; The electrophilic carbon is attacked by water, which leads to 
the formation of a tetrahedral intermediate. The oxygen is deprotonated by water to neutralize the 
charge, and the R 2 - 0 group is protonated to be a good leaving group. The electrons of the adjacent 
oxygen push out the neutral R 2 - 0 H (LPC) and reveal the C = 0 of the carboxylic acid (fatty acid). The 
acid catalyst is regenerated. 
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It is expected that CADs dissolve into OA / LPC fragments once LPC molecules are 
able to form micelles i.e when there are about 30 % of LPC molecules in the 
membrane [163], although lysolipids and fatty acids form bilayers and are stable in 
the membrane [167]. Finally it is likely that the LPC ester bond is degraded into OA 
molecules as the reaction progresses. 
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III.3 Detection of the degradation products by 
normal phase high pressure hquid chromatography. 
111.3.1 HPLC system 
Detection of DOPC and CADs as well as degradation products LPC and OA was 
investigated by normal phase HPLC equipped with an evaporative light scattering 
detector (ELSD). Normal phase HPLC consists on separating the lipid: drug mixture 
according to their polarity. They are separated using a polar stationary phase made of 
silanol and a nonpolar mobile phase made of hexane, isopropanol, water and acetic 
acid. After dissolution into the mobile phase, the lipid:drug mixture is injected and 
run by the mobile phase through the column. The products associate with the matrix 
and are retained on the column. Adsorption strengths increase with an increase in the 
compound's polarity. Elution of lipid: drug species is possible when a more polar 
mobile phase is run through the column. Detection was possible with the ELSD 
detector that converts the effluent off the column into lipid nebulized lipid droplets 
that scatter a beam of light. The detector response is a function of the quantity of 
lipids within the droplets. Therefore, attribution of retention times for each lipid 
species as well as its quantification is possible. Normal phase HPLC was a system of 
choice as it allowed the separation of the DOPC, LPC, CAD and OA on the same 
chromatogram with a gradient from an apolar mobile phase, mobile phase A to a more 
polar mobile phase, mobile phase B (details on the mobile phase composition and 
gradient as well as detector descriptions are given in chapter II). 
111.3.2 Standards 
Standards were dissolved in mobile phase B and injected separately to determine 
retention times and resolution of peaks. Figure III. 10 shows chromatograms of DOPC, 
HPD, SPIP, LPC and OA. Each peak looks sharp and well resolved. Attribution of 
retention time is therefore possible apart from the OA that is eluted at 3 min, which 
overlaps with the injection peak. The minor peaks present in figure 111.10 b,c,d at 2 
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and 11 min correspond to the injection peak and the mobile phase respectively. Table 
III.2 shows retention times attributed to each species. 
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Figure III.IO: Normal phase HPLC elution profile for (a) OA, (b) DOPC, (c) LPC, (d) 
HPD. 
Injected molecules 
OA 
DOPC 
LPC 
HPD 
Table I I I .2: Standard elution times 
Retention time (min) 
2 8 0 
17.75 
2L48 
13.85 
Injection of the four compounds together showed a clear separation of peaks on the 
chromatograms. These sets of results are encouraging as they allow the separation of 
the 4 main compounds, namely DOPC, LPC, CAD and OA. All chromatograms 
obtained have a clear baseline and peaks are well resolved, showing the accuracy and 
efficiency of the ELSD detector (Figure III. 11). 
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Figure I I I .11 : Normal phase HPLC elution profi le for a mixture of the 4 standards. 
The fatty acid is eluted first at 2.80 min, followed by HPD at 13.84 min, DOPC at 
17.75 min and finally LPC at 21.48 min. This elution profile was already observed in 
the literature [168]. 
Calibration curves were obtained for individual lipid or fatty acid molecules by 
injecting a range of concentrations from 0.002 |j,g to 1 |j.g of compound in the HPLC 
system. The results showed a linear response of the detector, with a range of linearity 
being around 0.99, the base line was stable and the retention times reproducible. 
Therefore it is possible to quantify precisely the amount of lipid species and drug that 
are present in the system except for the fatty acid, where an error coming from the 
injection peak is added to the fatty acid signal, is not possible to quantify. The 
calibration curves for DOPC, LPC and OA are represented on figure in . l2 . 
The normal phase HPLC system investigated in this section is very accurate and 
reliable, with reproducible DOPC, LPC and HPD retention times, and a linear 
calibration curve. 
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Figure III .12: Calibration curves for DOPC (a), 
LPC (b) and OA (c). These calibrations were 
used to calculate the quantity of DOPC 
remaining and LPC formed in the samples at 
different times. 
III.3.3 Detection of the degradation products in DOPC: CAD 
systems 
Detection of degradation products was undertaken in DOPC: HPD systems with the 
system described above. Figure III. 13 depicts the chromatograms obtained after 
dissolving a DOPC: HPD 20:1 sample four days old in the mobile phase B. The 
chromatogram shows four sharp and well resolved peaks, of which the retention times 
all correlate with the standards i.e. 3 min for OA, 13.84 min for HPD, 18 min for 
DOPC and 21.48 min for LPC. The DOPC: HPD and DOPC: SPIP have effectively 
degraded into OA and LPC. The peak emerging at 12.73 min is attributed to the 
mobile phase signal; this peak is present in all samples as well as blanks. 
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Figure I I I 13: Detection of the degradation products in DOPC;HPD samples after 3 days 
at room temperature. 
Nonnal phase HPLC allows the detection of the degradation products as well as their 
quantification. However care must be taken when measuring the OA peak, as this also 
correlates with the injection peak. Different gradient systems were tried but none 
could shift the OA peak away from the injection peak. This might suggest that the OA 
is not retained on the column at all. 
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III.4 Direct visualization of the degradation 
III.4.1 Use of giant unilamellar vesicles (GUVs) as model 
membranes. 
Giant unilamellar vesicles (GUVs) are model systems with a diameter range of 1 |im 
to 100 fj,m. Correlation between GUVs and biological cells is possible thanks to 
numerous features such as size, lipid composition and osmotic balance inside and 
outside the vesicle. GUVs are attractive systems to examine biological functions 
ranging from membrane fusion to membrane fission [169]. They can be used for 
physical and biological investigations and are convenient models that can be observed 
directly under a light microscope. Observation of shape changes of GUVs induced by 
interactions of small molecules have been extensively investigated in the literature 
[170] [171]. Shape changes are directly correlated to elastic properties of the 
phospholipids that form the vesicles, this feature allows the detection of the change in 
the area of the membrane with high sensitivity [172] [173]. Several methods exist to 
form GUVs, the most used ones being the spontaneous swelling [174] and the 
electro formation [148]. Electro formation was the method employed in this section. It 
consists of drying the lipids on a platinium electrode followed by hydration under 
alternative current. The GUVs formed are mostly unilamellar with a size greater than 
1 |im. 
The use of electroformed GUVs allowed the direct visualization of the CAD 
interacting with the phospholipid bilayer. Two main experiments were performed: the 
electroformation of GUVs where DOPC and HPD were dried and electroformed 
together, this method will be referenced as "the co-lyophilised method"; and the 
addition of fluorescent SPIP to electroformed DOPC vesicles "the addition method". 
The co-lyophilisation method enables the drug to sit at the water-bilayer interface 
during the electroformation, whereas the addition method consists of injecting the 
fluorescent drug to preformed vesicles. 
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III.4.2 Electroformation of Giant Unilamellar Vesicles with 
HPD. The co-lyophylised method. 
Giant DOPC:HPD co-lyophilised vesicles grown in a buffered system at a 4:1 molar 
ratio were observed with transmission microscopy over an hour. Figure 111.14a shows 
a micrograph of GUVs made of pure DOPC. The vesicles adopt a perfect spherical 
shape under minor tension, are symmetrical with a large internal core, and reach a size 
of 10 |im. These vesicles are stable for more than 6 hours. 
Electroformation of GUVs made of DOPC and HPD appears to be complex. The 
formed vesicles encounter difficulties to grow, and they do not reach the expected size 
nor the shape of a pure DOPC GUV vesicle. The DOPC: HPD vesicles appear small, 
elongated, distorted and disproportionate (Figure III. 14b). In addition, membranous 
fragments are being formed as well as an appearance of vesicles inside other vesicles 
that are not present in the pure DOPC vesicles. Figure III. 14c shows how the vesicles 
are destabilized in the presence of HPD, until they lose their shape and shrink to a 
uniform size, over 30 minutes. 
m 
Figure III .14: Electroformation of DOPC: HPD GUVs in physiological buffer, 
(a) Electroformation of pure DOPC GUVs. The vesicles are symmetrical and 
spherically shaped, (b) The electroformed DOPC: HPD GUVs are irregularly 
shaped and distorted. Membranous fragments are also observed inside the 
vesicles, (c) The DOPC:HPD GUVs are short lived and shrink to a multi-layered 
vesicles of drug / lipid mixture that is monodisperse. 
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Electro formed DOPC: HPD GUVs are unstable and short lived, and typically mutate 
into severely distorted vesicles, in which there are a myriad of different smaller 
vesicles evident. From these results combined with SAXS and NMR it is reasonable 
to assume that the shrinkage of the vesicles is due to the degradation of the DOPC 
bilayer by the CAD, that takes place during the electroformation of the GUVs. The 
DOPC: HPD GUVs cannot grow and are elongated because of the appearance of LPC 
and oleic acid as the degradation goes on. The effects of LPC and oleic acid on 
vesicles made of DOPC were described to significantly decrease the size of the 
vesicles as well as promoting the formation of disc-like structures and threadlike 
cylindrical micelles. The small membranous fragments seen to appear inside the 
vesicles can be attributed to the formation of CAD / lipid / fatty acid / micelle mixture 
as a result of the catalytic reaction. As the reaction proceeds the vesicles shrink and 
result in small monodisperse vesicles that aggregate together. It has been already 
observed that equimolar mixture of PC:LPC:OA would form monodispersed closed 
structures, whereas the presence of more fatty acid considerably alters the shape of the 
vesicles (Figure III.15b,c) [165]. 
b 
W i 
Figure III.15: Cryo T E M representing vesicles formed in an equimolar mixture (b) and in 1:1:4 molar 
ratio of eggPC, LPC and OA. The figure is taken from reference [165]. Bar=100nm. 
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III.4.3 Addition of Flucrescently labeled SPIP to GUV 
Visualization of the degradation was also carried out using fluorescence microscopy 
by injecting fluorescent NBD-tagged-SPIP which is a SPIP analogue, to 
electroformed GUVs made of DOPC residing on the electrode in buffer. The structure 
of NBD-tagged-SPIP is shown on figure III. 16. 
N N 
Figure III.16: Chemical structure of the NBD-tagged-SPIP (NBD-
Aminohexanoylaminophenetylspiperone) 
In this method, the fluorescent CAD is injected to the vesicles whereas in the 
colyophilised method, the drug was already sitting at the interface. GUVs made of 
DOPC were grown and stabilised as desribed in chapter II. NBD-tagged-SPIP and 
SPIP were solubilised together in a 1:1000 molar ratio in pure ethanol prior to 
injection. The CADs were then injected outside the DOPC vesicles and left to interact 
with the lipids. A movie showing the degradation of DOPC vesicles was recorded 
over 40 min (Please see DVD attached). 
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Figure III.17: Injection of NBD-tagged-SPIP to GUVs made of DOPC. (a) Binding of the fluorescent 
drug occurs within 150 ms and is uniform on the bilayer (GUVs and the platiniu wire), (b) The vesicles 
are being distorted and membranous fragments are present, (c) The fluorescence intensity increases on 
the surface of the vesicle due to more membranous fragments formed, (d) The vesicle acquires an 
irregular shape caused by the lipid hydrolysis until it is destabilized (e) and leaves the electrode after 40 
min. 
Uniform distribution of NBD-tagged-SPIP is initially evident on the vesicles as well 
as on the platinum wire. Binding of NBD-tagged-SPIP to DOPC vesicles occurs 
within 150ms, confirming the preference of the CAD at the membrane interface 
(figure III. 17a) despite the NBD tag that makes it more soluble. The degradation takes 
place in the first minute, where membranous fragments and small vesicles are 
visualized. After 5 min, the vesicles are visibly distorted and elongated, confirming 
the results obtained with the colyophilised method (Figure III. 17b). Fluorescent 
membranous fragments containing SPIP and NBD-tagged-SPIP are also being formed 
inside and outside the vesicles and float away from the host GUV (figure III. 17c) as a 
result of the action of the drug. There is evidence of vesiculation and detachment of 
lipids from the vesicle as a result of the hydrolysis of the ester carbonyl bond of 
DOPC. The intensity of fluorescence increases on the surface of the vesicle due to 
newly formed micelle / membrane fragments and small vesicles [175] (Figure 
III.17d). The hydrolysis goes on with enrichment of membrane fragments and fatty 
acid both on vesicles and the platinium wire, until the vesicle becomes unstable at 39 
min, which subsequently triggers the detachment of the vesicle from the wire at 40 
min (Figure III.17e). 
Here evidence of the hydrolysis of the lipids comes from the shape shrinkage 
distortion of the vesicles and formation of fluorescent membranous / micelle 
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fragments. Morphological modifications of GUVs due to lipid hydrolysis by 
phospholipases showing significant shrinkage of the vesicles inducing vectorial 
budding of smaller vesicles from the surface of the GUVs was already described in 
the literature [176] [177]. Fluorescence microscopy was found to be highly revealing 
showing the GUVs being chemically degraded by the CAD when it is added to the 
bilayer, this occurring on time scales consistent with observed pharmacokinetics 
[178]. 
Direct visualization of the degradation of the phospholipid fabric of GUVs was 
observed with transmission and fluorescence microscopy. The formation of 
membrane fragments is a result of drug-induced ester-hydrolysis at the membrane 
level. The results described above confirmed the initial assumption made from SAXS 
and NMR data. 
III. 5 Importance of the phospholipid ester hnkage 
The above sections demonstrated how CADs catalyse the acid-hydrolysis of the ester 
linkage present in the phospholipid chains, producing a fatty acid and single-chain 
lipid. To test the hypothesis of the membrane hydrolysis through acid catalysed ester 
cleavage, interactions of CADs with ether-linked PC lipids 
(dioctadecenylphosphatidylcholine) were investigated by SS-NMR and fluorescence 
microscopy. Ether-linked PC lipids are species that are present in nature; in particular 
they can be found in tissues such as heart muscles and in the nervous system [179]. 
Ether-linked PC lipids are characterized by an ether bond in the glycerol vicinity 
resulting in the absence of hydrogen that prevents them from taking part in hydrogen 
bonding (Figure III. 18). 
Figure I II .18: Structure of the ether-linked PC lipid used (l ,2-Di-0-Octadecenyl-5«-Glycero-3-
Phosphocholine) 
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These lipids are stable with the ether bond remaining intact under the conditions of 
the experiments and therefore are not subject to acidic hydrolysis. Therefore in the 
presence of an ether linkage the proposed reaction mechanism should be incapable of 
causing chain hydrolysis. 
III.5.1 Evidence from static solid-state NMR 
Figure III. 19a illustrates a characteristic lamellar powder pattern obtained by ^'P static 
NMR, similar to that of DOPC bilayers that comes from the broadening of the CSA. 
This pattern shows that ether linked PC bilayers are in a single phosphorous 
environment with a CSA of 50 ppm. Ether-linked PC bilayers are in the fluid lamellar 
phase La at room temperature (Tm= -22°C) [75]. 
In the presence of DOPC: HPD 4:1 lipid to drug molar ratio, the static ^'P pattern is 
unaltered over two weeks (Figure III.19b,c), this is contrary to DOPC systems where 
an isotropic peak is evident after one day at that lipid: drug ratio. The ether-linked PC; 
HPD system is very stable over two weeks, showing no signs of micellar isotropic 
phases. 
20 - 2 0 ppm 
Figure III .19: ^'P solid-state NMR time evolution of Ether-
linked PC: HPD 4:1 in physiological buffer A. (a) Ether-
linked PC powder pattern appears characteristic of a lamellar 
phase with a CSA of 50 ppm. (b) Ether-linked PC:HPD 4:1 
powder pattern after two days and (c) two weeks. The system 
is stable and remains in the lamellar phase. 
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III.5.2 Fluorescence microscopy 
Similarly to DOPC experiments, injection of fluorescent NBD-tagged-SPIP to 
electroformed GUVs made of ether-linked PC was undertaken in a buffered 
environment. It is shown on figure III.20a that the drug binds homogeneously to the 
ether-linked lipids confirming the ability of the drug to reside at the water-bilayer 
interface. The vesicles are spherically shaped and symmetrical upon the addition of 
the drug and stay stable for more than 40 min. There is no evidence of distortion of 
the vesicles as described for DOPC or presence of membranous fragments at any 
point over the course of the experiment (Figure III.20b,c). 
40 mm 20 mm 
20pm 
Figure 111.20: Injection of NBD-tagged-SPIP to GUVs made of ether-linked PC. (a) The fluorescent 
drug binds homogeneously to the vesicles, (b) After 20 min the GUVs are perfectly stable and 
spherically shaped, (c) There is no evidence of formation membranous fragments after 40 min due to 
the absence of ester linkage, (d) Transmission micrograph confirms the integrity of the vesicles. 
The major difference between this set of experiments and the former ones is the lack 
of ester bonds in the phospholipids. The lipid bilayer is not degraded by the drug 
when an ether bond replaces the ester bond; therefore the presence of the ester linkage 
of the phospholipids is compulsory for the reaction to occur. 
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III.6 Binding and partitioning of the CADs into 
vesicles 
This section will focus on the investigation of HPD and SPIP binding properties to 
bilayers made of DOPC followed by an examination of its hydrolysis using an 
original fluorescence technique [143]. Binding constants of these drugs to DOPC 
bilayers will be also determined. 
III. 6.1 Background 
The basis of the detection method for measuring CAD binding phenomena to lipid 
bilayers is linked to variations in membrane electrostatic potentials. It is well known 
that when molecules such as ions, peptides, drugs bind to membranes, they induce a 
change in the bilayer electrostatic potentials in both biological and model systems [92, 
135,180]. 
Three electrostatic potentials are associated with membranes: the transmembrane 
potential Avj;, the dipole potential 0^ and the surface potential Oj. The transmembrane 
potential arises from a gradient of electric charges across the membrane, the dipole 
potential originates from the molecular dipoles of the lipids that form the bilayer and 
the surface potential arises from a net electric charge at the membrane surface. 
The surface potential represents the potential difference between the membrane 
surface and the bulk aqueous phase [137]. In that respect, 0^ properties can be utilized 
to characterize binding events by monitoring changes and variation of Os upon 
addition of CADs to lipid bilayers. It has been reported that electrostatic details can be 
obtained by using spectrospcopic probes that change their spectral properties 
according to their electrostatic potentials [181]. Characterization of the variations of 
Os upon addition of various types of molecules to cell membranes and model 
membranes has been studied extensively using the fluorescent lipid 
fluoresceinephosphatidylethanolamine (FPE) [143, 147, 182]. FPE, which contains 
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the phosphatidylethanolamine motif, has the ability to incorporate into lipid bilayers, 
leaving the fluorescein moiety exposed to the aqueous phase. This enables the probe 
to be sensitive to changes in the surface potential 0^. FPE is a real time probe for the 
study of molecules binding to lipid bilayers. 
Adding positive charges to a bilayer system containing FPE will reduce the size of the 
membrane electronegative potential that deprotonates the fluorescein xanthene group. 
This is reflected by an increase in the fluorescence signal. The theory of the 
fluorescence binding assay involving the use of FPE is fully described in chapter II. 
III.6.2 Binding kinetics of HPD and SPIP to vesicles made of 
DOPC. 
As described in chapter I, HPD and SPIP exhibit common structural features that 
allow their classification into the cationic amphiphilic drug family. It has been noted 
that these type of drugs have the ability to partition into lipid bilayers according to 
their amphiphilic properties [123, 149]. Moreover, these molecules are protonated at 
pH 7.4, as HPD pKa= 8.7 and SPIP pka= 8.3 [42, 44]. Therefore binding properties of 
the mentioned drugs can be investigated using the FPE and are expected to alter the 
surface potential Og. 
III.6.2.1 DOPC vesicle labeling 
Figure III.21 shows the absorption and emission spectrum of 100 nm extruded FPE 
labelled DOPC vesicles. The obtained spectrum shows the excitation and emission of 
the fluorescein at the bilayer surface, with an excitation wavelength A,exc=495 nm and 
an emission wavelength A.em=530 nm. 
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Figure 111.21: Absortpion (black) and emission (red) spectra 
obtained for FPE labelled DOPC vesicles. 
The shoulder observed at 463 nm on the excitation spectra is due to the presence of 
the mono-anionic form of the fluorescein at pH 7.4 (figure III.22). 
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Figure 111.22: The four ionization states of fluorescein (a). Each 
state has a distinctive excitation spectrum (b). As FPE is inserted in 
phospholipids vesicles at pH 7.4, it is expected that its excitation 
spectrum correspond to a mixture of the monoanionic and 
dianionic form, (figure taken from reference [142]). 
The absorption emission spectra obtained are in accordance with the literature [142, 
184]. The absorption as well as the emission fluorescence of FPE is responsive to the 
surface potential. As emission fluorescence is more sensitive than absorption [143], 
only the change in the fluorescence emission will be considered and correlated to a 
change of the surface potential. The maximum emission intensity corresponds to 
labelled vesicles before the addition of drug molecules. 
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III.6.2.2 Addition of HPD and SPIP to FPE labelled DOPC vesicles. 
The change in fluorescence was monitored upon injection of the protonated drug. 
Addition of protonated HPD and SPIP to FPE labelled DOPC vesicles triggered an 
increase in fluorescence intensity reflecting a decrease in the surface electronegativity 
and deprotonation of the fluorescein xanthene ring. Figure III.23 represents the 
change of fluorescence intensity after subsequent additions of 1 |imol of HPD to FPE 
labelled vesicles. 
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Figure I I I .23: Addit ions of protonated H P D induces a change in the 
f luorescence intensity, indicating a decrease in the electronegative potential. 
The initial f luorescence is circled in red. The arrows represent subsequent 
addit ions of HPD. 
The rapid increase of fluorescence indicated that the binding of the protonated drug 
occurs v^thin the timescale of mixing. Binding of protonated HPD to the vesicles is 
observed in real time with great sensitivity. The interruption of the fluorescence is 
caused by the closure of the fluometer shutter during the addition of HPD. 
Interestingly, the change in fluorescence intensity is relative to the amount of 
protonated CAD added at a constant lipid concentration. Figure III.24 shows an 
increase in fluorescence as a function of the amount of HPD added before reaching a 
saturation value. A similar profile is also obtained in the presence of SPIP. 
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Figure I I I .24 : Subsequent addit ions of protonated H P D to FPE labelled 
D O P C vesicles cause an increase in f luorescence until saturation is 
reached. The initial f luorescence is circled in red. 
The fluorescence traces are also seen to evolve with time when more than 5 jimol of 
HPD are added. This feature is explained in section III.6.3. 
The change in fluorescence intensity F associated with the CAD titration was 
calculated from the initial fluorescence value corresponding to the fluorescent labelled 
vesicles before the addition of CADs. To disregard the increase of fluorescence with 
time, only the early points were taken into account for the absolute fluorescence 
calculation. 
From these values binding curves were extracted and data were fitted to a single site 
binding model, (equation III.l) [143] 
F = 
Equation l l i . l 
where F is the fluorescence change, Fmax the maximum fluorescence change, [CAD] 
the concentration of the added drug and Kd the affinity of the drug for the membrane. 
Fitting the single site binding model leads to HPD Kd = 40.38 ± 1.09 |iM and SPIP Kj 
= 102.60 ± 4.64 pM (Figure 111.25). 
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Figure III.25: Absolute f luorescence correlation with H P D and 
SPIP titration. The data were fitted by a single binding site model 
and yielded a H P D Kd=40.38±1.09|aM and SPIP 
Kd=102.60±4.64 | iM. 
III.6.3 Detection of the bilayer hydrolysis 
Protonated HPD and SPIP bind rapidly to FPE labelled vesicles; this is observed from 
the rapid increase of the fluorescence intensity. The fluorescence traces resulting from 
the HPD binding are flat when the concentration is less than 5 pM; which confirm 
that the system is at equilibrium. However, further additions of HPD led to different 
fluorescence traces; these are seen to constantly increase with time. Therefore the 
surface potential is constantly altered when more HPD binds to the vesicles (Figure 
111.26). 
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Figure I I I .26 : Addit ion of protonated H P D to FPE labelled 
vesicles. The initial f luorescence is circled in red. The 
system is at equil ibrium up to 5 ^iM of added HPD. When 
more H P D is added, the f luorescence traces are seen to 
increase with time. 
This unusual fluorescence profile can be attributed to several reasons; the most 
obvious one being that the system is not at equilibrium when more HPD is added and 
it can be argued that protonated HPD binds more slowly to the vesicles. This would 
be true if there was no change in fluorescence at all when more HPD is added, which 
is not the case. Addition of HPD triggers a change in the fluorescence until saturation 
at 200 )j,M as reported on figures III.24 and III.25. 
The action on HPD upon FPE labelled vesicles was followed by a real time 
experiment by recording the fluorescence evolution with time after subsequent 
additions of HPD. The system was left to equilibrate after addition of 57 p-M of HPD 
(Figure 111.27). 
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Figure 111.27: Time dependence of the addition of 57 pM of 
HPD on the fluorescence of FPE labelled vesicles. The initial 
iluorescence is circled in red. The arrows represent subsequent 
additions of HPD. 
The fluorescence is seen to increase with the amount of added HPD, which is 
consistent with previous results, but also with time after addition of 7 |iM of HPD. 
The same pattern is observed with other concentrations tested. The DOPC: HPD 
system is left to equilibrate after addition of 57 )j,M of HPD, which results in the 
increase of the fluorescence linearly with time. The system cannot reach equilibrium 
after 90min. This time dependent fluorescence behavior is not dependent on the CAD 
concentration. This observed profile is expected for a surface potential becoming 
more positive with time. Comparable traces were observed with SPIP binding to FPE 
labelled DOPC vesicles. 
Wall and coworkers have observed similar fluorescence traces for the action of 
neuraminidase upon FPE labeled erythrocytes ghosts membranes [135]. The 
neuraminidase is an enzyme that removes sialic acid from the cell surface. 
Fluorescence traces are explained as sialic acid being removed from the membrane, 
causing a loss of negative charge from the cell surface that leads to an increase in the 
surface potential (Figure III.28). 
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Figure I I I .28: Time dependence of the effect of neuraminidase on FPE 
labeled erythrocytes ghosts membranes. The fluorescence is linearly 
increasing with time, due to the removal of sialic acid from the membrane 
surface (Figure taken from reference [135]). 
Fluorescence traces of HPD binding to FPE labeled vesicles are similar to that of 
neuraminidase binding to erythrocyte ghosts; a linear relationship between the 
fluorescence intensity and the surface potential is observed for both neuraminidase 
action on cell membranes and HPD action on DOPC bilayers. The fluorescence trace 
is due to removal of negatively charged molecules from the membrane surface; 
consequently the surface potential becomes more positive with time. 
The use of FPE labeled vesicles can be used to demonstrate that kinetic events such as 
the bilayer hydrolysis occur at the membrane surface upon addition of protonated 
drugs which strongly correlates with the previous results on the membrane digestion 
by CADs. It is indeed expected that half of membranous fragments composed of LPC 
and OA will be negatively charged at pH 7.4, as it was determined that fatty acids pkg 
in a bilayer is approximately 7.5 [160]. This will cause an alteration of the membrane 
surface potential, which can be followed by an increase of the FPE fluorescence 
intensity with time, as it was described for neuraminidase action on membranes [135]. 
This brings the conclusion that membrane hydrolysis can also be detected using FPE 
labeled vesicles. The removal of charges from the membrane surface due to 
membrane hydrolysis can easily be followed by an increase of FPE fluorescence with 
time. To confirm this hypothesis, studies involving the use FPE labeled vesicles made 
of ether-linked PC were undertaken. 
118 
IIL6.4 Addition of HPD to FPE labeled ether-linked PC 
vesicles. 
As it was described previously, the presence of the carbonyl ester function is 
compulsory for the membrane degradation to occur. Therefore, vesicles made of 
ether-linked PC were made and FPE labeled. Addition of protonated HPD should not 
cause any linear increase of fluorescence with time. 
III.6.4.1 Ether-linked PC vesicles labeling 
Figure III.29 represents the excitation and emission of FPE labeled ether-linked PC 
vesicles. The maximum excitation wavelength is 494 nm, and emission is 524 nm. 
The shoulder due to the mono-anionic form of the fluorescein is also seen at 460 nm. 
These values are similar to that of FPE labeled DOPC vesicles (Figure III.21). 
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Figure III .29: Excitation (black) and emission (red) 
spectra of FPE labeled ether-linked PC vesicles, 
exc=494 nm, Xm»xcm=524 nm. 
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111.6 A2 Addition of HPD to FPE labeled ether-linked PC vesicles. 
Addition of protonated HPD to FPE labeled ether-linked PC vesicles triggered an 
increase in fluorescence due to an increase of the membrane surface potential 
electropositivity. HPD binds rapidly to ether-linked PC bilayers, as it was observed 
for FPE labeled DOPC vesicles. Similarly to DOPC systems, the change in the 
fluorescence intensity is dependent on the quantity of added HPD, leading to a 
saturation effect with 220 |iM of added HPD leading to a Kd = 32.99 ±1.51 |iM 
(Figure 111.30). 
Fluorescence traces resulting from the binding of HPD to the vesicles are relatively 
flat and stable with time, even after the addition of 220 pM of drug in contrast to the 
results with DOPC vesicles. Additions of protonated HPD affect the membrane 
surface potential; however there is no evidence of a linear relationship between the 
surface potential and the fluorescence intensity evolution with time. Therefore there is 
no sign of membrane hydrolysis in vesicles made of ether-linked PC lipids. 
It has already been shown that the membrane digestion does not occur in ether-linked 
PC membranes, this is due to the stability of the ether bond in these experimental 
conditions [149]. 
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Figure I I I .30: (a) Addit ion of protonated HPD to FPE labeled ether-
linked PC vesicles. The arrows represent subsequent addit ions of HPD 
( l ,2 ,3 ,5 ,20 ,30 ,40^mol) . The initial f luorescence is circled in red. The 
f luorescence increases with the amount of drug added. The f luorescence 
signal remains flat with time, this shows that no hydrolysis occurs in the 
ether-l inked PC bilayer. (b) Absolute change of f luorescence 
association to H P D titration. The data were analysed according to a 
single site binding model that yielded a Kd=32.99± 1.51 ^M. 
It is interesting to observe that the HPD binding constant is in the same order of 
magnitude in DOPC and ether-Unked PC systems. This impUes that the binding of 
HPD at the interface is independent of the type of hnkage. This was also observed for 
Raclopride, another CAD, which had the same binding affinity for DOPC and ether-
linked PC vesicles [185]. 
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The fluorescent probe FPE can be used to estimate the binding kinetics of CADs to 
membrane bilayers. This technique is irmovative, and allows real time measurements 
of binding in a non invasive manner. HPD and SPIP interact with the membrane 
bilayer in a saturation binding manner. Both drugs have an affinity for the membrane 
interface and partition thanks to driving forces such as the hydrophobic effect. HPD 
exhibits a higher affinity for the membrane interface than SPIP according to the Kj 
values. Therefore, only HPD was tested on ether-linked PC vesicles. Moreover FPE 
measurements can also be used to detect the membrane acidic hydrolysis triggered by 
the protonated drug as a function of removal of charges from the parent bilayer. This 
hypothesis was confirmed by using FPE labeled ether-linked PC vesicles where no 
hydrolysis was detected. 
1 2 2 
in.7 Model proposed 
HPD and SPIP are CADs that were shown to bind rapidly and avidly to bilayers made 
of DOPC. It was shown by SAXS, fluorescence microscopy and FPE fluorescence 
assays that they partition at the water-bilayer interface close to the ester carbonyl 
vicinity; this is in good agreement with the literature [46, 97, 107]. CADs are 
protonated at physiological pH and when bound to the lipids, they were shown to 
destabilize the physical structure of the bilayer over time by i) altering the membrane 
surface potential, ii) repelling the bilayers apart, iii) disrupting the lamellar stacks, and 
iv) promoting the formation of two other mesophases i.e. the micellar and inverse 
hexagonal phase % . These effects were shown by fluorescence assays, SAXS, SS-
NMR, and confirmed by microscopy. 
The simplest hypothesis to explain the appearance of both these phases and the earlier 
visual observations is that an acyl chain is being formed from the hydrolysis of the 
DOPC ester structural group, resulting in the creation of single chained lipid LPC and 
oleic acid. LPC in the fluid lamellar phase shows a narrower CSA pattern due to the 
increased conformational freedom of the interfacial region. When LPC monomers 
aggregate together, they phase separate [165] leaving behind a membrane enriched in 
oleic acid and DOPC which will ultimately drive the remaining membrane mixture 
into an inverse hexagonal phase. When fatty acids interact with phosphatidylcholine 
bilayers, they are solubilised in the mesophase and alter the hydrophilic / hydrophobic 
balance, thus reducing the headgroup area relative to its volume [186]. Fatty acids 
bind to the carbonyl group of DOPC molecules resulting in a larger chain pressure, 
promoting the formation of the Hn phase. However, formation of the inverse 
bicontinuous cubic phase using lipid systems other than DOPC has been described in 
the literature [187]. 
The presence of LPC in the bilayer induces a desire for positive curvature, whereas 
the presence of OA induces negative curvature. This change in lipid composition with 
time has a serious effect on the bilayer topology leading to the formation of 
membrane fragments and the Hn phase. It has been established that lysolipids 
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detabilise membrane morphology, which makes bilayers more sensitive to fusion and 
fission processes [188]. In addition, small vesicles can be formed due the presence of 
the LPC, this was detected by ^'P SS-NMR and cryo-microscopy [163], and 
confirmed by the fluorescence experiment described above (section 111.4.3). 
The presence of fatty acids in the bilayer induces the formation of non-lamellar 
structure [187] thus destabilising the membrane which becomes sensitive to fusion 
processes [94]. 
Therefore, it is likely that the degradation products induce the formation of membrane 
fragments, micelles, and vesicles via local rearrangement of the lipid species as 
described for vesicle budding [189] (Figure 111.31). In this process, products of the 
lipid hydrolysis induce the formation of intermediate structures, which require the 
deformation and the disruption of the parent membrane [190]. The membrane adopts 
a neck-like shape and the formation of intermediate structures is observed. By 
creating a negative curvature, the fatty acid might controle the orientation of lipid 
fragments and small vesicles towards the inner side of the membrane. 
Membranous 
fragments 
Positive 
curvature 
J; Negative 
curvature 
yfj 
Figure I II . 31: DOPC (grey circles) hydrolysis by the CAD (green rectangles) generates two products, 
the LPC (red circles) and the OA (blue chains). The LPC induces the desire of positive curvature, 
whereas the OA induces the formation of inverted phases. The lipid rearrangement in the bilayer 
induces the formation small vesicles. When about 30% of LPC is produced, micelles are formed. The 
presence of OA creates negative curvature which might orientate the direction of the fragments. 
However, the orientations of the vesicles and fragments remain unclear. 
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Requirements for the hydrolysis to occur are the binding of the protonated drug in the 
close vicinity of the lipid ester bond and protonation of the nitrogen, the latter being 
an absolute requirement for the hydrolysis to start. Protonation and charge ensure that 
the CAD will reside in the vicinity of the ester bond that is essential for the hydrolysis 
to happen. The DOPC: CAD system must be in excess buffer thus providing a big 
water reservoir available for the hydrolysis. The mechanism by which the lipid is 
degraded by the CAD follows the classical pathway of an ester acidic hydrolysis by 
water. Degradation of the lipid bilayer is time dependent, the lipids will be consumed 
until no or few LPC molecules remain in presence of a high number of oleic acid 
molecules. 
III.8 Biological relevance 
This chapter has highlighted a new type of CAD interaction with fluid lamellar 
bilayers, leading to their disruption as a result of ester acid hydrolysis. The resulting 
membraneous micellar products are highly dynamic structures that are reflected by 
the motional properties of the monomers within the micelle, allowing rotation about 
their long molecular axes, and lateral diffusion along the micellar surface. Therefore 
CADs bound to micelles are likely to be transported to the next membrane interface to 
undergo the same process of degradation again (figure III.32). These features would 
allow CADs to effect a new transport pathway involving the degradation of the 
phospholipid matrix of the bilayer into membrane fragments. 
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Figure 111.32: Cartoon for the proposed mechanism for the membrane translocation of 
CADs. (1) CADs (green) bind avidly at the polar / apolar interface. (2) Once bound, 
they initiate the ester acidic hydrolysis of the phospholipid fabric that generates LPC 
(red) and fatty acid (dark blue) (3). The drug diffuse through the bilayer and (4) 
generates more LPC. (5) The LPC that is created will form phase separated micelles 
and other membrane fragments on either side of the parent membrane. (6) CADs bound 
to these fi-agments are then carried in the micelle to the next membrane interface to 
undergo the same process again (7). (Figure taken from ref [149]) 
The effects of CADs in-vivo have been reported as inducing cytotoxic effects in cells. 
They induce the development of excessive membrane growth and accumulation of 
abnormal vesicular bodies [123]. This effect known as phospholipidosis is also 
characerised by a high level of PC fragments [121] which could be due to the 
hydrolysis process depicted above. In addition, it has been reported that PC 
production is dependent on the level of stored curvature elastic stress in membranes 
[191], and this level is altered by the change of lipid composition due to CADs 
actions. 
Moreover, the effect of membrane hydrolysis can also be triggered by other molecules 
than CADs. For example, it has been shown that dynorphin, a peptide that binds to 
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opiate receptors, is able to induce the formation of the isotropic micellar phase in 
bilayers made of DMPC [192]. Therefore, this mechanism can take place for peptides 
that are protonated at physiological pH and are susceptible to bind to bilayers, such as 
the arginin rich proteins which sequences are found in HIV. 
127 
CHAPTER 4 
Effects of CAD's formulation on the 
kinetics of the membrane hydrolysis: 
Towards an understanding of the molecular 
basis of non-specific binding. 
This chapter will firstly describe the effect of the CAD's counterion on binding events 
and hydrolysis of the bilayer. Because of a decrease in the solubility of the bought 
CADs, crystallization events were observed in DOPC: CAD systems. As this 
phenomenon was related to counterion recondensation, different experimental 
conditions were studied. To avoid the crystallization of the drug and increase its 
solubility, DOPC: CAD systems with different counterion were studied and 
hydrolysis kinetics measured. Then a kinetic model of the bilayer hydrolysis by three 
CADs, (HPD, SPIP and WAY) was investigated. Hydrolysis rates were determined 
from HPLC traces that were shown to detect the reactants and products of the 
reaction, i.e. DOPC, CAD, LPC and OA. Comparisons of hydrolysis rates in DOPC 
bilayer systems have been considered for each drug and related to biological 
processes that occur in-vivo such as the non-specific binding (NSB) of CADs. The 
hydrolysis rates of DOPC bilayers by CADs give the first insight of the molecular 
basis of the NSB in-vivo. 
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IV. 1 Crystallization of the CADs and counterion 
recondensation 
IV 1.1 Background 
The nature of the counterion has already been described to be of major importance as 
it affects drug's solubility. Different salts are also critical factors in the development 
of pharmaceutical formulations as more than half of the drugs used in medicinal 
therapy are administrated as salt forms [193]. Factors such as the intrinsic solubility of 
acidic or basic drugs, solubility of salt forms, and concentration of buffering agent 
contribute to the dissolution of the drug [194]. Specifically, the effect of the CI' anion 
was shown to slow down the dissolution process of HPD whereas the mesylate and 
the phosphate salt were shown to enhance the dissolution of the drug [195, 196] as 
these salts have a higher aqueous solubility than that of hydrochloride salts. 
Altering the counterion has been shown to affect the solubility of many systems [197, 
198]. This a phenomenon was first seen by Hofmeister in the ability of certain salts to 
precipitate a mixture of hen egg white protein [197]. 
The Hofmeister series was used to measure the strength of hydration between of the 
ions. When in the water, ions perturb the natural hydrogen bonding network of water. 
Ions can be divided into two categories; they are chaotropic, or "structure breakers" 
when the interactions with water molecules are weaker than the water itself, or 
kosmotropic "structure makers" when the interactions with water are stronger. 
Characteristics of anions belonging to the Hofmeister series were studied and 
classified according to their charge density, size, polarisability and potentiality of 
loosing their hydration sheath. Therefore, kosmotropic anions are small, usually with 
a small polarisability and need a great energy to lose their water hydration layer, 
whereas chaotropic anions are big, and characterized by a significant polarisability, 
they can also lose their water layer easily [199]. The Hofmeister series is listed below 
129 
with the ions on the left of CI" being referred to as salting-out (kosmotropic ions) and 
on the right being referred to salting-in ions (chaotropic ions). 
s o / - HP04' > OH" > F > HCOO" > CHsCOO" > CI" > Bf > T >SCNr 
Salting-out ions were shown to reside preferentially in the water, as they do not bind 
to micelles [200], they were also found to stabilize proteins solubility [201]. Small 
ions are strongly hydrated and create local order. Oppositely to salting-out ions, 
salting-in ions such as CI" and Br" can loose their water easily, this leads them to bind 
and interact preferentially with bilayer surfaces and perturb the lipid headgroup [202]. 
These anions were also shown to denature proteins. The less hydrated large singly 
charged ions act like hydrophobic molecules that bind to surfaces; this is dependent 
on the charges and the van der Waals interactions. 
Table IV. 1 recapitulates the properties of anions belonging to the Hofmeister series. 
Anion Radius 
(A) 
AG Hydr. 
kcal/mol 
Polarisability 
a(A^) 
Stabilizing SO/- 2.30 -258 633 
H P O 4 " 
Salting-out OH" 1.33 -102.8 2.25 
F" 1.33 -111.1 1.30 
Kosmotropic HCOO" 4.2 
CHsCOO" 
Destabilizing CI" 1.81 -81.3 3.76 
Salting-in Br" 1.96 -75.3 5.07 
Chaotropic 1" 220 -65.7 7.41 
Table IV. 1: Physical propert ies of anions belonging to tlie Hofmeis te r series (adapted f rom references 
[201], [199] and [203]). The size of the multicentred anions formate and acetate have not been 
measured. 
Moreover, studies undertaken by Shearman [87] showed that chaotropic ions such as 
CI" caused membranes in the lamellar gel phase to collapse due to the ion's 
condensation into the bilayer; the direct result of such a process being the water 
expelled from the system and the membrane to shrink considerably. The collapsed 
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lamellar phase is more likely to occur in the presence of chaotropic ions than 
kosmotropic ions. 
As counterions have an effect on a CAD's solubility as well as on the bilayer 
organization, it is therefore likely that they have an effect on DOPC: CAD systems. 
IV. 1.2 Crystallization of the CADs in the presence of the bilayer 
and counterion recondensation 
While determining the kinetic rates of bilayer degradation, the solubility profile of the 
CADs provided by the manufacturer had substantially reduced. HPD was initially 
soluble in 5mM water, 50 mM ethanol and 25 mM DMSO, but its solubility decreased 
to lOmM in ethanol and 25 mM in DMSO over the course of this study. As a result 
HPD was found to be less soluble in our experimental conditions which affected the 
binding kinetics and as a consequence the hydrolysis reaction. HPD was no longer 
residing at the bilayer interface, which mitigated against the bilayer hydrolysis as 
observed by using SAXS. 
Figure IV. 1 represents the evolution of a DOPC: HPD 20:1 sample over 8 days. The 
obtained diffraction patterns are typical of a diffuse swollen lamellar phase in the 
presence of the CAD as already observed in chapter 4. At day one and five, the lattice 
parameter increases from 94.71±0.54 A to 107.70±3.20 A. This effect is associated 
with the protonated HPD partitioning at the bilayer interface which causes bilayer-
bilayer repulsion (Figure IV.la,b). However, after 5 days, the DOPC; HPD system is 
seen to reorganize to a distinct lamellar phase, with less diffuse rings and a d-spacing 
collapsing to 89.46±1.07 A (Figure IV.Ic). Although this value is still higher than a 
pure DOPC La phase (61.36±0.57 A), the system exhibited no degradation, with no 
OA and LPC detected by HPLC. Therefore, we hypothesized that the HPD was not 
residing long enough at the bilayer interface having been expelled to form crystals. 
This mechanism would prevent the hydrolysis of the bilayer, as was observed. 
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Figure IV . l : DOPC: HPD 20:1 SAXS diffraction patterns evolution with time. 
The obtained diffraction pattern (a) corresponds to a swollen lamellar phase with 
the lattice parameter d-spacing= 94.71 ±0.54 A one day after the sample was made; 
(b) d-spacing=107.70±3.20 A five days after the sample was made, (c) After eight 
days, the DOPC:HPD 20:1 system is reorganizing to a less swollen lamellar phase 
with d-spacing=89.46±l .07 A. (d) d-spacing=61.32±0.57 A for DOPC. 
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Crystallization of the CAD was also detected from other SAXS studies on DOPC: 
HPD 20:1 systems, where no swelling was observed at all, and where the bilayer 
repeat spacing was found to be smaller than expected for pure DOPC systems (Figure 
IV.2). 
The obtained diffraction patterns depict a DOPC: HPD system in the lamellar state 
with equally spaced well defined rings with a repeat spacing of 56 A. The lack of 
swelling on these diffraction patterns are indicating that the CAD is not bound at the 
bilayer interface. In addition, the calculated d-spacing is constant over a week which 
is again contrary to what has been observed previously. The repeat spacing value is 
5A smaller than pure DOPC implying a significant loss of water / buffer between 
bilayers. As a result, the loss of water would also enhance crystal formation. This 
might explain the CAD's crystallization. 
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Figure IV.2: SAXS diffraction pattern evolution with time of DOPC: HPD 20:1 systems. No 
swelling is observed over the course of one week. The d-spacing value is SA smaller than for 
a pure DOPC system, and is constant 1 day (a), 4 days (b) and 7 days (c) after the sample was 
made. 
HPD crystallization was confirmed by microscopy which showed the formation of 
HPD crystals in DOPC: HPD 20:1 samples as exemplified on figure IV.3. HPD was 
excluded from the bilayer interface which was detected by SAXS and crystallized out 
of the bilayer. Crystals of HPD are also seen to grow with time. 
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Figure IV .3: Bright field micrograph (x40) 
representing DOPC: HPD 20:1 sample. The HPD has 
been expelled from the bilayer interface which led to 
crystal formation. 
These resuhs correlate strongly to the Hofmeister effect, where chaotropic ions are 
able to bind to bilayer surfaces [202] and precipitate proteins [204]. The HPD 
counterion in this sample is CI' which belongs to chaotropic counterions; as a result, it 
is likely that this anion condenses onto the bilayer. Hence, a simple assumption can be 
made for the reason of HPD crystallisation: if the CI" counterion is likely to bind at the 
membrane surface, therefore it is also likely to be attracted back by the protonated 
drug, leading to recondensation and precipitation of the drug away from the bilayer 
interface. This would mitigate the hydrolysis reaction. 
Counter ion recondensation on bilayer surfaces affects the lamellar organization. It 
has been reported that chaotropic solutes have an effect on altering phase transitions 
of bilayers [205], but also these anions can cause the collapse of the Lp phase 
resulting in the water / buffer expelled off the water channels, and drive the formation 
the Lc phase [87]. These results lead to the conclusion that the CADs catalysed bilayer 
hydrolysis is strongly dependent on the solubility and formulation i.e. the nature 
(chaotropic / kosmotropic) of the counterions of the CADs. For the hydrolysis to 
occur, at least two conditions have to be fulfilled: 1) the CAD must reside at the 
bilayer interface; 2) CAD's counterion must not recondense onto the bilayer as it will 
cause the crystallization of the CAD and the collapse of the bilayer. These features 
explain the absence of hydrolysis in these samples. This shows that CADs counterions 
have an important effect on its ability to bind at the bilayer interface and thus on the 
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bilayer hydrolysis. Therefore, the lipid: CAD preparation protocol was optimized to 
increase the CAD's solubility and minimize the crystallization effects. 
IV. 1.3 Optimization of sample preparation 
The initial sample preparation consisted of dissolving the lipid and the CAD together 
in organic solvent to assure complete homogenization. The solvent was removed and 
the lipid: CAD mixture dried under vacuum until complete dryness. Then the dried 
mixture was hydrated by the required amount of buffer and the sample left to 
equilibrate for 15 minutes before any measurements were made. This procedure as 
well as the sample storage was undertaken at room temperature. One of the major 
changes in the sample preparation was the drying procedure that involved the use of a 
vacuum oven at 40°C for 24hours. Then the sample was hydrated by the appropriate 
buffer, left to equilibrate and stored at 31°C. 
The increase of the temperature during the sample preparation and storage had a 
profound effect as the crystallization of the CADs was stopped. This was confirmed 
by polarizing microscopy on DOPC: HPD 20:1 samples (Figure IV.4) and HPLC, 
where LPC and OA were detected (see next section). 
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Figure IV.4: Bright filed micrograph (x40) 
representing DOPC: HPD 20:1 sample after 
optimization of the sample preparation protocol. No 
crystals of drug are detected. 
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Crystallization processes are controlled by numerous factors depending on 
experimental conditions (concentration, temperature, presence of salt). As reported 
elsewhere, the effect of temperature strongly influences the rate of crystal growth in 
crystallization processes, in particular in the nucleation sites [206]. Keeping the 
samples at higher temperature mitigates the formation of nucleation sites and also 
weakens the crystal's packing forces. In addition, it has been reported that the 
counterion condensation effect was considerably diminished by increasing the 
temperature [87]. Elucidation of the kinetics of crystal growth is beyond the scope of 
this thesis. 
Optimization of the sample preparation protocol was a major step in the elucidation of 
the counterion recondensation issue and the CADs crystallization. Using the new 
optimized protocol allowed better control of sample handling and thus of the 
hydrolysis processes. The following sections will describe the kinetics of the 
membrane hydrolysis using different CADs with different counterions. 
IV.2 Kinetics of the membrane degradation 
IV.2.1 Kinetic model of the degradation 
The bilayer hydrolysis comprises three steps which are 1) proton transfer of the 
protonated CAD to the lipid ester function, 2) hydrolysis of the lipid chain into LPC 
and FA, and 3) hydrolysis of the produced LPC into another molecule of FA. 
Protons are propagated by water through a random walk that is controlled by the 
membrane electrostatic potential. The mechanism of proton transfer necessitates a 
donor and acceptor that are the CAD and the lipid ester function in this case. The 
proton transfer depends on the distance and orientation of the reactants, which are 
only a few A apart. It has been reported that proton transfer between molecules occur 
in the picosecond - nanosecond time range [207]. Early experiments showed that the 
rate CADs binding to the bilayer and the bilayer hydrolysis were in the range of 
minutes - hours. Therefore, the step of proton transfer and the rate at which it occurs 
will be ignored for the determination of the rate of the bilayer hydrolysis. 
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The degradation model of the bilayer involves the formation of three mesophases, the 
lamellar phase where the reaction starts, the inverse hexagonal phase that is a result of 
the fatty acid curving the membrane towards the water / buffer, and the micellar phase 
that arises from the aggreagation of LPC molecules. Each of these mesophases 
exhibits a different degree of stored curvature elastic stress. Therefore it is expected 
that the rate of hydrolysis is dependant on the bilayers mechanical state, as has 
already been described for the action amphipathic molecules at the membrane 
interface [191]. 
Degradation rates were defined by using the model depicted on figure IV.5. 
LPC„ 
1 kbm 
FA, 
DOPCb 
FA^ 
Figure IV.S: Kinetic model describing the degradation kinetics 
of the D O P C bilayer into LPC and FA. The model comprises the 
degradation products in the bilayer and micellar state. The 
kinetic parameters are k|b, the rate of degradation of D O P C into 
LPC and FA in the bilayer, k^b the rate of degradation of LPC in 
the bilayer into FA in the bilayer, k2m the rate of formation of 
LPC micelles from LPC in the bilayer, the rate of LPC 
molecules partitioning into bilayers and kbm the rate of 
degradation of LPC micelles into FA that reintegrates the bilayer. 
This model involves numerous kinetic parameters such as kib, the rate of degradation 
of DOPC into LPC and FA in the bilayer, kib the rate of degradation of LPC in the 
bilayer into FA in the bilayer, kzm the rate of formation of LPC micelles from LPC in 
the bilayer, k'lm the rate of LPC molecules partitioning into bilayers, kbm the rate of 
degradation of LPC micelles into FA that reintegrates the bilayer; this could happen 
through fusion processes. Unfortunately the model does not comprise the choline 
headgroup as it was not possible to detect it using the normal phase HPLC system due 
to its high hydrophilicity, which prevents its elution. 
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The degradation kinetics follows a catalytic hydrolysis process where the 
disappearance of DOPC, the appearance of LPC or the appearance of FA can be 
detected. The CAD molecule is regenerated after the hydrolysis is completed and its 
concentration is constant over the course of the reaction; therefore because of this 
catalytic process the concentration of the CAD will not be taken into consideration in 
the model. This also assumes that CADs work independently from each other. 
The disappearance of DOPC into LPC is only due to the action of the CAD that 
remains constant during the whole process; therefore the disappearance of DOPC 
follows a pseudo first order exponential decay as 
at 
[DOPC] = 
Equation IV. 1 
Equation IV. 2 
The rate of formation of LPC depends on the disappearance of DOPC but also on the 
rate of formation of LPC micelles and formation of FA in the bilayer and in the 
hexagonal phase. Similarly, the rate of appearance of FA depends on the rate of 
disappearance of DOPC into LPC and FA in the bilayer and on the disappearance of 
LPC micelles. The determination of kam, k'lm, kbm and k^y requires an accurate 
measurement of the FA signals; this is found to be complicated as the FA signals 
overlap with the injection peak signal on the HPLC (see chapter 3 for more details). 
Therefore, the only parameter that can be determined accurately is kib that 
corresponds to the disappearance of DOPC upon addition of the CAD. kib will be 
determined according to equation IV. 1. 
IV.2.2 Effect of different CADs on the membrane degradation 
Kinetics of the membrane hydrolysis were followed by using normal phase HPLC 
equipped with an ELS detector. Normal phase HPLC was the method of choice in the 
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detection of the membrane degradation products. The measurement consisted of 
injecting an aliquot of a DOPC: CAD mixture of known mass into the HPLC system. 
The amount of each product formed was determined from the area under the peak 
according to the prior calibration curves obtained for each standard. Errors in the 
measurements were calculated from three sets of experiments. 
A typical degradation diagram obtained from HPLC traces of the membrane 
hydrolysis is depicted on figure IV.6. 
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Figure IV .6: Qualitative diagram representing the membrane 
degradation into LPC and FA. The DOPC in consumed into LPC and 
FA. LPC is ultimately degraded to FA with t ime. 
The disappearance of DOPC follows an exponential decay model, whilst LPC and OA 
appear initially at equal rates. The LPC formed is then consumed leading to the 
production of FA; this is seen with a plateau on the LPC signal. As already described, 
the LPC formed firstly resides in the bilayer; when enough LPC monomers are 
formed, they will aggregate into micelles that are able to leave the bilayer. It is 
unfortunately not possible to measure the LPC micelles formation in this system as 
only total LPC entities are measured. However, it is assumed that LPC monomers 
have to form 30% of the bilayer to form micelles [163]. The FA formed comes from 
the degradation of DOPC and from LPC in the bilayer and in micelles. 
IV. 1.2.2 Comparison of the hydrolysis kinetics due to three CADs: HPD, SPIP and 
WAY. 
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The three different CADs: HPD, SPIP and WAY were tested on condensed fluid 
lamellar phase bilayers made of DOPC in a 20:1 lipid: drug ratio. The effect of HPD 
and SPIP has already been described previously [149], but the kinetics of the 
membrane hydrolysis had not be fully investigated at this stage. Therefore, 
comparisons between the rate of hydrolysis in the presence of HPD, SPIP and WAY 
have been undertaken. 
These studies were carried out to establish a relationship between the hydrolysis 
reaction and the type and specificity of CAD investigated. Specific actions of CADs 
were already described on the membrane lateral organization with clozapine, another 
CAD, increasing the average area / molecule more than HPD [97]. In addition, and as 
shown in chapter 4, CADs exhibit different binding affinities for PC bilayers [38] and 
also different partition coefficients values depending on their structure [119]. 
Therefore, the hydrolysis rate is expected to be dependent on the CAD itself 
Figure IV.7, IV.8 and IV.9 show the typical chromatograms obtained for DOPC:HPD, 
DOPC:SPIP and DOPC:WAY at a molar ratio of 20:1 after Ih, 4h, 72h and 152 h 
respectively. Each chromatogram depicts the DOPC peak (17.7 min), the drug peak 
(13 min) and the hydrolysis products LPC (21.4 min) and OA (2.8 min). The HPLC 
traces are seen to evolve with time. Additional peaks are also present at 1 Imin. Mass 
spectrometry did not reveal any new products that could have been formed from the 
interaction between the products of the hydrolysis reaction. Therefore these peaks 
were attributed to the mobile phase signal as they are also present in the blanks. 
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Figure IV.7: Normal phase HPLC chromatograms representing the evolution of 
DOPC: H P D 20:1 samples with t ime. There is little formation of LPC in these samples 
with t ime. The chromatograms are normalized so the D O P C peak is constant. 
Figure IV.7 represents the evolution of DOPC: HPD 20:1 samples with time. 
Surprisingly there is very little LPC produced, even after 152h. This is contrary to 
what was observed in chapter 4 where HPD was shown to completely degrade the 
bilayer after 3 days at this ratio. This could be due to numerous factors such as the 
sample preparation method that is different from the one used in chapter 4. Also the 
change in ionic strength of the buffer might have a significant effect on the hydrolysis 
properties. These sets of samples are made in buffer B (10 mM Tris pH 7.4) whereas 
the former results were obtained in buffer A (50 mM Bis-Tris, 100 mM NaCl) which 
has a considerable effect on screening the electrostatic interactions at the membrane 
surface [88, 158], as well as increasing the drug's solubility [195]. The effects of the 
ionic strength are discussed in section IV.2.4. 
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Figure IV .8 : Normal phase H P L C chromatograms representing the evolution of 
D O P C : S P I P 20:1 samples with t ime. LPC is already present after 4h, and is half of 
the height size of the D O P C peak after 72h. The O A signal is also see to grow with 
t ime. The chromatograms are normalized so the D O P C peak is constant. 
Figure IV.8 represents the HPLC traces obtained for DOPC: SPIP 20:1 evolution with 
time. Here again, the traces of the blank are present at 1 Imin. In addition, the LPC is 
present 4 hours after the sample was made, and the signal is constantly evolving until 
the peak reaches half of the size of the DOPC peak in height. The OA signal is barely 
present after 4 hours, but is growing with time. Although the OA signal cannot be 
measured accurately, trends are seen in the evolution of the OA with the signal 
increasing with time. According to the kinetic model, the DOPC is consumed to form 
the products LPC and OA. This is not shown on these graphs as the DOPC peaks 
were normalized to 100 to observe the growth of the LPC and OA signal. The 
disappearance of the DOPC peak will be investigated in the following section. 
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Figure IV .9: Normal phase HPLC chromatograms of DOPC: W A Y 20:1 samples 
evolution with t ime. The LPC is present 1 hour after the sample was made, and is 
constantly growing with t ime. More OA signal is also produced with time. The 
chromatograms are normalized so the D O P C peak is constant. 
Figure IV.9 represents the HPLC traces of DOPC: WAY 20:1 samples. Two 
additional peaks are present on the chromatogram: the mobile phase signal at 1 Imin 
and the maleate counterion at 29 min. It is noticeable that the LPC is present Ih after 
the sample was made; this already indicates that this drug degrades the bilayer quicker 
than SPIP and HPD. After 4h, the LPC signal is more intense. The LPC and OA 
signals are significant after 72h and 152h. The DOPC peak is altered at 72h, showing 
a large shoulder starting at 15min. Assumptions on the formation of DOPC: WAY 
intermediates were made, but no evidence was shown by mass spectrometry. 
The amounts of DOPC, OA and LPC were calculated from the area under the peaks, 
and correlated to the calibration curves obtained for each standard. From these values 
degradation profiles were constructed, where the DOPC is seen to disappear, and the 
LPC and OA to appear (figure IV. 10). The degradation profiles obtained correspond 
to the typical profiles shown on figure IV.6. 
The combination of these three sets of chromatograms and degradation profiles lead 
the following conclusion: the hydrolysis rate is dependent on the type of drug. Early 
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assumptions can be made on the rate of reactions, with WAY being the fastest drug, 
followed by SPIP and HPD. These kinetic results differ from those presented in 
chapter 3; this is due to a change in the solubility of the drug, which led to a change of 
the sample preparation protocol. (See chapter 2 for more details). In addition, there is 
no NaCl in the buffer used in these experiments. The effect of NaCl is investigated in 
section IV.2.4. 
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Figure IV.IO: Degradation profile obtained for the 
action of three CADs: (a) HPD, (b) SPIP and (c) 
WAY on DOPC bilayers in 10 mM Tris, pH 7.4. 
Error bars represent estimated experimental error 
on three experiments. 
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• Disappearance of DOPC 
For the sake of consistency, the degradation parameter kib will be referred to as 
kiDOPC- kiDOPc was determined according to equation IV. 1 from the hydrolysis profile 
shown on figure IV. 11. As previously stated, kmopc is the only parameter that can be 
measured accurately from the experimental data. 
The values obtained are k, DOPC WAY=7.72X10"^ ± 0.27x10"^ |a,mol.h"', k, DOPC SPIP= 
3.96 xlO"^ ± 0.20 xlO^ iimol.h"' and ki DOPC: HPD= 0.33 xlO^ ± 0.04 xlO^ nmol.h"'. 
From these rates, it is possible to determine that WAY degrades DOPC bilayers twice 
as fast as SPIP and that HPD exhibit the slowest rate. 
100 150 
Time (Hours) • HPD 
• SPIP 
A WAY 
Figure I V . l l : DOPC hydrolysis profile by the three CADs, 
HPD, SPIP and WAY. Curves were fitted using equation IV. 1. 
Error bars represent experimental errors on three experiments. 
• Initial rates of appearance of LPC and OA 
Determination of the rate of appearance of LPC and OA is complex as it requires an 
accurate measurement of kzb which depends on the appearance of the OA. This is 
found to be difficult because the OA elution time also corresponds to the injection 
peak that is not constant. 
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For these reasons, the initial rates of formation of LPC and OA ko LPC and ko OA were 
determined. This only involves the measurement of the reaction at very short times 
when the bilayer is still in the fluid lamellar state with no micellar or H,, phases 
present, which would affect the hydrolysis rates. Initial rates can be calculated from 
the slope of the tangent to the curve at t=0. Initially LPC and OA appear with the 
same rate as 1 molecule of DOPC is hydrolyzed into 1 molecule of LPC and OA; this 
can be seen on figure IV. 10 where LPC and OA appear with the same slope. This 
feature will make possible the determination of the initial rate of formation of LPC 
and consequently the OA (Figure IV. 12). 
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Figure IV.12: Initial rates of the appearance of LPC in DOPC: 
WAY, DOPC: SPIP and DOPC: HPD 20:1 samples. 
Calculations of the slopes yielded the following initial rates: ko LPC WAY = 0.1984 
limol.h ', ko LPC SPIP = 0.0924 lamol.h"' and ko LPC HPD was not detectable. These values 
are in accordance with the ki values obtained earlier for the disappearance of DOPC 
with WAY hydrolyzing the bilayer as twice as fast as SPIP, and HPD exhibiting the 
slowest rate. 
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• DOPC initial degradation rate ki 0 DOPC 
Initial rates kooopc of the DOPC degradation were calculated from the slope of the 
tangent at t=0, and led to KO DOPC WAY = 0.3317|amol.h"', KO DOPC SPIP = 0.1877 |imol.h"' 
and KO DOPC HPD = 0.00237 )u,mol.h"' (Figure IV.13). 
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Figure IV.13: Initial rates of the disappearance of DOPC in DOPC: WAY, DOPC: 
SPIP and DOPC: HPD 20:1 samples. 
The initial rates of disappearance of DOPC and appearance of LPC / OA correlate 
with the stoichiometry of the degradation model of one molecule of DOPC into one 
molecule of LPC and one molecules of OA. Although the initial rates are greater than 
the reaction rates, these cannot be compared directly as they both come from different 
curve fit equations. However, an assumption can be made on the rate being faster 
initially as the DOPC is in excess. Also the reaction starts when the system is still in 
the fluid lamellar phase where DOPC is predominant. When more LPC i.e. type I 
molecules and OA i.e. type II molecules are appearing, the membrane mechanics is 
altered with a drop in the stored curvature elastic stress. Therefore, the kinetic rates 
are expected to slow down. This effect is related to the stored curvature elastic energy 
that evolves in the system; this has already been described as having an impact on the 
modulation of amphipathic molecules such as the CTP: phosphocholine 
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citidyltransferase (CCT) or other enzymes such as phosphoHpases activity [191, 208]. 
The effects of curvature elastic stress on the membrane hydrolysis will be fully 
investigated in chapter 5. 
The calculated degradation parameters for each drug are summarized in Table IV.2. 
ko DOPC (M-inol.h ') ko LPC/OA(M-inol-h ') kiDOPC (M-mol.h ') 
WAY 0J317 0T984 0.00772±0.00027 
SPIP 0U877 0.0924 0.00396±0.00020 
HPD 0.0024 
-
0.00033±0.00004 
ko DOPC 
(molecules.s' ' .CAD molecules"') 
ko LPC / OA 
(molecules.s"'.CAD molecules"') 
klDOPC 
(molecules.s"'.CAD molecules"') 
WAY 4.91x10-5 2.93x10'" 1.14x10" 
SPIP :L68xlO^ L36xl0^ 5.86x10' 
HPD 3^0x10^ - 4.88x10^ 
Table IV.2 : Rates obtained for D O P C bilayers hydrolysis by W A Y , SPIP and HPD. KO DOPC and KO LPC/ 
OA are the initial rates obtained by calculating the slope of the tangent at t=0; k,DOPc is the rate obtained 
f rom the disappearance of D O P C calculated f rom equation IV. 1. Values were converted in molecules.s" 
' .CAD molecules"' 
These sets of results show that a trend exists between the rate of hydrolysis and the 
different CADs. Therefore it is reasonable to assume that each drug has a distinctive 
effect on the bilayer, and that the hydrolysis rates are dependent on the drug itself as 
shown by WAY exhibiting the fastest degradation rate, and HPD the slowest. These 
parameters are of main importance, they can allow the classification of the drugs 
according to their efficiency to hydrolyze the bilayer. However, the rate values 
obtained after correlation to the number of CAD molecules present in the system 
yielded an insignificant rate. From these values, it can be calculated that only one 
molecule of DOPC can be hydrolyzed in ten hours in the presence of WAY. This is 
not consistent with the experimental data as LPC and OA are detected one hour after 
the sample was made. Therefore, these degradation rates show that not all CADs 
reside in the bilayer interface and that some CADs might have precipitated out of the 
bilayer, as described in section IV. 1.2. To get an absolute rather than relative rate, we 
therefore need to know how many CAD are actually resident in the membrane. In 
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addition, it is also important to notice that the water availability is restricted between 
the lamellar stacks in these systems, in comparison to vesicles where water / buffer is 
largely in excess. 
Although the CADs studied are planar molecules, it can be observed that WAY, SPIP 
and HPD exhibit dissimilar bilayer hydrolysis rates. HPD, WAY and SPIP have 
similar protonation sites which consist of a piperidine function and is localized in the 
middle of the molecule. The proton transfer from these functions to the lipid ester 
function is essential for the hydrolysis to occur; this depends on the proximity and the 
steric hinderance around the protonation site of the drug at the bilayer interface. One 
of the main differences between these three CADs is the counterions, with the maleate 
being WAY's counterion and the hydrochloride being HPD's and SPIP's counterion, 
this might also play a role in the difference of kinetics observed between the CADs, 
due to counterion recondensation onto the bilayer. Counterion recondensation and its 
effect on the bilayer hydrolysis kinetics will be discussed in the following section. 
IV.2.3 Effect of chloride (CI"), formate (HCOO"), 
trifluoroacetate (TFA-CF3COO") and maleate 
(HO2CCHCHCO2H) counterions on the hydrolysis 
This section will describe the effect of different CAD's counterions on the hydrolysis 
kinetics. As described in the beginning of the chapter, the solubility features of the 
HPD reduced dramatically during storage and this led to its crystallization. As this 
process ended the hydrolysis reaction, swapping the CI' counterion for more aqueous 
soluble counterion would increase the CAD solubility and therefore allow a more 
efficient hydrolysis reaction as the counterion does not condense onto the bilayer 
surface. This was already verified by the kinetics of the reaction of WAY carrying a 
maleate counterion and being twice as fast as SPIP and much faster than HPD. 
Therefore, CADs with four different counterions from the Hofmeister series namely 
chloride, formate, maleate and TFA were synthesized [145] and tested on bilayers 
made of DOPC. This was based upon the hypothesis that different counterions with a 
large hydration shell will reside preferentially in the aqueous medium, leaving the 
CAD at the interface, making the recondensation impossible. 
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The formate counterion is a kosmotropic ion that would therefore reside preferentially 
in the aqueous medium leaving the CAD at the interface enhancing the hydrolysis 
rate. The position of the TFA is unclear in the series, but as a hydrophobic ion i.e. 
chaotropic, it is expected to bind to the bilayer. TFA was also reported to behave as a 
co-surfactant in micellar systems [209] and to have a salting-in effect similar to that of 
thiocyanate [210]. The use of the maleate counterion was undertaken as this 
counterion was present in systems that exhibited the fastest rate of hydrolysis, namely 
DOPC: WAY systems. Although its effect as a salting-in or salting-out anion remains 
ambiguous, it is likely to be classified as a salting-out ion by its diacid function. In 
addition, this counterion was reported to have the same effects as citrate which is a 
kosmotropic ion, on bacterial growth, this phenomenon being dependent on the water 
structure led by anions from the Hofmeister series [203]. Figure IV. 14 represents the 
degradation profile of DOPC: HPD 20:1 systems in the presence of four different 
counterions. 
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Figure IV.14: Comparison of hydrochloride, formate, trifluoroacetate and maleate counterion on the 
hydrolysis of DOPC (a) into LPC (b) in DOPC: HPD 20:1 systems. 
The four tested counterions had dissimilar effects on the bilayer hydrolysis. The 
degradation profile obtained for the maleate salt is similar to that of the hydrochloride 
salt, where only little / no degradation of DOPC and appearance of LPC are evident. 
The presence of formate counterion has enhanced the degradation of DOPC and the 
formation of LPC with time in comparison to that of chloride and maleate salts. 
Likewise, it can be observed that the hydrolysis of DOPC is clearly enhanced in the 
presence of the trifluoroacetate salt, where DOPC is being degraded considerably and 
LPC formed until a plateau is reached. From these profiles, the initial rates for the 
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disappearance of DOPC kooopc, and appearance of LPC KO LPC, are calculated from the 
slope of the tangent at t=0 (Figure IV. 15). The degradation parameter kioopc was 
calculated from equation IV. 1 (figure IV. 16). Only the systems in the presence of 
formate and trifluoroacetate were considered as they were the only systems that 
produced measurable amounts of LPC . 
It can be seen on figure IV. 15 that the initial rates of degradation of DOPC are much 
faster in DOPC: HPD TFA 20:1 samples with k o o o p c TFA =0.262 jj-moles.h"' than in 
DOPC: HPD formate samples with k o D O P C formate = 0.008 jamoles.h"'. Similarly, the 
initial rates for the appearance of LPC is more effective in the presence of 
trifluoroacetate with k o t p c TFA = 0.127 jamoles.h'\ than formate with k o o o p c formate = 
0.007 |j,moles.h"'. 
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Figure IV.15: Initial rates for the degradation of DOPC (a) and the appearance of (b) LPC in 
DOPC:HPD 20:1 samples in the presence of formate and trifluoroacetate counterions. 
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The degradation parameters K I D O P C T F A and K I O O P C formate were determined according to 
equation IV. 1 from the hydrolysis profile shown on figure IV. 16. The values obtained 
are ki DOPC TFA~8 .72X10 ^ ± 0.57x10 ^ nmol.h ^ and kj DOPC formate ~ 3x10 ^ ± 2x10 ^ 
l^mol.h"'. From ko DOPC, KO LPC and k, DOPC, ko LPC it can be established that the 
presence of the TFA counterion enhances the degradation rate by 30 times in 
comparison with the formate counterion in DOPC; HPD 20:1 samples. 
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Figure IV .16; DOPC degradation profile in DOPC:HPD TFA and 
DOPC:HPD formate samples. The disappearance of DOPC follows 
an exponential decay model with K , D O P C TFA=8.72X10"^ ± 5.7x10"* 
Hmol.h ' and k, DOPC formate = 0.3x10"^ ± 2x10"' nmol.h"'. 
From these measurements it is reasonable to assume that changing the hydrochloride 
HPD counterion to formate and TFA considerably improved the degradation kinetics 
of DOPC: HPD 20:1 systems, with DOPC:HPD TFA hydrolysing the bilayer 
approximately 30 times faster than DOPC:HPD formate 20:1. 
The DOPC: HPD TFA degradation profile strongly correlates with those obtained in 
the presence of WAY maleate with the ki DOPC rate being in the same order of 
magnitude (kiDOPc WAY=7.72 xlO^ ± 0.27 xlO^ |imol.h''). 
Swapping the counterion in DOPC: HPD 20:1 systems clearly influenced the 
hydrolysis rates. 
155 
The presence of the formate and TFA counterions was shown to trigger the hydrolysis 
and considerably improve its rate in DOPC; HPD 20:1 samples. In the case of the 
formate, this was expected as according to the Hofmeister series this ion is strongly 
hydrated and preferentially resides in the aqueous medium, leaving the protonated 
HPD in the interface. The results obtained with the TFA were unexpected given the 
fact that the TFA would behave as a chaotropic ion that also bind preferably to the 
membrane. However it has been reported that fluorocarbon counterions such as TFA 
were able to form micelles involved in solubilisation processes [211]. In addition, 
TFA has also been described as a powerful amplifier for the translocation of large 
molecules such as carboxyfluorescein across phospholipid bilayers by polyarginines 
[212], interestingly polyarginins are also protonated at physiological pH and have 
been reported to cause the leakage of phospholipids vesicles [213]. This would 
explain the effect of TFA on the hydrolysis kinetics. In addition, it is important to 
notice that no crystals of drugs were detected in DOPC: HPD 20:1 with different 
counterion samples. This is probably due to the fact that the degradation was occuring 
in these samples, preventing the crystallization of CADs from happening. 
Surprisingly, the presence of the maleate counterion in DOPC: HPD 20:1 samples did 
not improve the degradation, as would have been expected. Similar results were 
obtained for DOPC: SPIP maleate where no DOPC degradation was detectable (data 
not shown). This is contrary to the results obtained with DOPC: WAY maleate, which 
exhibited one of the fastest degradation rates. Therefore, two separate effects might be 
present, the counterion effect and the CAD efficiency to hydrolyze the lipids. The 
degradation rates are summarized on table IV.3. 
Drug Counterion k 1 (H mol.h"') k 1 (DOPC molecules.s"' .CAD molecules' ') 
HPD Hydrochloride 
- -
HPD Formate O.SlxlO " ±0.02x10-" 4.58x10'" 
HPD TFA 8.72x10 '" ±0.57x10'^ 1.29x10"'' 
HPD Maleate 0 0 
SPIP Hydrochloride 0 . 3 9 x 1 0 " ±0 .20x10 " 5 .86x10' ' 
SPIP Maleate 0 0 
WAY Maleate 7 . 6 7 x 1 0 " ±0.27x10 '" 1.13x10'" 
Table IV.3; Rates obtained for DOPC bilayers hydrolysis by WAY, SPIP and HPD with different 
counterions, in buffer B. k, is the rate obtained from the disappearance of DOPC calculated from 
equation IV. 1. 
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Although the counterion recondensation onto the bilayer triggered the crystallization 
of the CAD off the bilayer interface (see section IV.2.2), it is also evident that the 
counterion has an increasing / decreasing effect on the rate of the bilayer hydrolysis. 
This effect does not necessarily follow the Hofmeister series as chaotropic 
hydrophobic counterions such as TFA exhibited the fastest reaction rates in DOPC: 
HPD systems. TFA was indeed expected to lower considerably the binding of HPD to 
the bilayer and therefore the hydrolysis rate due to the counterion recondensation. In 
addition, kosmotropic counterions such as maleate that exhibited the fastest reaction 
rates in DOPC: WAY systems, had no effect on DOPC: HPD and DOPC: SPIP 
systems. Changing the CADs counterions affect their solubility, however these 
measurements show that the hydrolysis rate in DOPC: CAD systems not only depends 
on the type of counterions, but is also dependent on the type of CAD investigated. 
The Hofmeister series does not work consistently across different systems, in 
particular in bilayer systems. 
IV.2.4 Influence of salt on the membrane hydrolysis. 
The nature of the drug's salt was shown to have a profound effect on the solubility of 
the drug and the kinetics of the bilayer hydrolysis. Similarly, the presence of salt in 
the buffer was observed to have considerable effects on the organization of lipid 
lamellar phases, by screening the electrostatic interactions and leaving the bilayer to 
shrink [87]. It has also been reported that increasing the ionic strength increases the 
drug release by promoting its solubility [214]. Indeed, the specific effect of salts in 
solution arise from the organization of water molecules that are more oriented, 
resulting in the increase of the solubility of the ionizable drug [215], with the rate of 
dissolution being dependent on the ionic strength [194]. Moreover, it is important to 
notice that salts are present in biological systems and participate in a wide variety of 
processes such as membrane fusion, bacterial growth, and cell communication [216, 
217]. Therefore, it is expected that the bilayer hydrolysis is affected by the presence 
of a high ionic strength, here 100 mM NaCl was used to represent physiological 
concentrations. 
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Figure IV. 17 represents the degradation profile of DOPC: HPD 20:1 samples in buffer 
C (10 mM Tris, 100 mM NaCl, pH 7.4). This degradation profile is dissimilar to that 
of DOPC: HPD 20:1 in buffer B (10 mM Tris, pH 7.4) where no sodium chloride is 
present. In the presence of 100 mM NaCl, the membrane hydrolysis by the protonated 
HPD is considerably enhanced. 
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Figure IV.17; Degradation profile of DOPC: HPD 20:1 in 10 
m M Tris, lOOmM NaCl at physiological pH. The 
disappearance of DOPC follows a first order exponential 
decay. The rate of disappearance calculated from equation 
IV. 1 led to kiDOPC HPDNaci ~ 6.93 x l 0 ^ ± 0 . 3 7 x l 0 ^ [iM. 
The rate of disappearance of DOPC in the presence of 100 mM NaCl was calculated 
from equation IV. 1 and led to kioopc HPD Naci = 6.93 xlO'^ ± 0.37 xlO^ p,M and 
compared to that in DOPC:HPD 20:1 in 10 mM Tris where little degradation 
occurred, the DOPC degradation rate was calculated and ki= 1.73 xlO^ ±0.24 xlO^ 
p,M (Figure IV. 18). 
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Figure IV.18: Ef fec t of 100 m M NaCl on the D O P C degradat ion 
profi le in DOPC: H P D 20:1 samples. The presence of NaCl is seen to 
enhance the reaction by a factor of 5. 
The DOPC degradation rate in the presence of 100 mM NaCl is faster than in DOPC: 
HPD 20:1 in 10 mM Tris only, with the rate being similar to that of DOPC: WAY 
20:1 in 10 mM Tris (ki= 7.72x10"^ i^mol.h"'). 
The addition of 100 mM NaCl is crucial for the reaction to happen in DOPC: HPD 
20:1 samples. The presence of 100 mM NaCl generates the organization of water 
molecules in the close vicinity of the HPD that increases its solubility. This 
concentration of NaCl is also known to screen the electrostatic interactions at the 
bilayer surface; with a calculated Debye length of lOA, this will enable the protonated 
solubilised drug to undergo steric interactions with the bilayer interface and trigger 
the hydrolysis. This result strongly correlates those obtained in chapter 3, where HPD 
is seen to degrade the DOPC bilayer within 3 days at this ratio. Indeed, these samples 
also contained lOOmM NaCl at physiological pH. 
The same types of experiments were carried out using WAY. Surprisingly, the 
presence of 100 mM NaCl did not affect the rate of hydrolysis of the bilayer (Figure 
IV. 19). Analysis of the DOPC degradation rate in the presence and absence of salt 
using equation IV. 1 led to KIOOPC WAYNaci~ 8.89 xlO 0.37 xlO ^p,M and KIOOPC WAY 
= 7.63 xlO"^± 0.37 xlO"^^M. 
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Figure IV.19: Ef fec t of 100 m M NaCl on the D O P C degradation profi le in DOPC: 
W A Y 20:1 samples. There is no change in the D O P C degradat ion rate in the presence 
of 100 m M NaCl . The degradat ion rate obtained f rom equat ion IV. 1 are kioopc WAVNaci 
= 8.89x10"^ ± 3.7x10"^ and KIDOPC WAY= 7.63X10"^ ± 3.7x10"* ^M. 
WAY molecules carry maleate counterions with them that enhance the drug 
dissolution in the buffer in the first place. Therefore, the addition of salt does not 
affect the dissolution of WAY. From these results, WAY acts independently from the 
salt present in the buffer. 
From these studies, it is becoming increasingly evident that the parameters that 
control the bilayer hydrolysis are extremely complex. The structure inherent to each 
molecule and its conformation plays an essential role on the bilayer hydrolysis, as 
exemplified by SPIP exhibiting more degradation than HPD in the same conditions. 
However, reaction rates are to be considered carefully as not all CADs are bound to 
the bilayer, and water availability is restricted between the lamellar stacks; which may 
impose a limit on the rate of reaction. 
In addition, the choice of the counterion also affects the biiayer hydrolysis in such a 
manner that it does not recondense onto the bilayer, as was shown for HPD HCl. 
Although the counterion recondensation follows the Hofmeister series [87], 
counterions that enhance the bilayer hydrolysis do not necessarily follow the 
Hofmeister series as described for the kosmotropic dianion maleate which exhibited 
160 
the fastest rate in DOPC: WAY systems, but did not trigger any hydrolysis in DOPC: 
HPD and DOPC: SPIP systems. 
Finally, the ionic strength of the aqueous buffer also plays a critical role as it firstly 
increases the drug dissolution and secondly reduces the surface electrostatic 
interactions, which enable the CADs to freely interact with the bilayer interface. 
IV.3 Correlation between the membrane degradation rate 
and the non-specific binding (NSB). 
IV.3.1 Background 
The concept of NSB in-vivo and in-vitro relates to the binding of drug molecules / 
ligand to sites other than their target sites which are commonly membrane bound 
receptors or enzymes. Binding of molecules to sites other than the intended target 
recognition site refers to as non-specific sites. Additionally, when the drug is trapped 
in the bilayer, the lipid bilayer is also considered as a non-specific site. Binding of 
drug molecules to the bilayer is predominant in the NSB issue as the bilayer is in large 
excess in comparison to specific receptors which are commonly present in 
femtomolar-nanomolar concentration, and often heterogeneously located in tissues 
(Please refer to chapter one for more details on NSB and references therein). 
One of the current techniques used to predict the degree of NSB of drug molecules in-
vitro is the measure of the lipophilicity of the molecules by using the octanol / water 
partition coefficient Log P [31]. This technique allows the determination of the 
likehood of a compound partitioning between a hydrophilic environment such as 
water or buffer and a hydrophobic environment such as octanol. Lipophilicity (Log 
P)oct-water of Central nervous system (CNS) drugs that exhibit low non-specific binding 
usually lies in the range of 1.5-3. An additional method that describes drug's 
developability is the Lipinsky's rule of five, where pharmaceutical compounds are 
likely to be successful when the molecular weight is smaller than 500 g . m o l L o g P 
is less than 5, and the molecules have less than 5 H bond donors and 10 H bonds 
acceptors [39]. 
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Although lipophilicity is known to increase the drug penetration within tissues such as 
the blood brain barrier (BBB), it is also known to increase the non-specific binding of 
the drug in-vivo [15]. This is principally observed using in-vivo methods such as 
positron emission tomography (PET), which shows that Log P is an imperfect 
predictor for the NSB in-vivo, as this phenomenon also depends on the affinity of the 
compounds towards the receptor, and the receptor concentration. The NSB 
phenomenon is poorly understood, and so far there are no available techniques that 
are able to predict it accurately from in-vitro to in-vivo studies. 
It has been largely reported that CADs have a high affinity for the bilayer interface 
[120, 157]. In addition, Lullman and coworkers highlighted a linear relationship 
existing between Log P and drug binding to bilayers made of phosphatidylcholine 
with hydrophobicity being the main driving force of such interactions [38]. Similarly, 
it has been observed that the increase in lipophilicity correlates with the increase of 
binding of CADs to membranes, this effect being dependent on the nature and 
structure of the CAD itself [125], 
As a matter of fact, correlations between the NSB in-vivo, the structure of the CADs 
and the rate of the bilayer hydrolysis by the CAD can be made. 
IV.3.2 Hydrolysis rates as parameters revealing the degree of 
NSB 
It has been discussed that the rate of hydrolysis is dependent on the nature and 
structure of the drug, with WAY degrading the bilayer quicker than SPIP and HPD. 
The ability of the CAD to transfer the proton necessary to the bilayer hydrolysis 
depends on the steric conformation of the drug. Surprisingly, the hydrolysis rates also 
correlate with the absolute in-vivo NSB distribution volumes obtained in-vivo from 
PET studies on humans. Drugs that trigger an elevated hydrolysis rate in DOPC 
bilayers also exhibit a low NSB degree in-vivo and vice versa. The parameters are 
summarized in table IV.4. 
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Drug LogP Ratio NSB / SB ki fimoLh"' 
WAY 3.69 13.83 7.67x10"^ 
SPIP 1.73 16&67 3.96x10^ 
HPD ++++[113] < 1x10"^ 
Table IV.4: Summary of hydrolysis rates, lipophilicity and NSB. 
These observations allow the understanding of NSB at a molecular level by the 
capacity of the CAD to digest the membrane system at different rates. 
A high degree of NSB is seen when the drugs do not trigger the acidic hydrolysis of 
the lipid chain, thus the molecules are trapped on the bilayer interface and are 
hindered from reaching their specific targets, and this is observed for HPD. However, 
when the rate of hydrolysis is high, there is little chance that the drugs stay at the 
interface as they are likely to be dissolved in membranous fragments that will carry 
them to other membrane interfaces, until they find their specific target (Figure IV.20). 
This is characterized by a low ratio of NSB over specific binding signal as seen for 
SPIP and WAY. Moreover, the rate of degradation is also in accordance with the 
specificity of the molecules, as it is seen for SPIP and WAY; WAY exhibits lower 
NSB than SPIP and degrades the bilayer faster. 
This correlation was also observed for raclopride, another CAD, where the hydrolysis 
rate was faster than that of WAY, and where the ratio of NSB / SB = 10.25 [185]. 
Interestingly, it has also been shown by Rosso and coworkers by computer modeling 
that a linear relationship exists between CADs electronic interactions and DOPC ester 
function [218]. The interactions were found to be less favorable for raclopride, 
followed by WAY and SPIP; this feature would allow the CADs residence to be 
shorter in the bilayer interface, which consequently will reduce the NSB signal. 
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Figure IV.20: Correlation between the bi layer hydrolysis and C A D s non-specif ic binding, (a) C A D s 
bind to the membrane interface and exhibit fast degradat ion rates. The fo rmed membranous f ragments 
and vesicles al low the C A D transportation until their specific site, (b) C A D s bind to the membrane 
interface but do not tr igger the lipid ester hydrolysis. Hence they are trapped in the bilayer and N S B is 
observed. 
At the moment, failure rate for useful radioligands is high due to the NSB. Analyzing 
the bilayer degradation rate by the CADs is a useful tool to predict the NSB in-vitro as 
this system takes into account the bilayer environment as well as its physicochemical 
properties. The degradation rates method is therefore more accurate than the 
lipophilicity measurements using the octanol / water partition coefficient protocol. As 
described earlier, lipophilicity measurements are used to predict the NSB of drugs in-
vivo, where octanol mimics biological membranes; this led to a huge discrepancy 
between in-vitro and in-vivo experiments. Model membranes are more similar to 
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biological membrane than octanol as phospholipids physical properties are present. 
Moreover, changing the lipid composition, i.e. changing the stored curvature elastic 
stress is possible using this method, which gives a better model for biological 
membranes (See chapter 5). 
This prediction would be very valuable for predicting the specificity of central 
nervous system drugs when binding in the brain, as these drugs have to cross the 
blood brain barrier and exhibit low non specific binding. 
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CHAPTER 5 
Modulation of the hydrolysis kinetics 
by membrane curvature elastic stress 
This chapter will investigate the effect of the membrane stored curvature elastic stress 
on the hydrolysis kinetics by three CADs: HPD, SPIP and WAY. Two pseudo binary 
systems with different stored curvature elastic stress will be considered from a least 
stressed system made of dilauroylphosphatidylcholine (DLPC), to a more stressed 
system made of different ratios of DOPC and dioleoylphosphatidylethanolamine 
(DOPE). Comparisons of hydrolysis rates will be considered for each drug. 
V.l Background 
A lipid bilayer is formed by two lipid monolayers that are forced to sit back to back so 
that the hydrocarbon chain are facing each other and the polar headgroups are 
oriented towards the aqueous medium such as the buffer; this effect being controlled 
by the hydrophobic effect. As it was explained in chapter one, lipids have intrinsic 
curvature that leads them to bend away (type I) or towards (type II) the water 
interface. When type I and type II lipids are present in the bilayer, they induce an 
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increased desire for monolayer curvature. As this desire can not be realised, the 
arrangement of phospholipids results in a frustrated structure that is locally flat. A 
curvature torque tension is then introduced in the bilayer that is forced to remain flat, 
which results in the storage of curvature elastic energy in the bilayer [79]. (Please 
refer to chapter one for more details on curvature elastic energy and references 
therein.) 
The addition of non bilayer lipids type I (LPC) or type II (DOPE) to a flat bilayer will 
also result in a change in the lateral pressure in the centre of the bilayer because of the 
collision between the hydrocarbon chains [67]. This effect may be an important factor 
in the modulation of the activity of many molecules such as proteins and enzymes like 
the phospholipase A2 in biological systems [219]. 
Many examples in the literature show the effect of lipid forces on biological systems 
and events. The binding of amphipathic molecules was found to be dependent on lipid 
packing as it was described for dystrophin, a cytoplasmic protein, with more binding 
affinity occurring when DOPE is added to DOPC bilayers [220]. It has also been 
reported that some protein activities were regulated by membrane curvature elastic 
stress. In processes such as vesicular transport and membrane trafficking, it was 
shown that amphipathic motifs of the golgi associated protein ArfGAPl were able to 
sense membrane curvature; this having an effect on trapping small vesicles in the 
golgi apparatus [221]. Moreover, it has been demonstrated that ArfGAPl which 
promotes the OTP hydrolysis involved in membrane budding was also sensitive to 
lipid packing and to positive curvature as the OTP hydrolysis decreases when the 
membrane is more positively curved [222]. The change in membrane curvature elastic 
stress is also involved in other processes such as membrane fusion [223]. Viral 
proteins were found to be activated preferentially by negative curvature, as it was 
shown for viral fusion peptides in the HIV, influenza, and leukaemia virus [224]. In 
addition it was demonstrated that the membrane curvature elastic stress increases the 
activation energy of insertion of transmembane a-helices in DOPC lipid bilayers; this 
was shown by adding the non-bilayer lipid DOPE to DOPC bilayers [225]. More 
importantly, it has been described that membrane curvature elastic stress alters the 
activation kinetics of membrane related enzymes. It has been reported that the 
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epithelial NaVH"^ exchanger (NHE3) system, which is responsible for the maintenance 
of osmotic pressure of the cell, is activated by positive curvature imposed by the 
membrane upon swelling. A positive deformation of the membrane by addition of 
LPC has reproduced a hypoosmolar activation of the NHE3 system [226]. The 
activity of another enzymatic system, the CTP (cytidine triphosphate): 
phosphocholine cytidyltransferase (CCT), an enzyme involved in the PC biosynthesis, 
was also reported to be dependent on the membrane composition [191]. It was 
determined that the CCT activity, which is modulated by the insertion of its 
amphipathic moiety in the lipid bilayer, is enhanced when the curvature elastic stress 
increases by adding more type 11 lipids to preformed bilayers. However, it was also 
described that the activity was drastically slowed down in the presence of type I 
lipids. 
As the effect of the membrane stored curvature elastic stress has been described to 
influence many biological systems and events, it is therefore supposed to also affect 
the kinetics in which the bilayer hydrolysis occurs in the presence of CADs. 
Therefore, adding DOPE to DOPC bilayers is expected to accelerate the hydrolysis 
kinetics, whereas, monitoring the hydrolysis in DLPC bilayers is expected to be 
slowed down in comparison to that of DOPC kinetics. 
V.2 Effects of systems with reduced curvature 
elastic stress on hydrolysis kinetics; DLPC bilayers 
V.2.1 DOPC vs. DLPC bilayers 
The membrane hydrolysis kinetics was monitored by using bilayers made of DLPC 
and compared to hydrolysis rates obtained with DOPC. DLPC lipids differ from 
DOPC in the length of their hydrocarbon chain and in the number of unstaurated 
carbons (Figure V.l). 
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Figure V . l : Comparison of DLPC (top) and DOPC (bottom) structure. 
Although DLPC and DOPC lipids form the fluid lamellar phase La at room 
temperature (Tm=-22°C [75] and -3°C [227] respectively), they both exhibit different 
spontaneous curvature. Because DOPC molecules contain an unsaturated double bond 
that allows the chains to splay, DOPC monolayers impart the desire of curvature 
toward the polar interface more than DLPC monolayers that contain no unsaturated 
double bond. Therefore, DOPC bilayers contain more stored curvature elastic stress 
than DLPC bilayers. This feature will also make the interface more accessible to the 
drugs in DOPC bilayers to that of DLPC bilayers. The number of carbons as well as 
unsaturations was already described as having an effect on the elasticity of bilayers, 
[171]. Therefore, bilayers made of DLPC exhibit lower stored curvature elastic stress 
in comparison to that of DOPC. 
V.2.2 Determination of the hydrolysis kinetics in DLPC: WAY 
and DLPC: HPD systems. 
The effect of reduced stored curvature elastic stress has already been described as 
lowering the CADs membrane-binding affinity and the reaction rates [149]. This was 
shown by static ^'P NMR on DLPC: HPD 4:1 and DLPC: SPIP 20:1 samples, where 
the detection of the isotropic peak corresponding to LPC micelles occurred with 
longer timescales with respect to DOPC systems. These measurements allowed the 
determination of the effect of the reduced stored curvature elastic stress; however 
accurate quantification of the hydrolysis rate could not be undertaken. Therefore, 
hydrolysis rates were determined from the degradation profile obtained from normal 
phase HPLC data as described in chapter 4. 
169 
Although it has been shown in the previous chapter that HPD has little impact on the 
hydrolysis kinetics of DOPC bilayer, the use of DLPC bilayers clearly shows that the 
kinetics are even slower in this system. 
Figure V.2 depicts the lipid degradation profile obtained from HPLC data for DOPC: 
HPD 20: and DLPC: HPD 20:1 samples. The lipid degradation rates ki DOPC HPD and 
ki DLPC HPD were calculated according to equation IV. 1 (see chapter 4) and yielded k, 
DOPC HPD = 1.52x10"^ ± 2.6x10"^ i^mol.h"^ andki D L P C H P D = 5X10"^ jimoLh '. The kinetic 
rate of degradation of DLPC bilayers is approximately 30 times slower than for 
DOPC bilayers. 
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Figure V.2: D O P C and D L P C hydrolysis profi le obtained by HPD. 
Similarly, measurements were undertaken on DLPC: WAY 20:1 systems. WAY is the 
CADs that exhibited the fastest kinetics in DOPC bilayers. The DLPC degradation 
profile compared to DOPC degradation profile is shown on Figure V.3. 
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Figure V.3: Compar ison of DOPC; W A Y and DLPC: W A Y 20: 
degradation profiles. 
Calculation of the degradation parameters led to k 1 DOPC WAY 8.28x10'^ ± 6x10" 
)Limol.h"' andki D L P C W A Y = 1.9X10"^ ± 7.85x10"^ lamol.h"'. The degradation kinetics is 
approximately 40 times slower in DLPC: WAY 20:1 than in DOPC: WAY 20:1 
systems. 
Degradation occurs in DLPC samples in a slower rate in comparison to DOPC 
samples; however, it was possible to detect the appearance of LPC in DLPC: WAY 
20:1 samples. Figure V.4 represents the appearance LPC with time in both DOPC and 
DLPC systems. Because it was not possible to calculate accurately k LPC from 
experimental data, only the initial rates were determined in DOPC and DLPC 
systems. 
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Figure V.4: Appearance of LPC in DOPC: W A Y and DLPC: WAY 20:1 systems. The initial 
rates were calculated from the slope of the tangent at t=0 (right). 
The initial rates of appearance of LPC in DOPC and DLPC systems are ko LPC = 
0.1136 )imol.h"' and ko LPC = 0.0028 |j,mol.h"' respectively. Although the kinetic rate is 
slower in DLPC bilayers, there are detectable amounts of LPC generated from the 
action from the CAD. The appearance of LPC is 40 times slower in DLPC systems 
than in DOPC systems. 
These experiments are of importance as they reveal that the hydrolysis is not only 
dependent on DOPC lipids, but also occurs in other PC lipids. In addition, these 
measurements have demonstrated that the kinetics of the bilayer hydrolysis is relative 
to the membrane stored curvature elastic energy, with the kinetics being 
approximately 30 to 40 times slower in membranes with reduced stored curvature 
elastic stress. DLPC bilayers exhibit more lateral pressure in the chain region than 
DOPC; and less packing frustration this is due to the lack of unstaurated carbons in 
these lipids. Also this has an impact on the interface accessibility for the drug as there 
is a strong hydrogen bonding at the headgroup [187]. These results strongly correlates 
with the results obtained with CCT binding to DMPC bilayers, where its activity was 
also found to decrease in DMPC bilayers with respect to DOPC [191]. 
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V.3 Effects of systems with increased curvature 
elastic stress; DOPC: DOPE systems. 
V.3.1 DOPC: DOPE systems 
DOPE is a non bilayer lipid that has the propensity to undergo La to Hn transition 
[228]. This inverted cone-shaped lipid has a curved interface that arises from the 
lateral pressure distribution in the chain region and the relatively small headgroup 
volume. DOPE lipids were extensively studied and used as a model to investigate the 
effects of solutes and other lipids on the change of mesophases and destabilization of 
biological membranes [229]. 
The effect of stored curvature elastic stress was widely described in the literature by 
using PC; PE model membranes. The mixed DOPC: DOPE system provides a well 
characterized environment in which the monolayer curvature and the lipid lateral 
pressure can be controlled. In such systems, the stored curvature elastic stress arises 
from DOPE lipids, where the pressure in the hydrocarbon chain region, the presence 
of unsaturated carbons, and the reduced hydrophilicity of the PE headgroup tend to 
curve the bilayer towards the aqueous phase [67]. Addition of DOPE lipids in DOPC 
bilayers causes a redistribution of the lateral pressure across the bilayer, and an 
increase in the pressure exerted by the lipid chains [228]. This was previously 
measured by using di-pyrenyl PC fluorescent probes [230]. Addition of DOPE in 
DOPC bilayers spreads the lipids apart; this results in a more favourable environment 
for the intercalation of molecules such as CADs in the interfacial region. The physical 
forces described above were shown to drive the La - Hji phase transition in DOPC: 
DOPE systems under various conditions such as variation of temperature, hydration, 
and the molar ratio of DOPC to DOPE [231]. 
DOPC:DOPE systems were used as model systems to quantify the effect of stored 
curvature elastic stress on proteins activities, such as bacteriorhodopsin [232], 
mutlidrug transporters [233] and CCT [191]. Activities were found enhanced or 
reduced according to the proportion of DOPE found in the bilayer. As the hydrolysis 
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kinetics was found to slow down in reduced stored curvature elastic stress systems, it 
is therefore expected that addition of DOPE will increase the bilayer hydrolysis by the 
CAD. 
V.3.2 Effects of DOPE on the hydrolysis kinetics 
Variation of the stored curvature elastic stress was undertaken by using increasing 
DOPE molar fractions in DOPC: DOPE systems, from 0 to 0.4. The experimental 
conditions in which the measurements are made do not allow the La- Hj, phase 
transition and only the La phase is predominant [234]. Thus, measurements were only 
made in the La phase. In addition, the homogeneity of such systems has already been 
studied by X-ray diffraction and polarizing microscopy, where DOPC:DOPE at these 
ratios form the La phase at neutral pH [67, 235]. Therefore, this is also applicable to 
the lipid: drug systems described above. Hydrolysis kinetics of DOPC: DOPE bilayers 
by two CADs (SPIP and WAY) were measured a 20:1 total lipid: drug molar ratio. 
Measurements of the disappearance of the lipids and appearance of the products were 
undertaken by normal phase HPLC as described previously, by considering the total 
number of moles of lipids DOPC and DOPE (DOPE elutes at 10.1 min) and product 
LPC+LPE (LPE elutes at 20.5 min). The production of OA comes from both DOPC 
and DOPE as these two lipids share the same fatty acid chain. 
The effect of increasing DOPE molar content on the total lipid disappearance in the 
presence of WAY and SPIP is shown on figure V.5. The disappearance of the lipids 
follows an exponential decay, as shown previously for pure DOPC bilayers. When 
DOPE is present, the rate of hydrolysis is altered in comparison to that of pure DOPC. 
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Figure V.5: Effect of various DOPC: DOPE molar ratio on 
bilayer hydrolysis kinetics by WAY (a) and SPIP (b). 
Fitting the disappearance of total lipids DOPC: DOPE in the presence of WAY and 
SPIP yielded to hydrolysis rates that are summarized in table V. 1. 
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ki (|j,mol.h"') 
SPIP WAY 
1 DOPC: 0 DOPE 3.18x10"'±4.1x10"^ 5.58x10" ±2.0x10"^ 
0.9 DOPC: 0.1 DOPE 3.05x10"'±3.8x10"^ 5.46xl0-"±3.8xl0"' 
0.8 DOPC: 0.2 DOPE 5.09x10" ±2.0x10"^ 8.05 xl0-"± 3.8x10"* 
0.7 DOPC: 0.3 DOPE 7.99x10" ±5.8x10"^ 7.73x10'" ±2.6x10"* 
0.6 DOPC: 0.4 DOPE 7.15x10'" ±2.7x10"* 9.21 xlO-"± 3.1x10"* 
Table V . l : Hydrolysis rates in DOPC; DOPE systems in presence of WAY and SPIP. 
The hydrolysis rate is clearly affected by the presence of DOPE i.e. by the increase in 
the stored curvature elastic stress in both WAY and SPIP systems. The hydrolysis rate 
is approximately twice as fast in DOPE systems that exhibit the highest stored 
curvature elastic stress, i.e. 0.6 DOPC: 0.4 DOPE in the presence of both of the drugs. 
Variations of hydrolysis rates as a function of DOPE molar fraction are represented 
on figure V.6. 
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Figure V.6: Hydrolysis rates as a function of DOPE mol fractions in 
the membrane. 
Although WAY and SPIP exhibit different absolute hydrolysis rates with respect to 
varying DOPE molar fractions they both rise with increasing DOPE molar fractions; a 
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similar profile has been observed for other systems, including the insertion of peptide 
assemblies such as CCT into DOPCiDOPE bilayers [225] (Figure V.7). 
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Figure V.7: Activity of CCT as a function of the 
molar fraction of DOPC (Figure adapted from 
reference [191]) 
The increase in hydrolysis rate from 0.1 to 0.4 DOPE molar ratios is a result of 
increased CAD binding at the interface. This is due to the decrease in the repulsion at 
the interfacial region and the increase in the hydrocarbon chain pressure [232]. The 
variation in chain pressure with increasing DOPE has been extensively studied using 
dipyrenyl lipids where the ratio of excimer to monomer fluorescence (E / M) is related 
to the measure of the lateral chain pressure. Overall, the E / M ratio was observed to 
increase monotonically with increasing DOPE concentration in model DOPC / DOPE 
bilayers (Figure V.8) which correlates with the variation in hydrolysis rates in these 
experiments. 
177 
w 
0.66-
0.64-
Mole Fraction of PE 
Figure V .8: Effect of DOPE molar fraction on the excimer to 
monomer ratio of dipyrenyl lipids in DOPC: DOPE bilayer. 
The increase of E / Ml ratio is due to the increase in the chain 
pressure in the centre of the bilayer (Figure taken f rom 
reference [232]). 
A maximum rate of hydrolysis occurs with SPIP at 0.3 DOPE molar ratios followed 
by a minor decrease in the hydrolysis rate at 0.4 DOPE molar ratio. This might be a 
result of accumulation of type I LPC-LPE monomers produced from the hydrolysis 
that accumulate into the bilayer. Addition of type I molecules to a membrane 
containing type II molecules reduces the desire for curvature towards the aqueous 
exterior; this effect has also been ascribed to the lower the binding affinity and 
acitivity of amphipatic molecules such as CCT [191]. The evolution of WAY kinetics 
shares the same profile, with the rate increasing considerably from 0 to 0.2 DOPE 
molar fractions, and slightly decreasing at 0.3 DOPE molar fractions. 
Monitoring the bilayer hydrolysis in DOPC: DOPE samples is complex as six species, 
namely the CAD, DOPC, DOPE, LPC, LPE and OA are present. When more LPC / 
LPE is produced, the bilayer is also enriched in OA; this will result in a alteration in 
the stored curvature elastic stress with DOPC, DOPE, LPC, LPE and OA being 
present in the system. 
The bilayer mesophase is uncertain at this stage of the measurements. Even if the 
DOPC:DOPE molar ratio at which the experiments are done do not allow the 
formation of the Hn phase, these do not take into account the accumulation of fatty 
acid and type I molecules that result from the bilayer breakage. It would be important 
to perform complementary measurements to map the bilayer state with time by using 
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SAXS and SS-NMR at the DOPC: DOPE: CAD ratios examined above. In addition, it 
would be interesting to increase the DOPE molar fraction up to 0.6 to evaluate the 
evolution of the kinetic rate. However, the rate is expected to considerably decrease in 
the Hn phase as the interface accessibility might be hindered and thus the hydrolysis 
rate would be affected. 
V.3.3 DOPC and DOPE relative degradation rates 
DOPC and DOPE relative degradation rates in DOPC:WAY 20:1 samples were 
calculated and analysed by considering the number of moles of DOPC and DOPE 
lipids separately using the HPLC data. The disappearance DOPE and DOPC lipids as 
a function of DOPE follows an exponential decay, as shown in total lipids samples 
(Figure V.9). 
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Figure V.9: Effect of various DOPC: DOPE molar ratio on 
DOPE (a) and DOPC (b) hydrolysis kinetics by WAY. 
Although DOPC and DOPE exhibit different absolute hydrolysis rates with respect to 
varying DOPE molar fractions they both rise with increasing DOPE molar fractions; 
as observed in the previous section. Variations of hydrolysis rates as a function of 
DOPE molar fraction are represented on figure V.IO. 
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samples. 
Interestingly, the rate of disappearance of DOPC is found to be the same as DOPE at 
the same DOPE molar fraction (Table V.2). This implies that the accessability and the 
proton affinity of the DOPC and DOPE carbonyl are the same. 
ki DOPC (^mol.h"') ki DOPE (iimol.h"') 
1 DOPC: 0 DOPE 5.99x10'^ ±4.00x10"* NA 
0.9 DOPC: 0.1 DOPE 3.58x10"" ±6.80x10"* 5.89x10'^ i 1.59x10'^ 
0.8 DOPC: 0.2 DOPE 6.23 xlO'^i 8.60x10"* 6.54x10'" ±2.14x10"' 
0.7 DOPC: 0.3 DOPE 6.19x10'^ ±5.30x10"* 6.97 xlO"'± 1.50x10"' 
0.6 DOPC: 0.4 DOPE 9.42 xlO'^i 1.02x10"' 8.75 xlO"'± 1.35x10'" 
Table V.2: DOPC and DOPE relative hydrolysis rates in DOPC: DOPE: WAY 20:1 samples. 
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V.4 Summary 
This section has described the effect of stored curvature elastic stress on the kinetics 
of the bilayer hydrolysis by the CADs. The binding and partitioning of the CADs are 
particularly affected by the stored curvature elastic energy. Low binding affinity and 
hydrolysis rate are observed for reduced stored curvature elastic stress bilayers such 
as DLPC, whereas partitioning and hydrolysis are clearly enhanced when the stored 
curvature elastic stress increases in DOPC, and DOPC:DOPE bilayers. Increasing 
DOPE molar ratios was found to considerably increase the hydrolysis rate in both 
CADs systems investigated. 
Hydrolysis rate are monotonically increasing as a function of DOPE molar ratios^ 
however, it is expected that the rate is decelerated when the formation of the Hn phase 
occurs from the accumulation of fatty acid in the bilayer. 
When CADs bind to the bilayer interface, they trigger the release of stored curvature 
elastic stress which allows the lipid chain to splay and therefore a better CAD-ester 
bond interaction. This feature will enable the hydrolysis to occur at higher rates. 
Interestingly, and this is to confirm the results obtained in chapter 4, the specificity of 
the CADs remains similar to that in puie DOPC systems, with WAY hydrolysing the 
bilayer as twice as fast as SPIP. 
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CHAPTER 6 
Conclusions and future work 
This thesis has presented original work undertaken on CNS drugs belonging to the 
CAD family, and their interactions with membrane bilayers. 
Using small angle X-ray scattering, NMR, fluorescence microscopy and HPLC, it has 
been observed that CADs rapidly partition to the polar / apolar interface of the 
membrane initiating acid catalysed ester hydrolysis of the phospholipid fabric in the 
membrane. This generates LPC species which destabilize the bilayer and induce 
membrane fragments and vesicles that carry the CADs with them. This previously 
unreported mechanism contributes to a novel drug translocation mecahnism across 
membranes. 
The rate at which this process occurs was found to be influenced by the chemistry of 
CAD molecule, and the mechanical state of the membrane. 
Furthermore, the rate of membrane hydrolysis appears to correlate with in-vivo non-
specific binding distribution volumes of the PET radioligands, where specific 
radioligands exhibit fast degradation rates. This allows the molecule to be transported 
to its specific site. Conversely, poor radioligands exhibit slow degradation kinetics, 
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which leave the molecule at the bilayer interface. This results in the detection of non-
specific binding. Therefore, in the future kinetic analysis of the membrane hydrolysis 
phenomena may provide additional mechanistic insight to the prediction of the non-
specific binding and the design of radiolabelled probes for in-vivo receptor imaging 
using PET and allied in- vivo imaging techniques. 
The discovery of the CAD activated lipid hydrolysis is crucial to the understanding of 
CAD interactions with membranes, and opens a new area in cell membrane research. 
The immediate step to this work is to pursue CAD interactions with membranes, by 
testing more CAD structures. An important aspect to investigate in this research is the 
design and syntheses of molecules which will either enhance or prevent the reaction; 
this will allow a better understanding of the molecules chemical structures that are 
able to trigger the reaction. 
A more complex lipid composition involving phosphatidylserine lipids and 
cholesterol will be considered. This will enable to obtain a lipid composition closer to 
biological plasma membranes. Detection of the hydrolysis reaction is also relevant in 
cell plasma membranes, which also contain embedded receptors. Receptors contain 
binding sites where CADs can bind to. Therefore, the hydrolysis rate might be altered 
as CADs bind to the membrane and to receptors. 
Another aspect to consider in this research is the syntheses of molecules which will 
either enhance or prevent the reaction; this will allow a better understanding of the 
molecules chemical structures that are able to trigger the reaction. Ultimately, 
evaluation of these molecules in-vivo by using PET will provide a more precise 
correlation between lipid ester hydrolysis rate in-vitro, and binding in-vivo. Therefore, 
the detection and measurement of the bilayer hydrolysis may be an accurate test for 
radioligand selection in-vitro. 
These observations form interesting lines of enquiry into related areas of membrane 
biology research, and drug design, and raise questions in relation to the non-specific 
binding: Does the membrane hydrolysis contribute to the BBB? Crossing? What 
governs the specific entry of CADs in the brain? 
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In another related area, studying CAD interactions with plasma cell membranes and 
identifying the hydrolysis products is also significant, in particular in relation to 
phospholipidosis cytotoxic effects in-vivo. This might enable or address issues such as 
how CADs activate the synthesis of more lipids upon binding. In other words, is 
phospholipidosis related to a variation of the stored curvature elastic stress upon 
binding? 
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